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The field of nanotechnology has given rise to advancements that continue to positively
impact our quality of life in a variety of different ways, in none more so than in the fields
of healthcare and medicine. Recent years have seen significant research effort into the de-
velopment of new techniques and materials, with the aim to form the basis of diagnostic
and therapeutic strategies in order to treat disease and injury more efficiently and effec-
tively. This has already resulted in a number of different ’nanomedicines’ approved for
prescription and use in products both in Australia and abroad, with an increasing number
undergoing clinical trials each year. Such agents have been tailored on the nano-scale to
possess superior qualities than their ’bulk’ counterparts, whether it be through improved
targeting, selectivity, or efficiency in order to improve patient outcomes. One such exam-
ple, one which as Australians has significant importance to us, is the use of metal oxide
nanoparticles within topical sunscreen and cosmetic products in order to reduce our ex-
posure to ultraviolet light and hence minimise the risk of developing skin cancers and the
other negative consequences of this exposure, such as skin aging and immunosuppres-
sion. Currently, ZnO and TiO2 nanoparticles are used in this application, due to their low
cost and optical properties, which are superior to their microsized counterparts. Some of
nanoparticles have the potential to act as potent photocatalysts and have shown to have the
capacity to degrade the other organic components of the sunscreen formulations, decreas-
ing their efficiency. There has been a plethora of studies which suggest that such particles
are not able to penetrate through the upper layer of skin to reach the underlying viable
skin cells, but inconsistencies in some of these results, small sample sizes, and many not
investigating the influence of ultraviolet light still poses some questions. As such, there
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has been some research interest into the investigation of alternatives metal oxide nanopar-
ticles with similar efficiency of UV-absorption with complementary properties. Given
that free radicals have consequence to some of the organic photochemistry resulting from
organic ultraviolet filters decomposing, nanoparticles with free radical scavenging proper-
ties with high ultraviolet absorption such as CeO2 have been proposed in the past. These
nanoparticles with free radical scavenging properties have also been proposed as the ba-
sis of therapeutic agents, as free radicals play important functions within human health.
Exposure to ionising radiation, drugs, environmental contaminants can result in a state of
increased free radical species, and if this is more than the body is able to neutralise with
antioxidants, this is known as oxidative stress. Oxidative stress phenomena also plays a
role in a large number of diseases including cancers, neurodegenerative diseases, autoim-
mune diseases, liver disease as well as in spinal chord injury. As such, these nanomaterials
have the potential to be multifunctional, in the context of providing ultraviolet protection
as well as protection from oxidative stress. In this thesis work, we investigate a number
of iron oxide-based nanomaterials targeted toward application in these two areas.
Firstly we investigated the toxicity of a number of hematite nanoparticles on the Madin-
Darby Canine Kidney (MDCK) cell line. These nanomaterials were synthesised through
two different methods and annealing conditions, spray precipitation and precipitation, and
resulted in particles with rod-like and spherical morphology, featuring different particle
sizes, surface features, and magnetic properties. Through flow cytometry it was found
that particle morphology heavily influences the degree to which the nanomaterials are in-
ternalised into the cells. It was also found that the ability of the nanoparticles to generate
free radicals species is hindered by the formation of tetrahedrally coordinated maghemite-
like (γ-Fe2O3) spinel defects on the surfaces of the particles. The combination of these
two factors resulted in variable cytotoxic effects of the hematite nanoparticles synthe-
sized with different conditions. This study highlighted the importance on the fabrication
method, materials properties, and surface characteristics on the cytotoxicity of hematite
nanomaterials and showed the potential tailorable nature of the free radical scavenging
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behaviour of such particles.
The next work within this thesis builds on the concept of combined free radical scav-
enging nanoparticles with high UV absorption, in the form of Fe2O3/CeO2 composite
nanoparticles for application as multifunctional ultraviolet (UV) filters. By precipitat-
ing ultra-small ceria (CeO2) nanoparticles (2.5-4.7 nm) onto the surface of much larger
(∼50 nm) hematite nanoparticles results in a synergistic combination of their properties,
resulting in stronger and more selective absorption in the UV region. These hematite
nanoparticles also have free radical scavenging properties due to the ceria nanoparticles,
as they are able to hinder the degradation of crystal violet by P25 through the scavenging
of photogenerated OH· radicals by half.
The final body of work investigated the application of hematite (α-Fe2O3) nanoparti-
cles encapsulated in poly(lactic acid) (PLA) microspheres as a ultraviolet filter in cosmetic
and sunscreen products. Hematite has been proposed in the past due to it’s strong absorp-
tion in the ultraviolet, but it’s efficacy has been limited by it’s colour. Encapsulation in
PLA however, results in a nanocomposite with increased UV attenuation, increased dis-
persibility and high biocompatibility in vitro. These nanocomposites were used to prepare
sunscreen emulsions and tested for their SPF rating and stability, using two different spec-
troscopic methods. Both indicate that these materials provide similar high UV protection,
coupled with lower photocatalytic activity compared to commercial ZnO nanoparticles,
and the encapsulation of metal oxide nanoparticles by PLA could provide a route for
improving their efficacy for use in this application.
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1.1.1 Nanobiotechnology: Nanotechnology for Biomedical and Health
Care Applications
Nanotechnology is a multi-disciplinary field at the intersection of chemistry, physics, ma-
terials engineering and biology which concerns itself with the manipulation and charac-
terisation of materials at the nanoscale. The prefix ”nano” means ”one billionth”, and as
such, one nanometer is equal to around 1 × 10−9 m or one billionth of a meter. Nanoma-
terials are objects, synthetic or found naturally, where at least one dimension is between
1-100 nm (nanometers) in size [1] (Figure 1.1). This is of interest to researchers because
in this size range, different forces have more influence of the behaviour of material at
this length scale compared to macroscopic objects. Furthermore, new or unique mag-
netic, electronic, optical and chemical properties [2] can emerge in materials compared
to their ’bulk’ (larger than a few hundred nanometers) counterparts. Another important
feature of nanomaterials is that a greater proportion of the material is present as surface
molecules, relative to their larger counterparts, meaning there is a greater interface be-
tween the surface of these particles and other molecules. As an example, a given mass
of 10 nm diameter particles will have 100× the surface area of the same mass of 1 µm
particles, assuming they share the same density. Material of this nature are synthesised
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using either a ’top-down’ approaches, which begins with bulk material and uses various
techniques such as lithography or milling processes to create materials with size features
in the nanoscale. The other is the ’bottom-up’ approach, which starts with raw chemi-
cals and involves their self-assembly into particles or structures with nanoscale features,
utilising controlled synthesis parameters, usually in the liquid or vapour phase. In materi-
als engineering, a composite is a material with two or more distinct phases or constituents
with differing chemical or physical properties, which are combined in a complex architec-
ture. This can result in final composite material with superior or altered properties com-
pared the to the two constituents separately [3]. Such materials are widely used within
a variety of engineering applications, with the most common examples being concrete,
carbon fibre-reinforced plastics, metal composites and ceramic composites. As such, a
nanocomposite material follows this same strategy in creating novel materials with en-
hanced properties, but with its final dimensions being in the nanoscale.
While the tools and novel materials developed by nanotechnology have been applied
to diverse range of fields within science and engineering including electronics, renew-
able energy, textiles, food and agriculture, industry and the environment, possibly the
most impressive are the potential impact of nanomaterials on biomedical and health care
applications. This has caused the development of an entirely different sub-field within
nanotechnology, known as nanobiotechnology, which studies the intersection of biology
and nanotechnology and investigates the application novel nanomaterials and nanocom-
posites to improve patient outcomes for existing therapies. This field has also seen the
emergence of creating therapies previous not possible with established treatment options
[4]. At the nanoscale (1-100 nm) such objects are in the same size range as membrane re-
ceptors, proteins, nucleic acids, and other biomolecules, and as such can diffuse through
cellular lipid membranes to be internalised within cells through endocytosis or phago-
cytosis and interact directly with these biological structures. Their small size and high
surface-to-volume ratio also means that they are more stable and dispersible than their
micro or mesoscale counterparts, as well as able to be conjugated with a large number
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of targeting agents or drugs on the surface of the nanoparticle. Furthermore, the unique
properties that can emerge in nanomaterials can also result in novel applications within
healthcare and medicine such as superparamagnetism [5], free radical scavenging [6], and
anti-bacterial activity [7].
The unique properties that can emerge from nanomaterials can potentially provide new
diagnostic and therapeutic tools for the diagnosis and treatment of a variety of diseases,
with plasmonic and fluorescent nanoparticles currently being investigated as biological
probes for the detection of pathogens [8] and proteins [9], as well as cell labelling agents
[10]. Magnetic nanoparticles have been proposed for use in hyperthermia treatment [11]
to destroy tumours from this inside, magnetic drug/gene delivery platforms [12] and con-
trast agents for Magnetic Resonance Imaging (MRI) [13]. Antibacterial nanoparticles
have been incorporated into clothing and wound dressing in order to minimise the risk
of infections and improve patient recovery post-surgery or injury [14]. The use of bio-
compatible polymer and ceramic materials has also seen recent advancement in the areas
of bone regeneration, tissue engineering and dental implants [15]. Nanoparticles them-
selves also have the potential to have some therapeutic effect, with free radical scaveng-
ing nanoparticles promising to treat the free radical associated oxidative stress associated
with many different diseases and injuries [16]. High ultraviolet absorbing nanoparticles
are also currently used within sunscreens and cosmetic products, in order to increase the
Sun Protection Factor of these products relative to their larger, micro-sized form [17].
(a) (b) (c)
Figure 1.1: Transmission electron micrographs of a number of nanomaterials with potential
biomedical applications; (a) carbon nanorods, (b) n-oleylamine coated-iron oxide nanoparticles
[18], (c) gold nanorods [19].
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As in the case with many new and emerging technologies, they can have unseen conse-
quences and these same properties of nanomaterials that make them great for application
within medicine and consumer products (small size, high surface-to-volume ratio) can
also result in them unpredictable and undesirable effects within the body and environ-
ment respectively.
1.1.2 Impacts of Nanotechnology on Human Health and the Environ-
ment
The increasing prevalence of nanomaterials within skincare and consumer and health-
care products, electronic products, biotechnology, engineering products, pharmaceuticals,
drug delivery, food and agriculture; they are beginning to be used and produced in larger,
industrial quantities. As such, accidental and occupational exposure along with uninten-
tional release into the environment are all inevitable, either through the atmosphere, as
solid waste, or in wastewater run-off. They can then find themselves contaminating soil
and ground water, and/or end up in wastewater streams to end up in aquatic environ-
ments. There has been significant research effort in order to understand the unintended
effects and consequences of these nanomaterials both on human health and within the
environment, a field of study known as nanotoxicology. It’s been observed in a number
of studies that the localisation of large concentrations of nanomaterials, which are more
persistent in the liquid phase and less likely to sediment like larger particles, are able to
cause many alterations to organisms in their fertility [20], behaviour [21], physiology [22]
and mortality rates [23]. In the same way that heavy metals and radioactive isotopes can
undergo bioaccumulation, nanomaterials able to persist within these organisms could be
transferred to species higher within the food chain [24].
There are a number of ways in which nanoparticles can enter the human body upon
exposure, including through the skin, eyes, respiratory system and gastrointestinal system
[27] (Figure 1.2). Exposure through inhalation is the easiest route of exposure of air-
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Figure 1.2: The demonstrated (solid lines) and hypothetical (dashed lines) translocation routes
of nanomaterials within the human body [25] (Modified and reprinted from [26]).
borne engineered nanoparticles, especially in industrial and occupational exposure. Be-
tween the functional pathways of the trachea, bronchi and bronchioles and the alveoli
gas exchange pathways, adult human lungs have a total area between 75-140 m2, and
engineered nanoparticles can be localised within different regions depending on particle
size. The size and solubility of these particles within the lung membrane mucus can then
influence whether they are absorbed into the blood or cleared through macrophage phago-
cytosis [28]. Given the increasing use of nanoparticles within agriculture and health care
products, exposure through accidental ingestion is also another potential route. The pH
variance within the gastrointestinal tract can affect the aggregation state, as well poten-
tially dissolve the material in question, resulting in the release of toxic ions. The particles
may pass through the intestinal walls via endocytosis, a multistep process with a number
of different mechanisms, with smaller particles more readily absorbed into the blood-
stream [29]. The skin is the largest organ in the body, providing a barrier between our
body and the environment, with its outermost layer comprised of dead skin cells known
as the stratum corneum. This is followed by the stratum lucidum, stratum granulosum,
stratum spinosum and stratum basal, all of which comprise the epidermis which is above
the dermis, the layer of skin between subcutaneous tissues and epidermis. While the stra-
tum corneum and epidermis provide a barrier against infection and pathogens, it’s still
possible for nanoparticles to permeate through these thick barrier layers into the body.
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This is most likely through two possible routes, either the intercellular route by follow-
ing lip channels between the cells in the stratum corneum through to viable skin cells, or
through appendages such as hair follicles and sweat glands. Much like the other routes of
exposure, the potential for nanoparticles to be internalised through this route is a complex
one, that is heavily dependent on the size, shape, and surface properties of the particles, as
well as the nature and integrity of the person’s skin [30]. Once these nanoparticles have
entered the body through these routes, they can then potentially be localised and accu-
mulate in more sensitive biological tissues as nanoparticles with a diameter ≤70 nm are
able to evade clearance by the body’s immune system. These include the central nervous
system (20-50 nm diameter), brain, liver, kidneys and lymph nodes, among others. These
nanomaterials can then cause a number of deleterious effects on these tissues through
a number of different mechanisms, including the generation of harmful and chemically
aggressive reactive oxygen species (ROS) [31].
1.1.3 Suppression and Prevention of Oxidative Stress
Molecular oxygen (O2) is the primary molecule in cellular respiration for all organisms
living in aerobic conditions, allowing for the evolution of complex organisms follow-
ing increases in oxygen in the earth’s atmosphere 2.5 billion years ago [32]. Oxygen is
responsible for the efficient product of energy from the electron transport chain within
the mitochondria of eukaryotic cells and cellular membranes of bacteria [33]. Despite
the need for O2 to support life, there are several oxygen derived species that are highly
toxic to living cells and these include reactive oxygen species (ROS), reactive oxygen
intermediates (ROI) and reactive nitrogen species (RNS) [34]. These are highly reactive,
chemically-aggressive species able to cause oxidative damage to cellular components in-
cluding DNA, proteins and fatty acids, among others. Generally, any chemical species
able to accept electrons is an oxidant or oxidising agent, while any able to donate elec-
trons is a reductant or a reducing agent according to the definitions of redox chemistry,
with ROS; ROI and RNS falling into the former category. These terms are often used in-
terchangeably depending on the type of species being referred to, with some defining two
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sub-categories of ROS; radical species and non-radical oxygen derivatives (Table 1.1).


















Others define ROI as products of the incomplete reduction of chemical oxygen, with
ROS including ROI and other derived species such as O3 and 1O2 [35]. Regardless, the
chemical property that constitutes a free-radical chemical species and owes to its highly
reactive nature is the presence of an unpaired electron, which is shown in the chemical
formula through a superscript ”·”, one example being hydroxyl radicals (OH·). The elec-
tronic configuration of several free radical species can be seen in Figure 1.3, with the dif-
ferent coloured dots highlighting the oxygen electrons (blue), hydrogen electrons (grey)
and unpaired electrons (red). Many of the non-radical species listed below, while not
featuring an unpaired electron, are still prone to be highly reactive. Technically ground-
state oxygen (O2) is a biradical species, with 2 unpaired electrons in different π∗ orbitals.
It is not however, a reactive radical due to spin restriction, meaning it must accept two
electrons with the same spin from a single reductant in order to engage in redox reactions
(Figure 1.5), meaning it can’t readily oxidise biomolecules on its own. It can however,
readily react with other radical species by single-electron transfer (Figure 1.4) resulting
in a significant variety of radical species [34].
This highly reactive nature also means that many of these species are short-lived, with
OH· having a lifetime of only 10−10 s in biological systems. While the oxygen derived
species can have much longer half-lifts even in biological media, factors such as pH and
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Figure 1.3: Electronic structures of some common reactive oxygen species, with the red dots
representing unpaired electrons [36].
presence of other species can greatly affect this. As such, organisms must balance the
level of intracellular oxidant species in the form of ROS, RNS and ROI, and the balance
between oxidants and reductants within biological systems is tightly controlled. Tipping
the redox balance in a biological system in the favour of pro-oxidants, or the organism
having more oxidants that it’s effectively able to neutralise with anti-oxidants, is a state
known as oxidative stress (OS). The inverse can also be true, with increasing this redox
balance in the favour of reductants leading to reductive stress [34].
Another important reaction concerning free radical species and oxygen derived species,
is their interaction with transition metals. An interaction between Fe2+ and H2O2 was
first observed by Fenton in 1894 [39], but it was 40 years later that Haber and Weiss
[40] showed that this oxidising behaviour was found to be the result of the it’s decom-
position into OH· catalysed by the iron. The resulting reactions are known as the Fenton
(Equation 1.1) and Haber-Weiss (Equation 1.3) reactions, with the Fenton reaction and
reaction 1.2 resulting in the overall Haber-Weiss reaction. The example here is iron, due
to its prevalence in biological systems, but most d-block transition metals would be able
to engage in these reactions. The net effect is the decomposition of superoxide and hydro-
gen peroxide into ground state oxygen, hydroxyl radicals and hydroxide anion, a process
Figure 1.4: Formation of a number of ROS from molecular oxygen, through energy and electron
transfer reactions from Krumova et al. 2016 [37], adapted from Imlay et al. 2003 [38].
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Figure 1.5: Electronic structures of some common reactive oxygen species, with the red dots
representing unpaired electrons [36].
which results in the oxidation and subsequent reduction of the metal species, meaning the
reaction can be effectively catalysed indefinitely under the appropriate conditions.
Given the extremely reactive nature of these free radical species and their interaction
with biomolecules, oxidative stress is involved in the pathology of many differing diseases
and injuries, covered in the next section of this chapter.
Fe+2 +H2O2 −→ Fe+2 +OH·+OH− (1.1)
O·−2 +Fe
+3 −→ O2 +Fe2+ (1.2)
O·−2 +H2O2 −→ O2 +OH
·+OH− (1.3)
Oxidative Stress in Injury and Disease
Elevated levels of ROS within biological system, resulting in oxidative stress, have been
implicated in the initiation and pathology of over 200 diseases reported in literature [34]
(Table 1.2). While these species are naturally occurring and play essential roles in normal
biological process, their high reactivity can mean they can also attack sensitive biological
components, with the three most vulnerable being lipids, enzymes and DNA [41, 42]. This
oxidative damage can result in impaired or altered function of these components [43], and
hence the cell as a whole, contributing to the initiation and/or progression of these dis-
eases. One important cell process which is directly controlled by ROS is apoptosis, also
known as programmed cell death. It’s a naturally occurring process that is essential for a
multicellular organism to maintain normal development on the tissue level, as its function
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is to remove damaged or infected cells. This cell death pathway differs from necrosis in
that apoptosis usually occurs in a group of cells resulting from damaged cell membrane
integrity, where apoptosis usually occurs on a cellular level [44]. The functional (ataxia)
and sensory (dementia) loss [45] resulting from this ROS and RNS-induced cell death
[46] plays a significant role in the progression of a number of neurodegenerative diseases
[42, 47–49], with accumulated Fenton chemistry (Equation 1.1 & Equation 1.3) of metal
cations (Fe+2, Cu+2, Zn2+) has been heavily implicated in this process. Elevated levels
of ROS, RNS and sustained periods of oxidative stress play a role in each of the different
stages of carcinogenesis: (1) Initiation; (2) Promotion and (3) Progression. Oxidative
damage to DNA by free radical species such as OH·can result in genetic mutations, which
play a role in the initiation of cancer [50]. Furthermore, ROS and RNS species can also
damage the DNA repair system, and are involved in cell signalling pathways, both which
can further increase the risk of the progression of a malignant tumour. It was also though,
since first proposed in 1956 [51], that ROS and free radicals may have the greatest influ-
ence over the ageing process, which was known as the ”free radical theory of ageing.”
While for some time this was thought to be an all-encompassing theory in explaining the
ageing process, it’s involvement with a significant number of diseases means it certainly
can influence the lifespan of organisms [52, 53] but is not the sole factor.
Table 1.2: List of diseases in which ROS and oxidative stress play a significant role [54, 55].
Category Diseases
Neurodegenerative diseases Allergic encephalomyelitis, Alzheimers disease, Amyotrophic
lateral sclerosis (ALS), Huntington’s disease, Parkinson’s dis-
ease, Prion disease
Autoimmune disease Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid
arthritis, Vitiligo
Infectious diseases Hepatitis, HIV, Influenza Virus, Pneumonia
Cancers Bladder, Bowel, Breast Colorectal, Oesophageal, Kidney,
Leukaemia, Liver, Lung, Prostate, Skin
Liver disease Alcohol-induced, Hepatitis-C induced
Cardiac, blood vessel, CNS injury Atherosclerosis, Head Trauma, Ischemia, Spinal Cord Trauma,
Stroke
Genetic and metabolic disorders Chronic granulomatous disease, Diabetes, Down’s syndrome
Ophthalmologic conditions Cataract, Glaucoma
The induction of oxidative stress can also result from a range of sources (Figure 1.6)
both originating from within (endogenous) and from outside (exogenous) the cell or group
of cells in question. The mitochondrial, the powerhouse of the cell, is the main source of
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endogenous ROS, as O·−2 , H2O2 and OH
·can be created as a by-product of the electron
transport chain (ETC) [56, 57] that converts oxygen and nutrients to adenosine triphos-
phate (ATP), the energy unit used within cellular processes [58]. There are also certain
enzymes [59, 60] are also known to create ROS, and white blood cells generate ROS to
destroy bacteria and other pathogens invading the body through phagocytosis [61]. There
are also a significant number of exogenous sources of ROS and RNS, some of which we
are exposed to frequently in our daily lives. Air pollutants, such as cigarette smoke [62],
car exhaust fumes [63, 64] and industrial contaminants [65], along with medications [66],
including chemotherapeutic agents [67] can all result in increased levels of ROS in certain
tissues in the body. A large number of xenobiotic chemical species that organisms could
be exposed to also induce harmful levels of ROS and oxidative stress such as chlorinated
compounds, quinones [68], metal ions [69], phorbol esters [70], nitroaromatics [71] and
bipyridium herbicides. Radiation is another major source of pro-oxidant species, includ-
ing ionising radiation such as X-ray and γ-rays [72, 73], as well as ultraviolet radiation
(UVR, λ = 200 - 400 nm) [74, 75].
Figure 1.6: Overview of factors influencing oxidative balance within the body, and the implica-




Excessive concentrations of free radical species within the cytosol of cells within tissues
in the body can potentially be harmful to human health and are play a role in a host of
diseases and medical conditions [54, 55]. Similarly, the role they play within the cyto-
toxicity of many common nanomaterials also means there has been a significant research
effort into understanding the ways in which nanomaterials interact with biological compo-
nents in the context of free radical species. This has resulted in the discovery of inorganic
nanoparticles that both do not generate free radical species but neutralise or scavenge
excess free radical species from within biological environments in a catalytic capacity,
acting as a synthetic antioxidant-mimetic with similar activity to Superoxide Dismutase
(SOD) or Catalase [16]. Thus far, there are only a few inorganic materials that have had
this behaviour reported in literature, with nanoparticles of cerium dioxide (CeO2) being
the most well-known and well-characterised of these [76–79]. These nanoparticles dis-
play this behaviour because of size-induced oxygen deficiency on the surface of the parti-
cles, causing increased quantities of Ce3+ as the particle diameter decreases in the sub-20
nm range. The concentration of these Ce3+ states has directly been correlated to the ex-
tent of this free radical scavenging behaviour, as these result in oxygen deficiencies on the
surface, allowing the materials to engage in its well-known oxygen absorbing-desorbing
activities [6]. There are a number of proposed mechanisms for this activity, with the most
likely being the oxidation of the Ce3+ state to Ce4+ (Figure 1.7) [80], followed by re-
generation of the Ce3+ through a subsequent reaction resulting in the neutralisation of a




Figure 1.7: Two different explanations for mechanism of action of antioxidant-mimetic ROS
scavenging activity of CeO2 nanoparticles of (a) OH· [81] and (b) O·−2 [80] radicals.
Yttrium oxide nanoparticles (Y2O3) have also been reported to display similar activ-
ity, showing the ability to reduce ROS concentrations within neurons [82] while DMSO-
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coated maghemite (γ-Fe2O3) and magnetite (Fe3O4) particles have also shown similar
antioxidant behaviour [83]. Other inorganic particles include nanoparticles of gold, sil-
ver, platinum [84] and palladium in both pure and alloyed forms [85], which are highly
conductive metals in their bulk state and as such point to some similar electron transfer
mechanisms involved in their scavenging activity of these radical species. Ceria is unique
among these materials is that it has been shown to be selective in this protective effect
of ROS scavenging, affording protection to non-malignant cell lines, while providing no
protection to cancerous cells [86]. Other materials have shown to have pH-dependant
ROS interactions though, which is thought to be the origin of this selective behaviour in
CeO2 nanoparticles (Figure 1.8). As such, this anti-oxidant behaviour of these particles
is also referred to as anti-apoptotic behaviour, due to the role that ROS plays in inducing
apoptosis or programmed cell death, resulting in loss of tissues.
Figure 1.8: Summary of different antioxidant enzyme-mimetic activity in inorganic nanoparti-
cles [85].
These nanoparticles (Figure 1.9) have been proposed as potential therapies for targeted
antioxidant activity, such as in neuronal cells, which are extremely susceptible to ROS-
induced damage [82]. Another potential application for these particles is the protection
from radiation-induced damage, as the action of ionising radiation such as X-rays or γ-
rays causes the generation of radical species from in the intracellular H2O [86–90]. Given
the variety of inorganic nanoparticles that have shown to exhibit this interaction with ROS,
and that it is dependent on the physiochemical properties of the nanoparticles themselves
there has understandably been significant research effort into further understand the in-
teraction of inorganic nanoparticles with biological media, and what materials properties
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cause the emergence of such a potentially clinically-relevant activity. In this work we ex-
plore the tailorable ROS-behaviour of hematite (α-Fe2O3) nanomaterials by controlling
specific synthesis parameters which have a lasting effect on their materials properties,
and finally explore what consequence this has for their interaction with ROS within the
biological environment.
Figure 1.9: Transmission Electron Microscopy images of CeO2 nanoparticles with selected area
electron diffraction (inset-left) and showing the <111> d-spacing (right) [6].
Nanoparticles as Ultraviolet Filters
Inorganic nanoparticles also seen widespread use in a protective role as ultraviolet ab-
sorbers in cosmetic and sunscreen products. This could be seen also as a prevention
of oxidative stress and direct DNA damage, both which are involved in the harmful ef-
fects of UV exposure on human epithelial tissues. These ultraviolet radiation light filters
or blockers are used in sunscreens and cosmetic products to increase their Sun Protec-
tion Factor (SPF) rating. This is because Ultraviolet radiation is a component of nat-
ural sunlight, comprising the 190-400 nm wavelength range of the ultraviolet spectrum
(Figure 1.10) and it can be subcategorised into UVA (320-400 nm), UVB (290-320 nm)
and UVC (100-290 nm) [91]. While ultraviolet light can be produced artificially through
specialised lamps, electrical arcs and LEDs, the main source of ultraviolet exposure for
most individuals is natural sunlight. Not all wavelengths of the ultraviolet spectrum are
within the sunlight that reaches the earth however, as the ozone layer in the stratosphere
absorbs the highest energy region (UVC), but it is still produced in certain ultraviolet
lamps [92] (Figure 1.11). The levels of UVA and UVB are significant enough to cause
biological effects in organisms at sea level, especially in the skin and eyes. The UVB
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section of the spectrum can cause erythema (redness of skin due to increased blood flow),
sunburn, and is the part of the spectrum known to cause skin cancer, while the UVA re-
gion of the spectrum is weakly carcinogenic and causes photoaging and wrinkling of skin,
with both able to cause suppression of the immune system [93–95]. The wavelength de-
pendency of two of these biological effects can be seen in the standard erythema action
spectrum, Figure 1.10, which was found experimentally, based on the absorption spectra
of biological molecules and standardised for the first time by the Commission Interna-
tional d’Eclairage (CIE) in 1987 [96].
Figure 1.10: The electromagnetic spectrum, showing the location of the visible and ultraviolet
regions along with the subcategories of ultraviolet radiation [91].
As such, these cosmetic and sunscreen products are typically water-in-oil emulsions
containing oils, emulsifiers, fragrances and pigments as well as inorganic and organic ul-
traviolet absorbers designed to limit the amount of UVA and UVB radiation that can reach
the skin. The extent that these products filter the ultraviolet light at wavelengths Due to
the quantisation of light, an incident photon can only give over all its energy, or none, and
as such the organic filters present within these products can absorb ultraviolet photons
by undergoing electronic transitions. An ultraviolet photon of the appropriate wavelength
is absorbed by the molecule, the energy allows an electron to transition from the High-
est Occupied Molecular Orbital (HOMO) to the Lowest Unoccupied Molecular Orbital
(LUMO). This wavelength must have energy equal to ∆E, the energy gap between these
two orbitals, and molecules that absorb strongly in the Ultraviolet-Visible region (190-
700 nm) are known as chromophores. Due to this physical requirement, these organic
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filters are classified as either UVA or UVB absorbers and are most commonly derivates
of Cinnamate, p-Aminobenzoate, salicylate, benzophenone, camphor, Dibenzoylmethane
and Anthranilate molecules [97]. They do have many shortcomings including causing
allergic reactions, photosensitising skin to UV, and estrogenic effects, due to their poten-
tially high skin penetration [98]. As such, inorganic ’mineral’ ultraviolet filters are also
now commonly found in these products, including titanium dioxide (TiO2) and zinc oxide
(ZnO). There has been an increasing trend of using these mineral filters as nanoparticles
as opposed to microparticles (d ≥ 0.1µm) due to their stronger and more selective absorp-
tion of light from the ultraviolet region. These materials are crystalline semiconductors,
and like organic filters, can absorb ultraviolet photons through an electronic transition in
this case resulting from the promotion of an electron from the valence band to the conduc-
tion band, over its optical band-gap Eg. Unlike ultraviolet filters, more unoccupied higher
energy states mean that these materials can absorb ultraviolet photons with Ephoton ≥ Eg
meaning that in some cases they are able to provide a broad wavelength range of protec-
tion. Both oxide materials have band-gaps of 3.2 eV for TiO2 [99] and 3.3 eV for ZnO
[100], meaning that they can absorb a significant portion of the ultraviolet without absorb-
ing any of the visible spectrum and as such, appearing transparent when well dispersed.
Figure 1.11: The ultraviolet spectrum measured from space (black) and on the earth’s surface
during summer (blue). Also shown is the absorption of this spectrum from stratospheric ozone,
the main contributor to a decrease in ultraviolet intensity with decreasing wavelength. Also shown
is the erythema action spectrum, showing the wavelength dependence of the ability for ultraviolet
light to have a biological effect [92].
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There has been some concern over the use of TiO2 and ZnO nanoparticles within sun-
screen products with many posing questions regarding of the effects they have on human
skin and other ingredients within the formulations. Particular types of TiO2 are known to
be extremely photocatalytically active, with the electronic transition from the absorption
of ultraviolet photons resulting in the generation of an electron-hole pair which migrate
to the surface of the particle and can react with neighbouring water molecules to generate
radical species including OH.. These same properties make TiO2 attractive for application
in photocatalytic water splitting, water cleaning, and dye sensitised solar cell applications
[101]. Previous studies have shown that this activity is substantial enough to cause con-
siderable damage to high-UV and weather resistant coatings for roofing products [102],
as well as engage in a host of photochemical reactions with the organic ingredients of
the sunscreen products [103]. The latest recommendation from the European Union’s
Scientific Committee for Consumer Safety states that while there is little safety concern
for topically-applied TiO2, photocatalytically active species are not recommended for use
within sunscreen products, and they should also not be used in spray products, which
carry a risk of inhalation of the nanomaterials [104]. It’s been shown that the photocat-
alytic activity of these TiO2 nanoparticles can have a major influence on their cytotoxicity
in vitro [105]. Nanoparticles of ZnO also have raised concern and were banned from use
in cosmetic products within the European Union for a period, due to being both cytotoxic
and genotoxic to a range of different types of cells in vitro [106–108]. This nanotoxicity
of this material is a result of its ability to generate free radical species and ROS within
living cells. There has been a significantly large body of work conducted on assessing
whether either of these nanoparticles are able to migrate from the surface of the stratum
corneum after being applied in a sunscreen emulsion to viable skin cells within the der-
mis where they could come into close contact with sensitive biological targets such as the
mitochondria, lipid membranes, nucleic acid, proteins and enzymes. While many of these
studies have been unable to find evidence of any penetration of the nanoparticles into the
dermis, appreciable variation in experimental protocols, including the role of UV expo-
sure, along with discrepancies within the extent of penetration of these into the epidermis,
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leaves much to be desired [109]. As such, there has been some research effort into both
understanding the ways in such metal oxides could potentially exhibit any harmful effects
on users following dermal application [110], as well as investigating potential replace-
ments for these two materials for application as ultraviolet filters [111].
This is another application that has been proposed for cerium dioxide nanoparticles,
as they have an optical band gap of 3.2 eV which is like that of titanium dioxide and
zinc oxide which can be further tailored through doping with elements, including calcium
[112]. As previously mentioned, the free radical scavenging properties of CeO2 are well
characterised and as such, not only does this material have the potential to be applied as
an inorganic ultraviolet filter, it can also scavenge the free radicals generated upon ul-
traviolet exposure, providing two different aspects of protection to the user. These free
radical scavenging properties have extremely high promise, due to the significant role that
such free radicals play in human health and disease [54, 55], and have been proposed in
application not only in cosmetics and sunscreen materials [113], as radioprotective drugs
[87, 89, 114] and neuroprotective agents [115]. Cerium is a rare-earth metal however, and
as such is much less abundant and more expensive as a material compared to TiO2 and
ZnO meaning that it has only been adopted into more niche, speciality cosmetic products.
However, given that this property results from some size-dependant surface characteris-
tics of CeO2, it raises the question, could similar activity be induced in other metal oxide
nanomaterials? As there have been several studies also claiming that CeO2 nanoparti-
cles exhibit cytotoxic effects on cells in vitro, it leads to the concept that the toxicity of
such metal oxide nanoparticles could be tailored, through careful manipulation of the size,
shape, structural and surface characteristics of a material. These two topics of nanotox-
icity and the application of nanomaterials within sunscreen and cosmetic products both
have similar methodologies in being able to tailor the effect of the nanomaterials on bio-
logical systems, as well as retain the properties that make it useful for the application, or




1.2.1 Increasing Prevalence of Nanotechnology and Nanomaterials
It’s believed that nanotechnology was originally inspired by a lecture at Caltech from
American physicist Richard Feynman entitled ”Theres Plenty of Room at the Bottom”
[116] in which he describes manipulating individual atoms and molecules. Since then,
nanotechnology has grown into a major field of research within science and engineer-
ing, spawning dedicated journals, books, conferences, societies, research institutions and
the awarding of Nobel Prizes in both Chemistry and Physics. The discoveries and tools
within Nanotechnology have influenced and allowed for advancements in nearly every
field, including pharmaceuticals and health care, agriculture and food, energy, materi-
als and information technology and as such, it’s impact on spawning emerging tech-
nologies is immense. As previously mentioned, impact of bionanotechnology in health-
care and medicine shows much promise, but this has also provided a challenge for con-
sumer safety regulatory bodies worldwide, such as the Therapeutic Goods Administration
(TGA) in Australia, Food and Drug Administration (FDA) in the United States and the
European Medicines Agency (EMA), who have the task of developing guidelines and
frameworks for approving medicines and healthcare products. Such products are subject
to a great level of scrutiny, with sterility, adequate physiochemical characterisation, chem-
ical residues, batch consistency, biocompatibility, in vitro stability and drug release rates
all contributing to the efficacy of the formulation. There are already several nanomaterials
that have been approved by the TGA to use in medicines and healthcare products here in
Australia (Table 1.3), and over 50 products that have been approved by the FDA, with an
increasing number of products undergoing clinical trials [117] (Figure 1.12).
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Figure 1.12: Graphics showing the number of FDA approved nanomedicines by (a) year ap-
proved and (b) category and nanomedicine clinic trials between 2001 and 2005 by (c) year and
(d) those currently under trial by type [117].
As novel nanomaterials are being reported daily in scientific literature, it’s not only
important to assess and understand the nano-toxicology of any material with potential for
commercialisation and application in consumer goods, medicines, industrial processes
and research practices, but also contribute to the wider body of knowledge in order to
better understanding the underlying mechanisms for this toxicity. The World Health Or-
ganisation is currently in the process of developing guidelines to address the issues sur-
rounding the impacts of these new technologies on workers health, ”Protecting Workers
from Potential Risks of Manufactured Nanomaterials” to assess the risks around workers
being potentially exposed to nanomaterials [119]. In the case of metal oxide nanoparti-
cles, there are a plethora of materials properties that can ultimately influence the nano-
toxicity of these materials including particle size, crystal structure, surface properties,
oxidation state, stability, shape and surface area. These materials are also some of the
most prevalent in current nanomaterial research, due to their chemical stability in a range
of pH environments, variety of materials properties, and ease and tailorability of their
fabrication. As such, there is understandably a push to understand the how the materials
properties of these metal oxide nanoparticles and nanocomposites can be used to predict
their toxicity to human beings and to the environment, in order to minimise the potential
harm of new technologies. As one of the mechanisms in which these nanoparticles can
negatively impact biological systems is through their generation of free radical species
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Table 1.3: List of ’nanomedicines’ approved for use in Australia by the Therapeutic Goods
Administration [118].
Type Product Name Active Ingredient Application
Liposome AMBISOME R© Amphotericin B Fungal Infections
ABELCET R© Morphine Pain relief
DEPODUR R© Verteporfin Macular degenera-
tion
VISUDYNE R©
Pegylated Liposomes CAELYX R© Doxrubicin Cancer





SOMAVERT R© Growth hormone recep-
tor antagonist
Acromegaly
PEGASYS R©, Interferon alfa-2a/2b Hepatitis C
PEGINTRON R©
Protein-drug conjugate KADCYLA R© Anti-HER2-G1/DM1 HER2-positive
breast cancer
ABRAXANE R© Albumin-bound pacli-
taxel
Cancer
Nanocrystal EMEND R© Aprepitant Chemo-associated
nausea
LIPIDIL R© Fenofibrate Hypercholesterolaemia
RAPAMMUNE R© Sirolumus Organ transplant
Nanosuspension RISPERDAL R© Risperidone Schizophrenia
CONSTA R©
Emulsions NEORAL R© Cyclosporine Immunosuppression
LIPURO R© Propofol Anaesthesia
Polymeric Nanoparti-
cles
COPAXONE R© Glatiramer acetate Relapsing-remitting
Multiple Sclerosis
RENAGEL R© Sevelamer Hyperphospataemia
Metal/metal oxides VENOFER R© Iron sucrose ↓ in haemodialysis





Vaccines PANDEMRIX R© Split virion, inactivated Immunisation








[120–122], this is an area in which more research needs to be undertaken to both under-
stand, and develop the ability to tailor these interactions. The ability to induce free radical
scavenging behaviour of a number of different inorganic nanoparticles including CeO2
[6, 89, 115], has highlighted the potential for the creation of entirely new approaches and
methodologies for treating a range of diseases. As such, this thesis work investigates the
potential for inducing the free radical scavenging behaviour in new metal oxide nanopar-
ticle and nanocomposite systems through novel synthesis methods to add to the broader
knowledge in this area.
1.2.2 Ultraviolet Exposure, Ultraviolet Index, Skin Cancer and Aus-
tralia
It’s well known that high levels of ultraviolet radiation exposure from natural sunlight is
carcinogenic and can result in the development of skin cancer. Ultraviolet radiation was
first classified as a carcinogen in 1992 by the International Agency for Research on Can-
cer (IARC) [123] and in 2009 it was confirmed to cause cutaneous malignant melanoma,
squamous cell carcinoma (SSC) and basal cell carcinoma (BCC) of the skin [124]. It’s
been estimated that between 50-90 % of melanomas and basal cell carcinomas, and 50-
70% of squamous cell carcinomas can be directly attributed to exposure to ultraviolet ra-
diation from the sun [125] for light-skinned populations. The amount of incident radiation
from sunlight is expressed on a scale known as the UV Index (UVI) [126] (Figure 1.13),
which is the maximum biologically effective solar ultraviolet radiation (UVRe f f ) for the
day over a 10- or 30-minute period. It’s calculated based on the erythema action spectrum
(E(λ )) according to the biological effectiveness of the different wavelengths of ultraviolet
radiation, and well as the spectral solar irradiance (S(λ )), both of which are wavelength
dependant (Equation 1.4). The effective solar ultraviolet radiation, UVRe f f , is expressed
in watts per meter squared (W m−2), and is multiplied by 40 in order to give the calculated







E(λ )S(λ )δλ (1.4)
UVI = 40×UVReff (1.5)
A study comparing the average UVI for several Australian cities compared to those in
the United Kingdom and a number of other countries (Figure 1.14), showed that Australia
has extremely high levels of UVR year-round globally [127]. Studies comparing the
ultraviolet exposure to Australian workers against their international counterparts also
showed that they on average had greater ultraviolet exposure, indicating that occupational
exposure is also a significant problem in Australia [128]. One study attributed 63% of
melanomas occurring in Australia and virtually all of keratinocyte cancers were a direct
result of the high level of ultraviolet radiation [129].
All these factors contribute to Australia and New Zealand having the highest incidence
rates of melanoma worldwide (34.9, 35.8 ASR respectively) (Table 1.4), resulting from
a combination of their proximity to the equator, clear atmospheric conditions and loss
of ozone layer in both spring and early summer meaning that the Australian and New
Zealand populations are exposed to extremely intense ultraviolet radiation year-round. In
fact, Australia and New Zealand had the highest incidence of cancer worldwide in 2012
according to the world health organisation, and a melanoma incidence was a major con-
tributor (∼10%) to that, only slightly falling behind prostate, breast and colorectal [130].
Some ultraviolet exposure is needed to catalyse the production of Vitamin D, an essen-
tial vitamin responsible for the maintenance of bone health, which itself is a necessary
hormone that controls calcium levels in the blood. Low levels of vitamin D have been
Figure 1.13: Graphic showing the protection required based on the UVI, with recommendations




Figure 1.14: The (a) annual mean UVI rating (black, left) and (b) annual total UV exposure
(red, right), as well as the (b) monthly mean UVI rating for a number of Australia cities between
1996-2000 and three locations in the United Kingdom between 1996-1999. Data taken from
[127].
linked to an increased risk in several different chronic diseases, including MS, Diabetes,
colon and prostate cancer, heart disease, autoimmune diseases, mental health conditions
and heart disease. Due to the extremely high levels of UVR in many regions of Australia,
studies have shown there are significant misconceptions from the public in their overesti-
mation amount of healthy daily UVR exposure, which is 2 to 6 minutes in summer and 4
to 17 minutes in winter in Brisbane, Queensland [131]. Regardless, strong public health
programs within Australia regarding sun exposure including SunSmart and Slip Slop Slap
have successfully increased awareness of overexposure to sunlight, with the use of sun-
screen products being the most frequently used method [132], estimated by one study to
have reduced melanoma and squamous cell carcinoma incidence by 14% and 9.3% re-
spectively.
Table 1.4: Comparison of cancer incidence, mortality and 5-year prevalence between Australia,
New Zealand and world average, for all cancer types and Melanoma of the skin, 2012 [130].
Incidence Mortality 5-year Prevalence
Region Type Number (%) ASR Number (%) ASR Number (%) ASR
Australia All 122031 100.0 323.0 43403 100.0 96.4 357982 100.0 1929.0
Melanoma 12265 10.1 34.9 1642 3.8 4.0 49121 13.7 264.7
New Zealand All 21337 100.0 295.0 8585 100.0 103.8 62511 100.0 1759.5
Melanoma 2473 11.6 35.8 377 4.4 4.7 9923 15.9 279.3
World All 7410376 100.0 204.9 4653385 100.0 126.3 15296119 100.0 589.4
Melanoma 120649 1.6 3.3 31390 0.7 0.9 452674 3.0 17.4
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Given how significant the UVR exposure in Australia is, and our culture being strongly
associated with spending time outdoors, our use of sunscreen products among other forms
of protection is extremely important, and continuing research and development into cre-
ating more effective protection products is an area of research interest. As previously
mentioned, the trend of many manufacturers in using nanoparticles of TiO2 and ZnO in
their sunscreen formulations has resulted in products with greater ultraviolet absorption
and superior photoleptic properties. A study in 2008 by Barker and Branch [102] found
that a number of sunscreen formulations sold within Australia contained highly photocat-
alytically active TiO2 nanoparticles as a UV filter within their products. This discovery
was made due to extremely accelerated weathering of a coated steel roofing product, espe-
cially designed to endure the extreme UV conditions present within Australia throughout
the year, attributed to residual sunscreen on the hands of workers contracted to install
the product. Barker and Branch firstly isolated the inorganic particles from a number
of different sunscreen products sold in Australia, and then performed X-ray diffraction,
Electromagnetic Spin Resonance (ESR) and finally outdoor exposure tests on the same
coated steel product. X-ray diffraction studies revealed a mixed phase anatase-rutile TiO2
nanoparticles, whose diffraction peaks matched those of Aeroxide R© P-25, an extremely
cheap, highly photocatalytically active nanomaterial. As previously mentioned, upon UV
exposure TiO2 nanoparticles can generate OH. radicals, and the formation of these rad-
icals was shown then through ESR measurements. Finally, long term outdoor exposure
tests were performed, in which sunscreen was coated onto these same steel products and
left in a low corrosion environment on outdoor testing racks during the summer months.
This confirmed the observations from the manufacturer that initially inspired the study,
with accelerated weathering of the surface coating, shown by a decrease in gloss reten-
tion over a period of 6 and 12 weeks, seen for the panels coating in sunscreens containing
the P-25-like TiO2 nanoparticles. This has raised many questions regarding how such
particles could interact with other components within the sunscreen formulations given
the potentially complex photochemistry occurring in a mixture of chromophores and in-
organic particles. As such additional studies into finding a highly UV absorbing, low
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photocatalytic activity, cheap and abundant ultraviolet filter for application in sunscreens
and cosmetic products have also continued.
1.3 Thesis Outline
The research undertaken in this doctoral thesis has several different aims, all centred
around the investigation of the materials properties of iron oxide base nanomaterials.
This includes studying which materials properties fundamentally influence the cytotoxic
behaviour of these nanomaterials in vitro, as well as fabricating nanocomposites for ap-
plication in ultraviolet filtration. One of the focuses of this thesis, especially regarding
the cosmetics research, to focus on abundant; cheap materials and scalable processing
techniques; to maximise the potential for research commercialisation. The goals of the
research conducted in this doctoral thesis can be summarised as:
(a) Synthesis of a number of different iron-based nanomaterials with tailored charac-
teristics, to investigate any potential alteration of their interaction with free radical
species in the context of non-malignant biological systems.
(b) Development of novel iron oxide-polymer nanocomposite particles with superior
ultraviolet filtration and photoleptic properties.
(c) Prepare a number of sunscreen emulsions incorporating the highly UV-absorbent
metal oxide nanoparticles; and metal oxide-polymer nanocomposite materials, and
then assess their efficacy as ultraviolet filters in sunscreens and cosmetic products
using industry-standard characterisation techniques.
(e) Design and fabrication of next-generation multifunctional core-shell metal oxide
nanocomposites which combine two materials to maximise the high ultraviolet
attenuation of the abundant and cost-effective iron oxide nanoparticles, with the
unique free radical scavenging properties of cerium oxide nanoparticles into one




(f) Develop new method of experimentation to characterise potential interactions be-
tween free radical scavenging and photocatalytic free radical generating nanoparti-
cles in solution.
The following thesis will be broken up into several chapters, which are described below:
Chapter 1 Provided background information into the fields of inorganic antioxidant nano-
materials for the treatment of oxidative stress as well as the role of nanoparticles as
ultraviolet filters within sunscreens and cosmetic products. It also included details
on the current motivation toward ongoing research into these topics.
Chapter 2 Will give a detailed review of the current literature published in these two
main topics, covering the relatively recent discoveries on inorganic nanomaterials
displaying the capability of scavenging free radical species in both in vitro and in
vivo experiments which have potential application as both radioprotective agents
and therapies for treatment of neurodegenerative disease. This is followed by a de-
tailed review of the literature surrounding the harmful effects of ultraviolet radiation
to human health, and the issues surrounding sunscreen and cosmetic products with
a Sun Protection Factor (SPF) rating, designed to protect from this exposure.
Chapter 3 Gives some details of the chemicals and materials used within this thesis
work, followed by the synthesis procedures used to prepare the nanomaterials fea-
tured in this study. It then goes into the different materials characterisation methods
used to probe the crystalline, morphological, elemental properties of all the nano-
materials prepared in this doctoral thesis, firstly providing some background or the-
ory on the technique, followed by technical details of the parameters used. Lastly,
this Chapter gives some background on the cell biology experiments used in this
study, following the same structure mentioned above for the materials characterisa-
tion techniques.
Chapter 4 Presents the in-depth study conducted on the synthesis-dependent cytotoxi-
city displayed by hematite nanoparticles in vitro. The in-depth materials charac-
terisation highlights subtle changes within the surface properties through altering
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synthesis parameters, and this is shown to impact the cytotoxicity and interaction
of these nanomaterials within the intercellular environment of Madin-Darby Canine
Kidney (MDCK) cells.
Chapter 5 Covers the experimental work performed on the synthesis of an iron oxide-
cerium dioxide nanocomposite system, that combines the high UV-absorption prop-
erties of both materials with the free radical scavenging properties of the ceria for
a next-generation multifunctional UV-filter to provide high SPF and antioxidant
stabilisation to sunscreens and cosmetic products.
Chapter 6 Details the work surrounding the synthesis and characterisation of hematite
nanoparticles and their encapsulation into poly(lactic acid) microspheres. These
were then prepared in a commercial sunscreen emulsion and tested to determine
their SPF rating and efficacy as an ultraviolet filter for application in cosmetic prod-
ucts.
Chapter 7 Provides a conclusion to summarise the outcomes of the previous chapters




The following chapter covers the previous studies and current progress on the topics of
free radical scavenging nanoparticles for the treatment of oxidative stress, and novel nano-
materials for application as ultraviolet filters within sunscreen and cosmetic products.
2.1 Free Radical Scavengers for Treatment for Oxidative
Stress
Pro-oxidants, such as reactive oxygen species (ROS) and reactive nitrogen species (RNS)
naturally occur in the body and play important biological functions, and as such have
significant implications for human health and disease. The discovery of nanoparticles
with the capability to catalytically neutralise or scavenge these species has opened the
door for novel therapies for the targeted treatment of chronic oxidative stress. The main
proposed applications for this technology include the prevention of the ROS-mediated
damage resulting from exposure to ionising radiation (radioprotection), and the treatment




2.1.1 Sources of Free Radical Species
These details regarding the chemistry of these free-radicals and non-radical oxygen deriva-
tives is of consequence due to the significant exposure that cells have to these species,
from both exogenous (from outside the cell) and endogenous (from within the cell) sources
Figure 1.6 [34, 37]. Endogenous sources of ROS and RNS are important to consider, due
to their presence being a result of continuous biological processes throughout the life span
of all cells within an organism.
Endogenous Sources
Arguably one of the most significant of these is the ROS generated from the mitochondria,
a cellular organelle which is the powerhouse within cells (Figure 2.1), responsible for the
conversion of oxygen and nutrients into adenosine triphosphate (ATP) through oxidative
phosphorylation in the mitochondrial electron transport chain (ETC). This process is aer-
obic respiration and the reason that aerobic organisms require oxygen, as this ATP is then
used to power the metabolic activities in within the cells [58]. The ETC can generate a
number of different ROS, include superoxide (O·−2 ), hydrogen peroxide (H2O2) and hy-
droxyl radicals (OH·) [56, 57], with some electrons leaking from the ETC to ground-state
oxygen (O2) resulting in significant production of O·−2 [133, 134], estimated to be around
1-2% of all oxygen involved in these processes [135]. This results from the reduction
of O2 to H2 which occurs as a part of the ETC and involves the transfer of 4 electrons
to the oxygen [136, 137]. This generation of ROS becomes worse as the cell ages, with
the mitochondria producing larger quantities of ROS as its function is impaired and the
membrane is damaged, which itself results from the oxidative stress resulting from this
same ROS production [138].
Under hypoxic conditions, where the oxygen supply to tissues is low, the respiratory
chain can also produce NO· in significant quantities resulting in the further generation of
ROS and RNS [140] (Figure 2.2). Certain enzymes, which are biomolecular catalysts, are
also known to generate ROS including two complexes (I and III, NADH and ubiquinone-
cytochrome c reductase) of the ETC responsible for the transfer of an electron to O2.
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Figure 2.1: Illustration of a cell with its cellular organelles [139].
Other intracellular enzymes that can act as sources of endogenous ROS include xanthine
oxidase [59], cytochrome p450 [60], lipoxygenases [141] and nitric oxide synthase [142],
among others. White blood cells (leukocytes) are also able to produce significant quan-
tities of ROS and agents that work synergistically with ROS as their function to devour
and destroy bacteria and other pathogens through phagocytosis [61]. They do this through
a combination of generating O·−2 and H2O2 from the NADPH-oxidase enzyme in what’s
called a respiratory burst (Equation 2.1), which then go to produce other ROS [143] in-
cluding OH· through the Haber-Weiss reaction (Equation 1.3). Non-chelated copper or
iron ions are also another source of endogenous ROS and can be released into cells from
iron-sulphur clusters, haem groups and metal storage proteins, similarly engage in the
Fenton and Haber-Weiss reactions to generate these radicals [144, 145]. While some of
the generation of ROS from endogenous sources are a part of normal cell function and
serve a positive function, there are over 200 diseases described in literature [34] in which
the continuo production of ROS is an important part of the pathology, either as initia-
tors or mediators. These are incredibly important when considering the impact of ROS
and radical species on healthy cellular function and as an extension, overall health of the
organism and these will be described in further detail in Section 1.1.3.




Figure 2.2: A schematic of the electron transport chain [58].
Exogenous Sources
As previously mentioned, there are also a substantial number of potential exogenous
sources of ROS and RNS that can damage an organisms cells and their organelles. In our
modern era, air pollutants are a major source of ROS and RNS, including cigarette smoke
[62], car exhaust fumes [63, 64] and industrial contaminants [65] able to cause damage
to skin, lungs, or other tissues following inhalation. Ozone can also be another source of
extrinsic ROS, and despite its role in absorbing UV-C radiation in our atmosphere, can
be extremely harmful to biological tissues acting as a powerful oxidiser [146]. Medica-
tions [66], narcotic drugs and anaesthetising gases [147] can also significantly contribute
to the production of ROS, with some drugs having a method of action that involves ROS.
These include a number of chemotherapeutic agents, who utilities ROS to induce apop-
tosis (programmed cell death) within cancer cells [67]. A large number of xenobiotic
chemical species that organisms could be exposed to also induce harmful levels of ROS
and oxidative stress such as chlorinated compounds, quinones [68], metal ions [69], phor-
bol esters [70], nitroaromatics [71] and bipyridium herbicides.
Significant ROS can also be generated within biological systems through exposure to
ionising and non-ionising radiation, which are both of significance to this thesis work.
Ionising radiation such as X-rays and γ-rays can produce a range of free radicals and
non-radical oxygen derived species through the ionisation or lysis of the H2O within cells
[72]. The difference between these two pathways can be seen in Figure 2.3, with an in-
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cident photon causing ionisation of the water, which results in the ejection of an aqueous
electron (e−aq) and H2O
+, or lysis, which results in OH· and H· radicals. These can then
go on to engage in a variety of reactions, resulting in a number of recombination products
including H2O2, and these can then go on to generate further radical species following
the aforementioned reactions [73]. Ultraviolet (UV) radiation is another potential source
of ROS that a large number of organisms, including humans are exposed to every time
we journey outdoors [93]. These can be subcategorised into UV-A (≥290 nm), UV-B
(290-320 nm) and UV-A (320-400 nm), and while UV-C is scavenged by O3 in the up-
per atmosphere, they can indirectly produce a variety of ROS and oxygen derived species
[74]. Furthermore, haemolytic cleavage of H2O2, which is cause by UV radiation ex-
posure, can produce OH· [75], which is of concern since H2O2 can be sometimes found
within cells.
Figure 2.3: Schematic showing the reaction pathways following the irradiation of water with
ionising radiation, with some of the free radical chemistry reactions inset [73].
2.1.2 Targets and Mechanisms of ROS-induced Damage
While these reactive oxygen species play important biological functions when in the cor-
rect quantities, accumulation of these radical and non-radical oxygen derivative species
can result in oxidative damage to various cellular organelles. Depending on the target and
extent of the damage, this may severely impair cell function, or result in the apoptotic
death of a cell. The three main cellular components most vulnerable to attack from ROS
are lipids, enzymes, and DNA [41, 42]. Lipids make up all the membranes present within
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cells, and they can be oxidised in a chemical reaction termed lipid peroxidation. The
presence of carbon-carbon double bonds (C=C) in the unsaturated fatty acids compris-
ing the lipid membrane structure makes the adjacent H groups more easily to be removed
through chemical attack from various radical species. This lipid fatty acid radical can then
undergo chemical rearrangement in its structure, and then react with surrounding oxygen
to form ROO·, which can then go on to strip a hydrogen from a neighbouring fatty acid.
This process can then propagate through all the fatty acids in the lipid membrane caus-
ing significant chemical changes [33, 148]. Free radical species are also able to cause
significant damage to proteins, with OH· and RO· the most significant. Protein oxidation
from these species can cause a significantly affect their activity, resulting in overall altered
cellular function [43]. DNA can also be prone to chemical attack from radical species,
resulting in the modification of base-pairs; single or double-strand breaks; cross-linking
with proteins; and damage to the DNA repair system; among others. Similar to proteins,
this damage is most likely to be caused by OH· through direct attack. While other less
reactive ROS aren’t able to directly attack DNA, they can indirectly result in damage
through engaging in reactions that result in the production of ROS that are able to [149].
Given the extremely short lifetimes, and high reactivity of many of these radical species,
the production of these species must be within close proximity to the target in order for
them to chemically attack the given component.
2.1.3 Defences Against Oxidative Stress
As previously mentioned, ROS in itself does not always negatively impact cells nor is it
always a bad thing, as it plays an important role in a number of biological functions in-
cluding cell signalling, differentiation, apoptosis, immunity and defence against invading
micro-organisms. An imbalance in the redox state of cells tipped in the favour of oxidants
however, i.e. oxidative stress; is harmful and cells have some different defences in or-
der to attempt to minimise the potential for oxidative damage. These include mechanisms
that indirectly and directly minimise this potential for harm, with the former including en-
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zymes that repair DNA following oxidative damage; metal chelating agents which attempt
to prevent significant ROS generation from free metal ions; and other physical defences
such as steric hinderance and biological site stabilisation. The other mechanisms can
be classified as the antioxidant defence system of cells, which itself includes antioxidant
enzymes that directly interact with ROS, such as superoxide dismutase (SOD), catalase
and glutathione peroxidase, as well as supporting enzymes such as glucose-6-phosphate
dehydrogenase (G6PD) and xanthine oxidase. These enzymes work together in order
to scavenge free radical species within cells and convert them to O2 and H2O, as can
be seen in the below reactions. Superoxide dismutase is able to catalyse the conversion
(Equation 2.2) of two O·−2 anions into H2O2 via a metal ion at its active site, with a series
oxidation and reduction reactions working extremely efficiently to engage in this reaction.
Humans have three types of SOD in their bodies, Cu/Zn-SOD, extracellular SOD and mi-
tochondrial Mn-SOD (Figure 2.4). Once these O·−2 anions have been converted to the less
reactive H2O2, this peroxide can then be converted to H2O by catalase (Equation 2.3) or
glutathione peroxidase (Equation 2.4). Of these, catalase is able to convert high concen-
trations of H2O2, doing so with the ferric ions in each of its subunits in multiple reaction
steps which includes the oxidation of Fe+3 to Fe+4 [54].
2O·−2 +2H
+ SOD−−→ H2O2 +O2 (2.2)
2H2O2
catalase−−−−→ O2 +2H2O (2.3)
2GSH+H2O2
peroxidase−−−−−→ GSSH+2H2O (2.4)
Apart from these enzymes working to minimise high concentrations of pro-oxidants,
there are also low-molecular weight antioxidant (LMWA) species which are produced
in limited number through cellular functions, none of which are strictly antioxidants
(Figure 2.5). These include Glutathione (GSH, glutamic acid-cysteine-glycine), which





Figure 2.4: The structure of (a) Zn,Cu-SOD and (b) Mn-SOD enzymes, adapted from [150].
other important cellular functions, including cell signalling, metabolism and a copper
chelating agent. Uric acid is another example of an LMWA, which is a product of cell
waste, resulting from the reactions of xanthine oxidase and can also exert an antioxidant
effect in sufficiently high quantities. Redox balance in the brain and muscles, regions
of the body susceptible to elevated ROS levels, is managed by group of molecules called
histidine dipeptides, which include carnosine; homocarnosine and anserine. These are ex-
tremely efficient antioxidants, able to remove a large variety of ROS species from within
these cellular environments. Another LMWA that is of particular concern in this thesis
work is the hormone Melatonin, which is synthesised in the pineal gland. It has a number
of functions, including potent antioxidant activity towards a variety of ROS species whose
mechanism of action is still is also not fully understood. Due to it appearing in cells in
relatively low concentrations, it’s thought to contribute to an antioxidant response through
inducing synthesis of antioxidant enzyme and other LMWAs. While these LMWAs are
produced in the body, dietary sources are where the body obtains most of its reducing an-
tioxidants. These include Ascorbic acid (vitamin C), tocopherols that make up the 8 sub-
stances in the vitamin E family, carotenoids (β -carotene), phenolic compounds, flavonoid
compounds and some nitrogen compounds (amines, betalines, alkaloids) [151].
Given the significant role that ROS and RNS play within disease and injury, along
with the plethora of exogenous and endogenous sources of ROS, the further research and
investigation into free radical scavenging nanomaterials with clinical potential is ongoing.
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Figure 2.5: The chemical structure of a number of LMWAs, (a) Ascorbic acid, (b) Melatonin,
(c) α-tocopherol and (d) β -carotene.
2.1.4 Free Radical Scavenging Nanoparticles
Ceramic and noble metal nanoparticles have found widespread research interest for biomed-
ical applications, due to their ease of synthesis and stability as well as their interesting
magnetic, optical, and surface properties. One such properties is the ability for certain
species to scavenge free radical species from within biological systems, acting like an an-
tioxidant mimetic. The following section will provide a review of the literature featuring
these materials and their novel radical scavenging properties.
Cerium Dioxide Nanoparticles
Cerium oxide (CeO2); or ceria; is a ceramic material that crystallises in a fluorite crystal
structure and is well known for its catalytic properties, having found application in solid
oxide fuel cells; oxygen sensors; catalytic converters in automobiles and cosmetic filters.
Cerium is the most abundant rare-earth element, the first element in the Lanthanides series
and lightest element to have a partially occupied f orbital. As an oxygen molecule is
released from the structure, the two electrons left behind are able to localise on the two
cerium atoms turning Ce4+ into Ce3+ [152]. This dynamic 3+/4+ valence state of the
Ce atoms within ceria allows it to catalytically absorb oxygen under oxidising conditions,
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and release oxygen under reducing conditions, with the latter resulting in the formation
of nonstoichiometric CeO2−x (Figure 2.6).
(a) (b)
Figure 2.6: Unit cell structure of (a, top) Ce2O3 and (a, bottom) CeO2, as well as the (b) process
by which an oxygen is released and Ce4+ becomes Ce3+ [152].
The size-induced effects on the crystal structure and the catalytic properties of this ma-
terial was noted in the one of the first publications to report the synthesis and characteri-
sation of 2.5 and 5 nm CeO2 nanoparticles by Masui et al. 1997 [153]. The CeO2/Al2O3
catalyst prepared by this method showed superior CO oxidative activity, an effect that the
authors attributed to the small size and morphology of these particles. It was later shown
in an article by Deshpande et al. 2005 [154] that there is a direct correlation between the
crystal size and lattice parameter a of ceria NPs, with a increasing for decreasing particle
size. This lattice strain is due to the increasing Ce3+ content on the surface of the nanopar-
ticles, which have a larger ionic radius (1.034 Å) compared to Ce4+ (0.92 Å). These are
created as the NPs reduce in size and more oxygen vacancies appear on the surface of the
NPs, and a larger proportion of the Ce atoms become surface states. This study estimates
that the portion of Ce3+ of the total Ce content should be 0.17 for 30 nm particles, 0.29
for 6 nm and 0.44 for 3 nm.
The first study to report the protective properties of CeO2 NPs in biological systems
was by Tarnuzzer et al. [86] in 2005 from M. D. Anderson Cancer Centre and Uni-
versity of Central Florida. In this ground-breaking letter to Nano Letters, they report
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preparing ceria nanoparticles with a 2-5 nm diameter using a microemulsion method and
showed that this resulted in a mixed Ce3+/Ce4+ valence state through X-ray Photoelectron
Spectroscopy (XPS). They then treated two different cell lines, CRL8798 and MCF-7, a
non-malignant human breast cell and human breast cancer cell lines with 10 nM of their
suspended cerium dioxide nanoparticles and exposed them to 10 Gy of X-ray radiation
(Figure 2.7). What was observed was that the ceria nanoparticles were able to prevent the
harmful effects of the ionising radiation in the healthy human breast cells, while having
no effect on the breast tumour cells. These nanoparticles acted as a selective antioxidant
by scavenging the free radicals generated from the ionising radiation interacting with the
H2O in the cytosol, which was directly attributed to the oxygen vacancies arising from
nonstoichiometric Ce3+ states on the surface of the particles and the Ce3+/Ce4+ catalytic
behaviour. Furthermore, the nanoparticles showed negligible toxicity to the CRL8789
cells.
Figure 2.7: Effect of 10 nM of ceria on normal (CRL8798) and malignant (MCF-7) human breast
cells with and without 10 Gy X-ray exposure [86].
The in vivo activity of CeO2 NPs to prevent the degeneration of rat retina was then
reported by Chen et al. [155] the following year, with this activity due to the ability of
these nanoparticles to scavenge ROI species and it’s also since been shown that ceria NPs
can protect against photoreceptor degeneration in tubby mice [156]. At this time, other
groups were attempting to elucidate the mechanism for this activity, with one of the next
studies observing that CeO2 NPs have free radical activity that was similar to the O·−2
scavenging enzyme superoxide dismutase (SOD) [157]. They similarly observed that
higher Ce3+/Ce4+ ratio displayed greater SOD-mimetic activity and proposed a possible




4+→ O2 +Ce3+ (2.5)
O·−2 +Ce
3++2H+→ H2O2 +Ce4+ (2.6)
The selective antioxidant behaviour of these ceria NPs toward normal and tumour cells,
first reported by Tarnuzzer et al. 2005 [86] was investigated in depth by Perez et al. [158],
which observed similar behaviour across 4 cell lines, human dermal fibroblasts (BJ), car-
diomyocytes (H9c2), lung cancer (A-549) and breast cancer (BT-474). They showed that
Ce3+ states within the dextran-coated NPs are consumed upon treatment with H2O2, and
these regenerate back to their initial concentration after 10 days under physiological pH
(7.4), while they do not in an acidic environment (pH 4). The inability for these Ce3+
states to be regenerated could be the reason for the lack of free radical scavenging in
cancer cells, which are under slightly acidic, oxygen-deficient conditions. Subsequent
studies have also confirmed that the rate constant of the free radical scavenging behaviour
of these nanoparticles is dependent on the surrounding pH in A549 cells [159]. The first
in vivo study of the radioprotective effects of CeO2 was reported by the group from M. D.
Anderson Cancer Centre and University of Central Florida, in which rats were exposed to
X-ray irradiation periodically, and treated with CeO2 nanoparticles intravenously or Am-
ifostine, the only radioprotective drug to be approved by the FDA. They showed that the
treatment of these rats with the ceria nanoparticles increased their rate of survival with X-
ray exposure compared to those given Amifostine, while the ceria NPs themselves did not
exhibit toxic effects [89] (Figure 2.8). Furthermore, Amifostine decreased the survival of
the rats compared to those only exposed to 5 Gy X-ray irradiation and was more toxic
than Amifostine in combination with irradiation. The results of this study are significant,
as it demonstrated that ceria NPs had the potential to be administered as a radioprotective
drug in order to prevent the effects of radiation on the body. A similar study was con-
ducted more recently by Popov et al. 2016 [160] which showed that these NPs can have
a significant effect on increasing survival rate of mice administered before or after being
exposed to 5 Gy X-ray radiation, with the former having the greatest survival rate . This
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same group also published a study showing the protection of human gastrointestinal ep-
ithelium from the effects of radiation through anti-apoptotic activity and up-regulation of
SOD-2 [87]. They also demonstrated the selectivity of ceria nanoparticles to protect pan-
creatic cells from the effects of radiation [90], while enhancing the effect on pancreatic
cancer cells, due to the suppression of Ce3+ regeneration by the neutralisation of H2O2
to H2O under acidic conditions, while still allowing for the conversion of O·−2 to H2O2 .
Subsequent studies also showed that the moderate atomic number of cerium means that
the energy of the ionising radiation can result in enhancement of the effect, which has also
been reported for oxide NPs of bismuth and tantalum [114].
(a) (b)
Figure 2.8: (a) Survival of rats treated twice weekly with 5 Gy X-ray radiation (Rad.), and/or
thrice-weekly injections of 15 nM CeO2 NPs, Amifostine (Amf), or Saline, adapted from [89].
(b) Influence of ceria nanoparticles (1 mM) on the survival of mice administered before or after
5 Gy X-ray irradiation.
Apart from ionising radiation, these nanoparticles have also shown to decrease the
apoptosis resulting from both direct and indirect cellular damage and ROS generation
upon exposure to UV radiation in vitro in mouse fibroblast (L929) and fibroblast-like
African Green Monkey cells (VERO) [161]. Given the role that oxidative stress and
free radical species play within neurodegenerative disease, the neuroprotective proper-
ties of ceria nanoparticles in vitro have been reported for nerve cells (HT22) [162] and
rat spinal cord neurons [163]. More recent studies have centred around in vivo exper-
iments, as ceria NPs have shown to partially protect from the apoptosis and oxidative
stress associated with Parkinson’s disease in rats [164] and also penetrate the brain tissue
in mice to reduce ROS in free radical-mediated autoimmune brain degenerative disease
[165]. Triphenylphophonium-coated ceria NPs could also be used to slow or halt the
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degeneration associated with Alzheimer’s disease, as they are able to localise within the
mitochondrial of brain tissues to prevent OS mediated neuronal death a morphological
mitochondrial damage [166]. Injection of rats with ceria NPs has also shown to result
in functional recovery in rats with contused spinal cords, highlighting it’s potential as a
treatment in patients with spinal cord injuries [167]. The cardioprotective effect of these
nanoparticles has also been reported in transgenic models of cardiomyopathy [168] and
cardiac progenitor cells [169]. They have also been shown to increase wound healing due
to reducing oxidative stress and inflammation, highlighting their potential for application
in wound dressings [170].
Along with these more targeted studies, the protective effects of CeO2 against ROS
and oxidative stress have been reported for EA.hy926 human umbilical endothelial cells
[171], J774A.1 macrophages [80], U937 [172], PC12 [173] and WiDr human colon can-
cer cells [164]. It’s There have been articles published investigating the origin of this
effect through EPR, highlighting the role of the Ce3+ states [174] and OH· scavenging
properties [175]. These properties have also been investigated through prevention of or-
ganic dye degradation [176, 177] by radical scavenging. Another study used S-nitroso-
N-acetylpenicillamin to show that ceria nanoparticles are also able to scavenge NO·, but
found that this activity was decreased with increasing Ce3+ concentration, in contrast to
ceria’s other protective properties [178]. Other in vitro studies have also confirmed that
this behaviour is Ce3+ dependant, with one study by Celardo et al. 2011 [6] showing that
this antioxidant behaviour can be reduced through the doping of Sm3+ ions, which take
up Ce3+ positions within the CeO2−x lattice. In a similar study, it was found that doping
with La3+, which has a similar ionic radius to Ce4+, increases the OH· scavenging abil-
ity of larger (50 nm) ceria nanocubes through enhancing regeneration of the small Ce3+
content [179]. The exposed crystal plane of the nanoparticles can also have an effect for
the same Ce3+/Ce4+ ratio [101, 180], as can the presence of buffer ions [156], and the
location of the NPs within the cells can also shift this cationic ratio [181] due to pH. Sur-
face coatings have also shown to have different effects on the scavenging ability of ceria,
with many examples of coated NPs still showing radical scavenging behaviour, include
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Figure 2.9: Schematic outlining the proposed mechanisms from which CeO2 obtains it’s se-
lective protective/killing effect in normal/malignant cell lines. At physiological pH (left) the
Ce3+ sites are oxidised to Ce4+, converting O·−2 to H2O2, and the Ce
3+ is regenerated when
the H2O2 is neutralised to H2O. Under acidic conditions, the regeneration of Ce3+ is suppressed,
allowing for the accumulation of H2O2. From [90].
citrate [162], dextran [158], oleic acid, poly(acrylic acid)-octylamine, polyethylene imine,
polymaleicanhydride-alt-1-octadecene, with smaller coatings causing less of a decrease
in activity [182], as well as having a greater effect when combined with Rhodamine B
[183].
Other Inorganic Free Radical Scavenging Nanoparticles
Since the discovery of the potent, selective free radical scavenging properties of ceria
nanoparticles, and the potential for such particles to form the basis of a therapy, there has
been a significant research effort into the discovery of other nanomaterials that display
similar behaviour. In terms of cerium-based materials, it has been reported that zirconium
(Zr) doping was able to increase the H2O2 scavenging activity of ceria NPs up to three-
fold by creating Ce0.7Zr0.3O2 solid solution NPs as determined through H2O2 scavenging
kit [184]. Another study showed that CeF3 and Tb-doped CeF3 nanoparticles display
lower cytotoxicity in vitro towards epithelial swine testicular cells (ST-cells), and showed
greater protection of these cells and an organic dye against the effects of H2O2 compared
to two different ceria sols [185]. As for other non-oxide ceramic nanomaterials, ultra-
small (5 nm) cysteine protected MoS2 NPs have also been reported in a recent study to
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possess powerful radioprotective properties, able to increase the survivability of mice up
to 79% after being exposed to 7 Gy of γ-ray radiation [184].
There have also been a number of studies reporting the antioxidant behaviour of noble
metal nanoparticles including gold (Au), silver (Ag), platinum (Pt), palladium (Pd) and
iridium (Ir). One of the first of these studies by Hamasaki et al. 2008 [84] used both EPR
and in vitro studies on a number of cell lines, both malignant and non-malignant to show
the powerful antioxidant potential of Pt nanoparticles to neutralise both O·−2 and OH
·, as
well as their low toxicity. In this article they show that a decrease in particle size of the
Pt nanoparticles, resulting in more active catalytic sites, results in higher antioxidant ac-
tivity and that the cytotoxic effects of these particles only occur upon NP agglomeration
within media which they address as a potential problem. A later study confirmed this be-
haviour of Pt nanoparticles, showed they protected HT-1080 human breast fibrosarcoma
cells from apoptosis following treatment with H2O2, to a similar degree as ceria [186].
Combining both chemical studies and calculations, Li et al. 2015 [187] concluded that
the pH-dependant antioxidant behaviour of these noble metal nanoparticles are an intrin-
sic property of the particles independent of the exposed facet of the crystal structure, due
to the preferential absorption of OH groups on the surface of these under basic conditions
responsible for the switchable activity. They also proposed that the relative absorption
kinetics of H2O2 onto the surface of these particles was the major influence on the rela-
tive activities. Other studies have confirmed this behaviour of Au NPs using EPR [188],
and have shown that this property can be tailorable through controlled surface function-
alisation [189] with tertiary amines. Au-Pt nanoparticles have also shown the ability to
be tailored and have been proposed for use as antioxidants to prevent the harm associated
with ROS and OS resulting from UV exposure [190] (Figure 2.10), as well as selective
antioxidants in plasmonic photo-thermal treatment of cancer [19] . Along with these, this
same switchable peroxidase-catalase resulting from a difference in pH has also recently
been reported for PVP-functionalised iridium nanoparticles (PVP-Ir) [191] through EPR,
chemical and in vitro testing.
Given that ceria is an oxide, and that there are many other examples of metal oxides
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Figure 2.10: The free radical scavenging behaviour of Au nanorods (GNR), Pt NPs, Au-Pt NPs
compared to enzymes SOD and catalase [190].
with multiple oxidation states used in catalysis, there has been a number of studies high-
lighting the free radical scavenging behaviour of other oxide materials. The first of these
was reported was yttria (Y2O3) NPs, which was reported to be protective to HT22 hip-
pocampal nerve cells, to a greater degree than ceria in an article in 2006 [82], and another
article has since reported that these same particles are able to prevent from the effects of
glucose-induced OS and apoptosis in PC12 cells [173]. This neuroprotective property of
Y2O3 is not yet fully understood however, but has been hypothesised to be due to the slight
non-stoichiometry of these NPs, in a similar way to ceria. Another rare-earth metal oxide
nanomaterial that exhibits free radical scavenging activity are La2O3 NPs, and these have
been shown to prevent the photobleaching of organic dyes [177]. Cobalt oxide (Co3O4)
nanoparticles have also displayed antioxidant enzyme-mimetic activity, with one study
reporting its catalase-like activity [192], and another it’s catalase-, peroxidase- and SOD-
like activity [193]. This activity is due to the Co3+/Co2+ redox activity of Co3O4, and the
first of these articles showed that this activity is also affected by the shape of the nano-
material. The most surprising of these metal oxides to exhibit free radical scavenging
properties is described in an article by Chen et al. 2012 [194] in 2012, where they re-
port pH dependant catalase-peroxidase activity of DMSO-stabilised Fe3O4 and γ-Fe2O3
nanoparticles (Figure 2.11). Through EPR, dye degradation, and in vitro testing they were
able to show that these nanoparticles have peroxidase-like activity at pH 4.8, degrading
H2O2 to OH· through Fenton chemistry expected of iron cations. At neutral pH however,
both nanoparticles decomposed H2O2 into H2O and O2 which is similar antioxidant ac-
tivity to the enzyme catalase. This article is especially noteworthy as iron oxide have also
been shown to generate reactive oxygen species in vitro [195, 196], indicating that there
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may be some way of tailoring these nanoparticles for desirable ROS interactions within a
biological context.
Figure 2.11: The pH-dependant enzyme activity of DMSO-functionalised Fe3O4 and Fe2O3
nanoparticles [194], where H2O2 is decomposed to H2O and O2 under neutral conditions, such
as in the cytosol. Under an acidic pH of 4.8 however, they decompose H2O2 into OH· [194].
Tailoring Iron Oxide Nanoparticles for Biological Applications
Iron oxide nanoparticles have long been one of the most frequently reported materials
for biomedical applications due a to the abundance and low cost of iron, their desirable
magnetic properties, and ease of synthesis. There are a number of different polymorphs
of iron oxide, with the most common being hematite (α-Fe2O3), magnetite (Fe3O4) and
maghemite (γ-Fe2O3), which can be distinguished by their crystal structure and/or stoi-
chiometry (Figure 2.12). Bulk magnetite and maghemite are ferrimagnetic at room tem-
perature with high saturation magnetisation (as high as Ms = 92 emu g−1), while hematite
is has very weak ferromagnetism at room temperature (Ms ≤ 1 emu g−1). These mag-
netic properties are dependent on particle size however, and magnetite and maghemite
can display superparamagnetism at room temperature once their particle size is below 15
nm. For super-paramagnetic particles, thermal energy at room temperature is sufficient
to overcome the anisotropy energy barrier of a single nanoparticle, meaning that in the
absence of an applied magnetic field their magnetic dipoles are randomly orientated, they
have a high magnetic susceptibility and a hysteresis that consists of a single line. It’s
these super-paramagnetic properties that make these iron oxide nanoparticles attractive
for application as therapies in medicine, as they can be directed around the body using
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external magnetic fields for drug delivery, magnetic contrast agents in Magnetic Reso-
nance Imaging (MRI) and hyperthermia cancer therapy [197]. In fact, there have been
three examples of super-paramagnetic iron oxide nanoparticles (SPION) approved by the
FDA for use as MRI contrast agents and hyperthermia agent for glioblastoma [117], al-
though one of the contrast agents GastroMARK, has since been discontinued due to side
effects. These products, as well as many other nanomaterials proposed for biomedical
applications featured organic or silicon-based surface coatings in order to help minimise
particle agglomeration.
Figure 2.12: The crystal structures of the most common iron oxide polymorphs hematite, mag-
netite and maghemite. The black balls are Fe2+, the green is Fe3+ and red are O2− [197].
Given the significant interest into iron oxide nanoparticles for biomedical applications,
there have been a significant number of different synthesis methods reported in litera-
ture including co-precipitation [198], thermal decomposition [199], hydro-/solvo-thermal
[5, 200], sol-gel [201], microemulsion [202], sonolysis [203], micro-wave assisted [204],
biosynthesis [205], and electrochemical [206] methods. Each of these approaches have
varying complexity, reaction time, yield and can have some control over size, size dis-
tribution and shape of the resulting particles. In our previous work [198] we described
a method combining the spray pyrolysis and co-precipitation methods in order to cre-
ate highly porous hematite nanorods for use in catalytic and energy storage applications.
Insight into controlling the free radical behaviour and cytotoxicity of such particles is
of concern, due to the interest in application of these particles in catalysis [207, 208]
and cosmetics [209, 210]. The cytotoxicity of such hematite nanoparticles has been fea-
tured in a number of studies [211], which often report the induction of oxidative stress
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[212, 213] through the generation of free radical species through Fenton-like reactions.
This is because the band-gap of this material is ideal for the decomposition of H2O2 into
the more harmful OH· radical species [214]. Previous studies have shown that smaller
hematite nanoparticles are more cytotoxic [215] and particles larger than 90nm show very
little evidence of toxicity [216], except at higher concentrations [212]. However, it has
also been suggested that the effects of agglomeration and the biological environment of
the particles can have more of an effect on their toxicity than purely their size [217] . It
has also been shown that this cytotoxicity can also be dependent on the cell line [218],
with toxicity to cancer cells demonstrated [219], indicating potential clinical application.
The role in which surface characteristics of these nanoparticles has not been fully ex-
plored, and there are a number of potential features which could have an implication on
the cytotoxicity of such nanoparticles. One article by Chernyshova et al. 2007 [220]
describes the size-dependent formation of thermodynamically-favourable γ-Fe2O3 sur-
face defects (T-defects) on the surface of hematite (α-Fe2O3) nanoparticles. Given the
aforementioned article by Chen et al. 2012 [194] describing the antioxidant properties of
maghemite and magnetite nanoparticles, the formation of such defects on the surface of
hematite nanoparticles could have implications towards their interaction with ROS within
biological environments and hence, the toxicity they may impart.
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2.2 Ultraviolet Filters in Cosmetic and Sunscreen Prod-
ucts
It’s been known since the early 1990’s that ultraviolet light is a carcinogen [123], respon-
sible for a significant proportion of skin cancers [124] including melanoma, basal cell
carcinoma and squamous cell carcinoma. Furthermore, certain wavelengths of ultravi-
olet light are also implicated in suppression of the immune system, while UVA causes
photoaging of the skin. However, small amounts of ultraviolet exposure are needed in
order for humans to synthesise Vitamin D, meaning that we cannot remove ourselves
completely from ultraviolet radiation exposure.
2.2.1 Effects of Ultraviolet Radiation Exposure Human Health
There are a number of different mechanisms through which ultraviolet radiation is able
to cause damage on a cellular level and as such, have an impact on human health. Ul-
traviolet radiation comprises a region of the electromagnetic spectrum between 100-400
nm, and as such has a shorter wavelength range than visible light (400-700 nm). Due to
the inversely proportional relationship between wavelength and energy, this means that
photons of ultraviolet light carry more energy than visible light, with the subcategories
UVA, UVB and UVC having increasingly more. The effect of this increasing energy on
biological systems can be best seen in the erythema action spectrum (Figure 1.11) which
shows the wavelength dependence of this effect, which increases at shorter wavelength of
ultraviolet light. These wavelengths of radiation can cause a host of effects through both
direct and indirect-damage mechanisms, changes to the cell cycle and immunosuppres-
sion (Figure 2.13).
Direct DNA Damage from UVB Radiation
First and foremost, UVB radiation can cause damage to DNA as it strongly absorbs wave-
lengths between 245 - 290 nm. This process can result in the formation of DNA lesions
and mutagenic photoproducts, which usually occurs through a direct excitation of the
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Figure 2.13: Graphic showing the penetration of UVA and UVB into different layers of the skin
[221].
nucleobases and further reactions in an oxygen-independent manner to result in their
formation of dimers with the DNA structure. There are a number of different types of
damage that can occur, with the most common at locations in DNA structure at which
there is adjacent pyrimidines, producing cyclobutane dimers (cyclobutadipyrimidines)
between thymine (T) or cytosine (C) (Figure 2.14), or 6-4 photoproducts (Figure 2.15)
[222]. These (6-4) photoproducts also occur between adjacent pyrimidines, resulting
from [2+2] cycloaddition between C6 and C4 carbons on adjacent prymidine and thymine
residues in which the dimers form. They can also be further converted into Dewar valence
isomers upon exposure to UVB, which are overall less mutagen than 6-4 photoproducts,
but also less specific and can result in a broader range of mutations [223]. The formed
cyclobutane dimers are more potentially mutagenic than (6-4) photoproducts the latter of
which is easier to be repaired [224]. Although much more unlikely than pyrimidine bases,
purine bases can also be photo-reactive, either through direct absorption of UVB radia-
tion resulting in adenine (A) dimerisation with another adjacent adenine [225] or thymine
residues [226]. It has also been shown that singlet oxygen can be generated between the
triplet state of purine and pyrimidine bases upon UVB radiation in the presence of ground
state oxygen without any photo-sensitising agents [227]. If such lesions within the DNA
are not properly repaired, they can go on to form mutations within the cell, causing al-
tered or diminished function, or lead to carcinogenesis. These photoproducts can lead to
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mutations through the ’A Rule’, where DNA polymerase-eta incorrectly inserts adenine
(A) residues due to being unable to interpret the opposite dimers, resulting in alterations
of base pairs [228].
Figure 2.14: Mechanism of formation for thymine cyclobutane dimers [227].
Indirect DNA Damage by UVA Radiation
There is also significant evidence that UVA radiation, while not able to cause direct
damage as UVB can, is able to cause oxidative damage to mammalian cells through
photosensitisers. Due to having a longer wavelength, UVA radiation is able to pene-
trate deeper into skin than UVB. There are two types of photosensitisation mechanisms
currently understood to result in photooxidative damage of DNA resulting from UVA
exposure [229]. These photosensitisers could potentially include porphyrins, bilirubin,
melanin and melanin precursors, flavins, pterins, B6 vitamins, Vitamin K, NAD(P)H,
trans-Urocanic acid, tryptophan, advanced glycation products, reactive carbonyl species
and lipofuscin [230]. This is known as Type I photosensitisation, and one of the likely
mechanisms is that these photosensitisers engage in a charge transfer reaction with the
target biomolecule after persisting in a triplet state (Figure 2.16) [231]. This results in
an electron abstraction resulting in the formation of two charged radicals, which can then
go onto to engage in deprotonation or hydration reactions to form neutral radical species.




These radicals can then go on to react with molecular oxygen or O·−2 radicals, and these
resulting peroxyl or hydroperoxides which are intermediates through which the final ox-
idation products are generated. These final oxidation targets are usually DNA, lipids and
proteins, resulting in the harmful biological effects of these reactions. Type II photosen-
sitisation involves energy transfer from a photosensitiser to molecular oxygen, resulting
in singlet oxygen (1O2) which can go on to engage in [4 + 2] Diels-Alder cycloaddition,
[2 + 2] cycloaddition and the ene-reaction. This can result in endoperoxides, dioxetanes
and hydroperoxides. A minor side-reaction of this process also involves a charge transfer
with oxygen, leading to O·−2 generation. Generation of these superoxide species can also
potential result in dismutation to H2O2, which though relatively unreactive, could also en-
gage in the Fenton reaction for further ROS generation [94, 95]. The main product of this
UVA-induced DNA oxidation is the 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxoGuo)
lesion, which is a biomarker of oxidative damage to DNA, also formed from OH· and
peroxynitrile.
Figure 2.16: UVA- and UVB-mediated reactions with DNA [94].
ROS Generation from UV Exposure
Along with these indirect and direct damage mechanisms of UVA and UVB light respec-
tively, both subcategories of UVR are able to trigger oxidative responses within mam-
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malian cells in the form of ROS and RNS in delayed biochemical processes which can
persist after exposure has ceased. UVA is able to induce inflammation in skin through
ROS initiating signal transduction processes [232], which in turn can result in increased
expression of nitric oxide synthase, an enzyme able to generate NO·. Nitric oxide radi-
cals can also be generated by UVA-induced photolysis of NO stores [233]. It’s also been
shown that UVA irradiation of human keratinocytes can induce ROS and RNS including
H2O2, peroxynitrile and other peroxides [232], and there is evidence to support a by-
stander effect from UVA excitation of dermal extracellular matrix protein chromophores
[230]. UVA irradiation can also potentially release iron in human skin cells, which is of
concern due to UVR’s implication in the generation of H2O2, which are the catalyst and
precursor to the Fenton Reaction, respectively [234]. Labile iron can also be release from
free heme through an oxidative response to UVA exposure resulting in up-regulation of
heme oxygenase-1 [235]. As previously mentioned, ROS is also generated through the
photosensitisation reactions that occur upon UVA exposure to cells.
Cell Cycle Alteration and Immunosuppression
Ultraviolet radiation is also able to cause changes within the lifecycle of cells, with sig-
nificant UV exposure causing the cell to stop replicating in order to repair any formed
damage, a mechanism to prevent the passing down of mutated genetic material to daugh-
ter cells, which can lead to carcinogenesis. This same process of DNA damage from UV
exposure, causes the up-regulation of p53 a protein which is responsible for halting the
cell cycle and can induce apoptotic pathways [236] if the damage to the genome is too
severe to be repaired. Exposure to UV can also alter the cell cycle in such a way to allow
less time for DNA repair before replication, resulting in a higher chance of mutation. Ul-
traviolet light exposure can also indirectly lead to carcinogenesis through another indirect
route, through the suppression of the immune system. of humans through effecting the
ability for certain specialised Langerhans cells within the skin to effectively communicate
with T-cells, thus decreasing the likelihood of the immune system recognising mutated or
transformed cells [237]. This is evident in studies showing a higher risk of skin cancer in
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patients undergoing immunosuppressive therapies [238].
Sunburn
The most noticeable harmful effects of UV on normal skin are sunburn, which is a com-
bination of inflammation, edema and erythema that begins to appear at just over 1 MED.
While the exact molecules responsible for the inflammation in sunburn are not known,
it’s thought that it is a consequence of DNA damage both through the direct formation of
DNA photoproducts as well as oxidative stress and the resulting oxidative damage caused
through UV-induced dismutation of H2O2, as well as generation of O·−2 through chro-
mophores in skin [239]. Sunburnt cells have been identified as keratinocytes undergoing
apoptosis [240].
Photoaging
Chronic ultraviolet exposure over long periods can result in significant photoaging of
the skin, which is marked by alternations of tissues at the cellular level. While UVB
is mainly responsible for cellular damage, UVA can cause these significant alterations
within the tissue, resulting in dryness, irregular pigmentation, wrinkling, elastosis and
telangiectasia; or the appearing of red lesions on the skin [237]. Studies have shown
that even low levels of UVA exposure (0.5 MED) over long periods was able to cause
cumulative photoaging effects including thickening of the stratum corneum, depletion
of Langerhans cells and epidermal hyperplasia [241]. It’s also shown to increase the
deposition of lysozyme on elastic fibres, which is associated with sun damage. Photoaged
individuals also have lower levels of antioxidants within their skins, along with increased
inflammation and neutrophil infiltration [242].
Vitamin D Production
One of the positive impacts that Ultraviolet light exposure has on health is as being
our main source of vitamin D, next to diet. Ultraviolet B radiation converts 7-dehydro-
cholesterol from within a reservoir in the skin, into pre-vitamin D3 that then undergoes
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temperature dependant isomerisation over the period of 3 days [243]. Vitamin D is a nec-
essary hormone that controls calcium levels in the blood, and low levels of vitamin D have
been linked to an increased risk in a number of different chronic diseases, including MS,
Diabetes, colon and prostate cancer, heart disease, autoimmune diseases, mental health
conditions and heart disease [244, 245]. As such, the advice from medical professionals
is to limit the amount of sun exposure in order to balance the need to synthesise vitamin
D whilst minimising sun exposure.
Skin Cancer
Many of the molecular effects of ultraviolet radiation previously mentioned in this sec-
tion, specifically those that can cause genetic mutations, changes within the cell cycle and
effect the immune system can result in carcinogenesis, the process of developing cancer.
Carcinogenesis is defined in three stages: (1) Initiation; (2) Promotion and (3) Progres-
sion [246] and the three most common types of skin cancer linked to UV exposure are
melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), which are
neoplasms (new, abnormal growth of tissue) within skin tissues. Like all cancers, these
cells then undergo unchecked, continuous proliferation and differentiation, and can then
potentially metastasise, shedding from the skin and spreading to other regions within the
body. Melanoma is a form of skin cancer that has the potential to be lethal, and can ap-
pear at sites of ’beauty spots’ and moles, or on plain skin, occurring more frequently on
regions of the body with continuous sun exposure, such as the face. While the underlying
influences that can affect the development of melanoma are not fully understood, it has a
very strong association with increased ultraviolet exposure. The other two major forms of
skin cancer BCC and SCC are neoplasms of keratinocytes, skin cells that produce keratin,
and they result from previously sun-damaged skin. Squamous cell carcinoma initially be-
gins as disordered keratinocytes which progress to precancerous lesions known as actinic
Keratosis which can then progress to invasive carcinomas. Basal cell carcinomas have
no precancerous lesions, but can arise from hair follicles, sebaceous glands and inter-
follicular basal cells, which are deeper regions within skin tissue and as such could be
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resulting from a longer wavelength of UV compared to SCC [247]. Regarding the molec-
ular mechanisms that can result in photocarcinogenesis, both ultraviolet-induced genetic
mutation and alterations in protein expression of a number of different tumour suppres-
sor proteins and proto-oncogenes, including p53, GADD45, p16, PTCH and Ras, among
others, have all be reported to play a role [248]. This is one of the biggest motivations
for increased research into the influence of ultraviolet light on human health, given the
significant burden that skin cancer causes on the population, especially in Australia and
New Zealand, that have an average incidence of melanoma roughly seven times higher
than the global average [130].
2.2.2 Sunscreens and Cosmetic Products with Sun Protection Factor
(SPF) rating
Given all the potential harm and deleterious effects associated with high levels of UV
exposure, the sometimes-unavoidable fact of having to perform some tasks or activities in
full or half sunlight during the day, and the increased UV levels within regional areas, a
number of strategies have been adopted to limit the amount of UV light incident on skin
to safe levels. The use of dermally applied sunscreens and cosmetic products which con-
tain ultraviolet filters is one such strategy that is very successful at decreasing ultraviolet
exposure during long periods in sunlight. Along with the oils, fragrances, and pigments
(in the case of cosmetic products), are components within these products to absorb ultra-
violet light, which are known as the ’active’ ingredients within sunscreens. The extent
to which these products are able to filter out the ultraviolet component within incident
sunlight and prevent it from reaching skin cells is known as the Sun Protection Factor
(SPF) rating (Equation 2.7). In Australia, the Therapeutic Goods Administration (TGA)
is responsible for the regulation of therapeutic sunscreens i.e. products whose primary
purpose is to provide sun protection, with a SPF rating ≥ 4, and/or that contain an insect
repellent. This also applies to ’secondary’ sunscreens, excluding those counted as cos-
metic products, which are instead regulated according to National Industrial Chemicals
Notification & Assessment Scheme (NICNAS) [249]. This SPF rating is defined based
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on the ability for the product to increase the minimum erythema dose on skin protected
by the product, compared to non-sunscreen-protected skin [250].
SPF =
minimum erythema dose on sunscreen-protected skin
minimum erythema dose on non-sunscreen-protected skin
(2.7)
Where the minimum erythema dose (MED) is defined as the minimum amount of ul-
traviolet exposure needed to produce a discernible ’sunburn’, or redness in the colour of a
person’s skin, 24 hours after UV exposure [251]. The ability for ultraviolet light to cause
erythema is wavelength dependant, and this is also considered when calculating the SPF
rating of a sunscreen emulsion. The below Figure 3.15 shows the erythemal effectiveness
spectrum E(λ ); with the spectral irradiance of the ’standard sun’ S(λ ); and the product of
these, showing the main wavelengths of erythemal action from sun exposure. The product
of these terms is in the equation used for the calculation of the SPF and PF-UVA ratings
of a sunscreen product (Equation 3.15, Equation 3.16) and as such, a greater absorption
of ultraviolet light at in the wavelengths of increased erythemal action results in a higher
SPF rating of the emulsion (Figure 2.17).
Figure 2.17: (a) Spectral erythemal effectiveness E(λ ) and spectral irradiance of the standard
sun S(λ ) and (b) their product [110].
While this is used as a major point of marketing for sunscreen brands, there are common
misconceptions in the relationship between the numerical SPF value and the amount of
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UV light the products prevent reaching the skin. As an example, a product with an SPF of
60 which filters out 98.3 % of erythemogenic UV photons is only 1.6% more protective
than a product with an SPF rating of 30 which filters our 96.7 % of these photons, and not
twice as effective (Figure 2.18) [252].
(a)
(b)
Figure 2.18: (a) Illustration highlighting the differences in SPF rating, in terms of average per-
centage of filtered erythemogenic ultraviolet photons and (b) dynamic view of how relative pro-
tection of sunscreens with different SPF over time [252].
However, the amount of ultraviolet exposure needed to illicit an erythemal response
is greatly dependant on melanin levels of the individual’s skin, with people with fairer
skin tone requiring less exposure to produce an erythema response, and hence being more
susceptible to develop skin cancer as a result [253] (Table 2.1). The use of sunscreens
has been adopted very successfully, especially in Australia, where awareness programs
and campaigns have encouraged the use of these products when exposed to ultraviolet ra-
diation during recreational or occupational activities. This has created fairly competitive
space within the already enormous cosmetics industry, which itself has a global market
size within the hundreds of billions of US dollars annually. As such, active ingredients
used within these products is a point of significant research and development, in order to
produce products with a high SPF rating over long periods with superior feel and appear-
ance. As of a review article published in 2009, there were 55 ultraviolet filters approved
for use globally [254]. These active ingredients fall into two categories, ’organic’ ul-
traviolet absorbers which are organic molecules that have strong ultraviolet absorption




Table 2.1: Details on minimum erythema dose and susceptibility, ability to tan and susceptibility
to skin cancer for different skin types. Note that SED is the standard erythema dose, which is 100
J m−2 [255].
Sensitivity 1 MED Susceptibility to
Skin Type Phenotype to sunburn (as SED) Tanning ability skin cancer
I White (very fair) Always burns 2-3 Never tans High
II White (fair) Burns easily 2.5-3 Tans minimally High
III Cream white Burns mildly 3-5 Tans gradually High
IV Light brown Burns slightly 4-7 Tans well Moderate
V Brown Burns rarely 6-20 Tans profusely Low
VI Black/dark brown Never/rarely burns 6-20 Always tans Low
2.2.3 Organic UV absorbers
Organic ultraviolet (Figure 2.20) absorbers vastly outweigh the number of inorganic ul-
traviolet absorbers in variety, with a large number currently approved by the TGA for
use here in Australia. These organic molecules are generally conjugated systems fea-
turing benzene rings within their chemical structure. When such a molecule absorbs an
ultraviolet photon of sufficient energy, an electron is promoted from its highest occupied
molecular orbital (HOMO) to the lowest unoccupied molecular orbital (LUMO), which
results in the formation of a singlet state (Figure 2.19a). This singlet state can then release
this energy by emitting another photon through fluorescence or undergoing photochemi-
cal reactions. However, in some cases the singlet state can undergo intersystem crossing
to result in a triplet excited state, where energy can only be released through phospho-
rescent emission, energy transfer to other molecules, or other photochemical reactions
(Figure 2.19b).
(a) (b)
Figure 2.19: (a) The absorption of an ultraviolet photon resulting in a HOMO-LUMO transition




Figure 2.20: The seven major sunscreen groups of organic UV filters currently used in commer-
cial sunscreen and cosmetic products [97].
This results in the chemical species exhibiting very strong, narrow absorption of ul-
traviolet photons of particular wavelengths with some λmax, and generally these organic
filters are classified as UVA or UVB filters. This absorption can result in electron delo-
calisation, tautomerism and photoisomerization (Figure 2.21). As such, organic filters are
often used in combination in order to provide sufficient protection over a large range of




Figure 2.21: Electron delocalisation resulting from ultraviolet photon absorption of (a) PABA,
(b) benzophenone and (c) a salicylate derivative. Also shown are two other types of transitions,




Issues Surrounding the Use of Organic UVA-UVB Filters in Sunscreens and Cos-
metic Products
The TGA is responsible for regulating sunscreen ingredients within Australia that qual-
ify as ’therapeutic’ sunscreens, and each active ingredient must be listed on the product
and present in no greater concentration than that set according to the guidelines which
can be seen in Table A.1 [249]. There have been some concerns raised over the use of
these organic ultraviolet filters within commercial sunscreen products as they are able
to be absorbed through the skin with an unknown fate, they can disrupt the endocrine
system, cause allergic reactions, and degrade under UV exposure resulting in unknown
photoproducts. Table 2.2 shows a list of the most common sunscreen ingredients cur-
rently used throughout Australia, USA and Europe. The Environmental Working Group,
an American environmental organisation that specialising into research into chemicals
that may be toxic to human health and the environment, released an article summaris-
ing organic sunscreen filters that have potentially adverse effects on human health [256].
With references to the appropriate literature, each sunscreen ingredient was assigned a
’Hazard Score’ based on its ability to penetrate through the skin, disrupt hormones and
cause allergic reaction, as well as any other concerns and these are listed in the below
Table 2.2.
Hormone Disruption
A review article by Krause et al. 2012 [98] summarised the current status of research
into organic ultraviolet filters that have been showed to disrupt endocrine function fol-
lowing exposure. The filters covered in the article include Benzophenone-3 (BP-3), Oc-
tocrylene (OCT), 3-benzylidene camphor (3-BC), 3-(4-Methyl-benzylidene) camphor (4-
MBC), 2-Ethylhexyl 4-methoxy cinnamate (OMC), Homosalate (HMS), 2-Ethylhexyl 4-
dimethylaminobenzoate (OD-PABA), 4-Aminobenzoic acid (PABA) along with inorganic
filters ZnO and TiO2. It should be noted that of these products covered in the review, 3-
BC is the only one to not currently be approved for use within therapeutic sunscreens in
Australia [249] or America [257]. Of these BP-3, 4-MBC, OMC, HMC and OD-PABA
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Table 2.2: Most common organic UV absorbers used in sunscreens worldwide.
Product Name Max Concentration
(w/w%)
Approved in EWG Hazard Score
UVA filters
Avobenzone 5 AU, USA,
EU
2






















Homosalate (HMS) 10-15 AU, USA,
EU
4






4-Aminobenzoic acid (PABA) 15 AU, USA
all exhibited estrogenic effects in vitro [258–260]. This means that these chemicals mimic
the activity of estrogens naturally occurring in the body, such as 17β -estradiol (E2) [261].
As such, they can disrupt the estrogen signalling activity within the body, and result in
many adverse health effects in mammals such as reduced sperm counts, altered func-
tion of reproductive organs, early puberty in females, altered sex-specific behaviour and
increased rates of some cancers including breast, ovarian, testicular and prostate [262].
This activity of these organics had varying effects in subsequent in vivo studies however,
indicating that there may be some limitations of the in vitro models [258]. Each of these
organics, along with 3-BC and HMS, also displayed androgenic activity or the male sex
hormone equivalent of estrogenic activity [260]. Some were also shown to have stark
effects on reproductive organs and developmental toxicity in a number of studies. These
effects included delayed puberty and reduced prostate weight in Long Evans rats [263],
along with altered protein and gene expression, changes in sexual behaviour in female rats
[264], decreased sperm count and male fertility [265]. Litter size and mortality rates were
also affected when female rats were exposed to high quantities of 3-BC [266]. Studies
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have also shown that 4-MBC, BP-3 and OMC may all effect the hypothalamic-pituitary-
thyroid axis (HPT) [267, 268], which is responsible for the regulation of metabolism.
Skin Penetration of Organic Ultraviolet Filters
There are currently four main methods for assessing the dermal absorption of chemicals
or substances in human or animal test subjects. They include tape-stripping, use of per-
cutaneous diffusion cells, and sampling of biological tissues and fluids. Tape-stripping
experiments on human and pig skin have shown era that EMD, BP3 and Avobenzone, 4-
MBC and HMS have shown dermal absorption between 0.1 to 4%, with many questioning
the accuracy of this test method. Cell diffusion experiments, in which excised human or
animal skin in placed in a diffusion cell and the amount of UV filter penetrated detected
in a receptor fluid has also been conducted on a significant number of filters, showing that
between 0.6-10% of these substances can be absorbed over a 24-hour period [269]. Hu-
man exposure studies sampling biological fluids have also shown that BP-3, 4-MBC and
OMC can easily permeate through the skin [270], and can be detected in blood plasma
1-2 hours after application [271]. It has also been shown that such UV filters are also able
to cross the blood-placenta barrier [272], and are also able to be transmitted to infants
through breast milk [273]. High levels of UV filters were also associated with decreased
birth weight for newborn girls and decreased head size for boys. This should be concern-
ing, as a study by Calafat et al. 2008 detected BP-3 in 96.8 % of 2,517 urine samples
taken from the general US population between 2003-2004. Many of the studies covered
in Section 2.2.3 assessing the effect of these UV filters on the endocrine system did so
through oral ingestion, while exposure through skin penetration could actually result in
these chemicals having a more marked effect on health. One study showed that dermal
absorption of 4-MBC had a three-fold greater estrogenic effect on rats after topical appli-
cation as compared to oral exposure [258] and 3-BC can easily reach all tissues unaltered
after dermal application [274]. This higher bioavailability is thought to result of these
filters entering systemic circulation directly following skin absorption, as opposed to with
ingestion where they are first metabolised and passed through the liver.
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Contact Allergic and Photo-allergic Reactions
These organic ultraviolet filters can also cause contact allergies and photo-dermatitis al-
lergic reactions and are the leading cause of photoallergic contact dermatitis in the UK
[275]. Both of these are immune responses from the body which recognise these or-
ganic filters as foreign bodies, with the latter resulting from photosensitisation occurring
when these organic products decompose or isomerise under UV-light. Oxybenzone is the
most well known to cause both of these reactions in small percentages human patients
[276, 277] and benzophenones are the most common photocontact allergen. Reports of
allergies to cinnamates, PABA esters and salicylates are less common, while there have
been a number of reports on contact allergies to 4-MBC [278, 279]. A more recent re-
view of allergic patch test results however, suggests that PABA 4 has similar frequency to
avobenzone, oxybenzone and benzophenone-4 citeVictor2010, with sunscreen allergies
being the some of the most common causes of photoallergic contact dermatitis. These
allergic reactions are far less serious and of consequence than the other potentially delete-
rious effects of the more harmful organic ultraviolet filters currently present within com-
mercial sunscreen formulations. However, these immune responses are one of the main
motivations for the inclusion of inorganic filters such as ZnO and TiO2 in modern sun-
screen products, as these can be included in significantly high concentrations without any
potential for an allergic response.
Photostability
The photostability of organic UV filters currently used in sunscreen products is also a
point of concern and has the potential to increase certain health risks. Many of these prod-
ucts are not photostable (Figure 2.22), evidenced by the inclusion of other components
within sunscreen formulations in order to attempt to increase their stability [97, 280–283].
These photodegradation reactions can result in photoallergic reactions or photoirratation
in the short term, and higher risk of skin cancer and photoaging in the long term. This is
due to two factors, the first being that the photodegradation products of these molecules
can induce such responses, as discussed in Section 2.2.3. Secondly, this photodegrada-
tion decreases in the effectiveness of these filters, exposures users to higher amounts UVR
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unknowingly, potentially shortening the time needed before reapplying. It is a complex
issue, as there is first the UV-photostability of individual components in various media
[97], the complicated photochemical reactions also potentially occurring, as well as the
potential influence of free radical generation. There are also questions regarding how
to best design and adopt experimental procedures that best represent the conditions that
such filter components would be exposed to while being used as in a sunscreen prod-
uct. The photo-instability of many of these filters are well known, with PABA, one of
the first widespread ultraviolet filters, shown to undergo photodegradation. While there
were many reports of photoallergic responses to this filter, it was shown that this ef-
fect was likely not a result of the photodegradation products, and it was also shown that
these products did not augment UV-induced skin carcinogenesis [103]. Avobenzone sim-
ilarly undergoes photodegradation upon UV exposure [284], with the potential that these
photodegradation products do induce a photoallergic response in a small portion of the
population [285]. Padimate-O (OD-PABA) is a derivative of PABA and shows similar
behaviour, degrading quickly under UV irradiation in a variety of neat solvents [97], with
the same study showing the significant instability in OMC, Oxybenzone and Ensulizole.
Other studies have confirmed this behaviour in Padimate-O, showing it is much less pho-
tostable that Octocrylene, BP-3 and IAMC [282].
Certain combinations of UV filters are also known to be very photo-unstable, such as
when OMC is combined with avobenzone or oxybenzone [97]. A number of studies have
also looked at the photostability of commercial sunscreen products themselves, showing
that some possess low photostability over time [287], with those containing avobenzone
the quickest to degrade [286]. Furthermore, the photodegradation of these organic filters
is accelerated significantly when irradiated in the present of photocatalytically active TiO2
or ZnO nanoparticles, common inorganic filters in modern sunscreen formulations. This
aspect of the photostability of sunscreen products will be further explored in Section 2.2.4.
While these unstable products should be of concern, they still aid in the prevention of skin
carcinogenesis and as such should be used when appropriate and to the manufacturer’s di-
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Figure 2.22: (a) The photodegradation of OMC (8 mg L−1) under combined UVA/UVB irradi-
ation [97] and (b) the degradation of a number of photounstable commercial sunscreen products
after UV irradiation [286].
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rections. There should, however, be the adoption of a standard model for both testing the
photostability of these individual UV filters and the sunscreen products that they are in-
cluded in, to be adopted as a part of the current measurements used to determine sunscreen
efficacy.
Antioxidants
Exposure to high levels of UVA radiation can induce the production of ROS within skin,
which can lead to an induction of oxidative stress and its associated deleterious effects
such as free radical mediated DNA damage, lipid and enzyme peroxidation as well as
photoaging. The body has a natural defence system of antioxidants in order to neutralised
increased levels of pro-oxidants, which include antioxidant enzymes such as superoxide
dismutase, catalase and glutathione peroxidase as well as low molecular weight antioxi-
dants, many of which originate from dietary sources, such as ascorbic acid (Vitamin C),
α-tocopherol (Vitamin E) and carotenoids (Vitamin A) [239]. While many of these an-
tioxidants have negligible UVR absorption, the application of topical antioxidants has
shown to have a protective effect through the suppression of the effects UVR induced
skin damage including erythema, immunosuppression and carcinogenesis and a number
of commercial products are now include these agents. It’s also been shown in a number
of studies that these antioxidants can also act as a stabilising agent [288, 289] for organic
UV filters, doubling their benefits. There are a number of technical challenges however,
regarding the solubility of these antioxidants within the sunscreen emulsion [83].
2.2.4 Inorganic UV absorbers
Inorganic ultraviolet filters have been used in sunscreens since the 1980’s, due to the
broad-spectrum UVA-UVB absorption afforded by some metal oxide minerals [290].
These products featured TiO2 and ZnO particles that were micro-sized (≥0.1 µm) or
larger in diameter, resulting in formulations that were thick and didn’t blend into skin
after application. Manufacturers continued to improve of these products however, and as
a result, the first sunscreen containing TiO2 nanoparticles was commercialised in 1989
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while the first product containing ZnO nanoparticles appeared in 1991 [221]. Nanosized
forms of these materials have higher, more selective absorption and scattering of UVR,
and emulsions containing them appear to be transparent and smoother after being rubbed
into the skin of the user. Currently, TiO2 and ZnO are the only inorganic ultraviolet filters
approved for use in therapeutic sunscreens by the TGA in Australia [249]. These two
materials are both n-type semiconductors, and they absorb ultraviolet photons through
promotion of an electron from the valence band to conduction band, as well as scatter UV
light strongly through Rayleigh Scattering.
Titanium Dioxide
Titanium dioxide (TiO2), also known as titania, is a white, non-soluble, non-combustible
and odourless powder that crystallises in three different allotropic forms, anatase (tetrag-
onal), rutile (tetragonal) and brookite (rhombohedral) (Figure 2.23). Alongside cosmetic
applications, TiO2 is the most widely used photocatalyst, with their high UV-induced pho-
tocatalytic activity useful for in water cleaning [291], dye-sensitised solar cells [292] and
photocatalytic water splitting [293]. Slight differences in the crystal structure of these
forms of TiO2 results in differences in the band structure, with anatase having an indi-
rect band gap of 3.2 eV, while rutile has a band-gap of 3.0 eV [294] with both of these
resulting in strong absorption in the UV spectrum.
Figure 2.23: Crystal structure unit cells for rutile, brookite and anatase TiO2 (left to right) [295].
Anatase also has a higher photocatalytic activity than rutile [296], with this difference
being owed to the mobility of charge carriers in the bulk of the material of the different
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crystal structures [297]. There are also however, a number of commercial available TiO2
nanoparticles (Figure 2.24) with exceptionally high photocatalytic activity that feature a
mixed anatase-rutile crystal structure, such as P25 and P90 made by Degussa [298]. De-
spite the potentially negative aspects that this photocatalytic activity may have on other
substances in the product, their high UV-attenuation means that some of these highly pho-
tocatalytic anatase-rutile TiO2 nanoparticles have been found in commercial sunscreen
products [102]. Furthermore, for sunscreen ingredients in Australia, the TGA approves
an ingredient based on chemical formula, meaning that there is no distinction between the
crystal structure or particle size of TiO2 to be used as an active ingredient, despite that
these have a significant effect on the properties of the particles.
Figure 2.24: Transmission electron microscopy images of commercial TiO2 nanoparticles (P-
25).
Zinc Oxide
Zinc oxide (ZnO) is the second most used semiconductor after TiO2, due to its low cost
and favourable photocatalytic activities. Similarly, it’s also a white, non-soluble, non-
combustible and odourless powder and has a wide, direct band gap of 3.2 eV for bulk
[294], and it has a strong broad band absorption across the UVA and UVB spectrum.
Zinc oxide crystallises most commonly in one of three different structures, rock salt,
wurtzite or cubic (zinc blende), with wurtzite being the most stable and commonly occur-
ring of these [299] (Figure 2.25). Due to these properties, ZnO nanoparticles have poten-
tial applications in solar cells [300], gas sensing [301], light emitting diodes [302], an-
timicrobial coatings [7], photocatalysts [303] alongside cosmetic applications [249, 304].
While ZnO is cheaper than TiO2 and has a lower refractive index, it is also less pho-
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tostable, able to undergo photo-corrosion under UV irradiation [303] which occurs in
4 steps (Equation 2.8-2.11, overall Equation 2.12) [305]. This dissolution of the ZnO
nanoparticles (Figure 2.26) results from the interaction of the UV-generated holes (h+VB)
and the surface oxygen sites on the ZnO particles, and this greatly effects the efficiency
of photocatalytic activity.
Figure 2.25: Structure of unit cell for (a) wurtzite, (b) zinc blende and (c) rock salt ZnO crystal
structures. The grey balls represent Zn atoms, while the red ones represent O atoms [299].
There are a number of different commercially available ZnO nanoparticles which have
found use in sunscreen products [304, 306], and there is no limit set by the TGA on
the amount of ZnO able to be used in sunscreen products in Australia [249]. However,
due to concerns regarding the toxicity of ZnO nanoparticles on mammalian cell lines,
they were banned in cosmetic products in Europe for some time, but have since been ap-
proved [307] but agrees that these nanoparticles are still not safe for use in spray products.
Some examples of commercial nanoparticles with potential use in sunscreens are TEGO
SUN R© Z500 (Goldschmidt), NANOXTM (Elementis specialities), Zinc oxide NEUTRAL
R© (Symrise), Z COTE R©MAX, Z COTE R© HP1 (BASF), Zinc oxide NDM R© (Symrise)









2(O−O2−)+2h+VB −→ O2 (2.10)
2Zn2+ −→ 2Zn2+(aq) (2.11)







Figure 2.26: TEM images of a number of ZnO nanoparticles with different aspect ratios [309]
UV-absorption Mechanism
As previously covered in Section 1.1.3, as these metal oxides are semiconductors, they
absorb incoming photons where the energy of the incoming photon is greater than the
energy size of their optical band gap (Eg) (Figure 2.27, Figure 2.28 & Equation 2.13).
Upon absorption, an electron is promoted from the valence band to the conduction band
resulting in charge separation, a process of photo-excitation. If the minimum energy
of this excitation involves no change in momentum the material is known as a direct
band-gap semiconductor, while if some change is moment is needed, the absorption of
a photon must be coupled with a phonon (lattice vibration) in order to produce photo-
excitation and such materials are known as indirect band gap semiconductors. As such,
absorption of a photon by a direct band gap semiconductor is much more likely, these
types of semiconductors have a much stronger absorption compared to indirect band gap
semiconductors.
Figure 2.27: Comparison between the absorption mechanism of organic UV filters (left) and
inorganic semiconductor UV filters (right) [308].
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E = h̄ω = Eg +Ee,kin +Eh,kin (2.13)
Figure 2.28: Promotion of an electron form the valence to conduction band in a direct band gap
semiconductor as a result of the absorption of a photon [310].
What makes these oxides the current standard for this application is the size of their
Eg’s, which are 3.2 eV for TiO2 [99] and between 3.2-3.7 eV for ZnO [100, 303] respec-
tively. These values for photon energy correspond to the wavelength boundary between
ultraviolet and visible light as photon with λ = 400 nm would have Ephoton = 3.1 eV,
and given the inversely proportional relationship between photon energy and wavelength,
coupled with the nature of their band structures, ZnO and TiO2 can absorb larger por-
tions of the ultraviolet spectrum (Figure 2.29, 2.30). The size of the optical band gap
within semiconducting nanoparticles such as these can be tailored, as due to the effects of
quantum confinement, the band structure is stretched as the diameter of the nanoparticles
decreases. This distortion of the band structure with decreasing particle size results in an
increasing optical band gap (Eg).




Following the absorption of an ultraviolet photon, the excess energy possessed by the
exciton can be expended through recombination of the electron-hole pair resulting in the
emission of a photon. If the electron and hole are able to migrate to the surface, they
are able to engage in redox reactions with surrounding molecules (Figure 2.31), which
can result in the generation of radical species such as OH· and O·−2 , a mechanism which
forms the basis of the photocatalytic activity of these semiconductor nanoparticles [312].
This is one of the major advantages of using these semiconductor UV filters in this appli-
cation, as many energy levels within the conduction band are available for an electron to
be promoted to upon absorption of an ultraviolet photon, compared to the discrete higher
energy level molecular orbitals present in an organic molecule.
(a) (b)
Figure 2.30: (a) Ultraviolet-visible absorption spectra and (b) Tauc plot of commercial TiO2
nanoparticles. P25 and P90 are mixed anatase-rutile, and UV100 and N100 and pure anatase
[298].
Another effect through which these nanosized metal oxide particles are able to block or
filter UV light is through the process of scattering light. Due to the size of these dispersed
nanoparticles being much smaller than the incident photons in the UV-visible spectrum,
they scatter light according to Rayleigh Scattering, as opposed to Mie Scattering. The




lengths are scatter much more intensely. For a source of unpolarised light Ii, incident on
a particle with radius r and refractive index n, located at a distance R from where the
scattered intensity is measured, the total intensity of scattered light Is can be found with
Rayleigh’s Equation (Equation 2.14):
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Figure 2.31: Processes that occur following the absorption of a UV photon involving excitons










This relationship and the phenomenon of Rayleigh Scattering is the reason that the
sky is blue, as small molecules in the air scattering blue light more strongly than other
colours, as blue light has the shortest wavelength in the visible spectrum [313]. As such,
these particles do not scatter any light within the visible range (Figure 2.32), causing the
resulting sunscreen emulsion to appear colourless when spread on the skin as opposed to
larger particles, which would result in a white tint.
Figure 2.32: Ultraviolet-absorption spectrum of commercial ZnO nanoparticle Z-Cote R© [314].
Despite these positive benefits of using TiO2 and ZnO nanoparticles in improving sun-
screen products to protect from carcinogenic UVR, there have been concerns raised re-
garding the potential toxicity of these nano-sized metal oxides on human health. The next
section, 2.2.4 will cover all of the relevant literature investigating any potential health
risks introduced in substituting bulk or micro-size TiO2 or ZnO with nanosized particles.
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Overview of Risks and Hazards of Nanomaterials in Sunscreens
While the use of nano-sized TiO2 and ZnO particles within commercial sunscreen and
cosmetic products has enhanced their ability to filter ultraviolet light, and increasing their
aesthetic appeal, some concerns have been raised over potential health effects that could
arise from their use. These concerns mainly revolve around the in vitro cytotoxicity re-
ported from both of these particles in numerous studies, and how this could translate into
toxicity through repeated application of nanoparticles to the skin and the translocation of
these particles into the body. These initially saw ZnO nanoparticles banned from use in
sunscreen and cosmetics in the European Union, but this decision has since been reversed,
due to additional studies being published stating that such particles should be safe to use
[307]. The European Commission’s Scientific Committee on Consumer Safety (SCCS)
still agrees that neither ZnO or TiO2 nanoparticles should be used in spray on sunscreen
or cosmetic products, due to risk of inhalation. The following section will summarise the
current status of literature on these topics.
In vitro and in vivo studies on TiO2 and ZnO nanoparticles
Given the widespread use of TiO2 and ZnO nanoparticles in cosmetic applications, as
well as increasing research interest in applying such materials to emerging technologies,
there has been a multitude of studies investigating the cytotoxicity of these nanomaterials.
While micro-sized TiO2 or ZnO powders may have low or negligible toxicity, decreasing
their diameter to nano-sized significantly changes the physiochemical properties of these
particles and as such, has the potential augment their activity, which in many cases is
marked by an increase in toxicity [315].
There have been a number of studies investigating the in vitro cytotoxicity of TiO2 nanopar-
ticles on both human and animal cell lines and a range of effects observed upon the ex-
posure of these cells to anatase, rutile and mixed phase nanoparticles. Anatase particles
have been shown to induce single strand breaks [316], oxidative damage [316], increase
oxidative stress and impair DNA repair functions in A549 human lung tumour cells [316].
They have also been shown to induce oxidative damage [315], increase oxidative stress,
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DNA-adduct formation [317] and induce apoptosis [318] in BEAS-2B human bronchial
epithelial cells, increase IL-1β production in human THP-1 cells [319], decrease DNA
synthesis in human dermal fibroblasts [320] and induce oxidative stress in mouse fibrob-
lasts [321]. Similarly, a recent study found that 10 nm anatase spheres were not genotoxic
to the thymidine kinase heterozygote (TK6) cell lines [322]. It’s also been shown that both
anatase and rutile NPs [114] have little cytotoxicity or genotoxicity on Chinese hamster
ovary-K1 (CHO-K1) cells, which were able to adapt to the increased ROS indicating that
some of the effects seen in these studies are cell line-dependant. Rutile TiO2 nanoparticles
were similarly genotoxic to HepG2 cells by increasing single strand DNA breaks [323]
and were shown to induce cytotoxicity and DNA damage in human amnion epithelial
(WISH) cells [324].
Similar to how the presence of the two mixed crystal phases anatase and rutile increase
the photocatalytic activity of TiO2 nanoparticles, they have also shown to be more toxic to
human U937 human monoblastoids through initiation both necrosis and apoptosis [325].
Further evidence for this was provided in a study by Gerloff 2012 [326], in which mixed
phase TiO2 NPs induce cytotoxicity, DNA damage, oxidative stress and LDH leakage in
human intestinal Caco-2 cells [326]. Mixed phase TiO2 was also shown to have a lower
cytotoxicity than ZnO on HK-2 and IP15 cell lines, while inducing a similar amount of
ROS increase in the cells (Figure 2.33) [327]. One of the most well-known and commer-
cially available TiO2 NPs, Degussa P25 (Evonik) has shown to induce oxidative stress
and apoptosis in PC12 [328], BEAS-2B [329] and human lymphocyte cell lines [330].
A number of studies have also investigated the photo-toxicity of these particles, as
the generation of free radical species such as OH· and O·−2 under UV-irradiation is well
known. This generation of ROS and NO· under UVA radiation (λ = 365 nm) was shown
to induce oxidative stress and apoptosis in HaCaT human keratinocyte cells [81]. The
experimental set up of some studies [331] showed the TiO2 NPs didn’t induce toxicity at
moderate concentrations in the absence of UV irradiation. Others have arrived at the same
conclusions as studies investigating the use of TiO2 nanoparticles for their photocatalytic
activity, that being smaller, mixed phase NPs with high surface area demonstrating the
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highest photo-toxicity on ARPE-19 retinal pigment epithelial cells [332] and RAW264.6
mouse macrophages RAW264.6 [333]. It’s also been shown that both simultaneous and
pre-irradiation of lymphocytes and sperm can produce cytotoxic through generation of
ROS [334] compared to cells treated with the same concentration of nanoparticles in the
dark.
In vitro studies have also provided additional insight into the potential cytotoxic and
genotoxic effects these nanoparticles could have on the whole body through a variety of
exposure routes. As with any fine powder, exposure routes through the lungs is one of the
most likely, and inhalation studies have shown TiO2 NPs cause inflammation in the lungs
of rats [335] which can then go on to impact vascular function [336–338]. Intra-tracheal
instillation studies showed the induction of inflammatory lesions [339], pulmonary in-
flammation [340, 341], evidence of lung damage [342], and deleterious effects on im-
mune function [341], effects likely caused by the induction of oxidative stress. There is
also evidence to suggest that this exposure can cause airway hyper responsiveness, simi-
lar to asthma [343]. Sufficiently high doses up to 150 mg/kg, which is the LD50 of these
particles, shows significant liver and kidney damage in mice [344]. There is also evidence
to show that intragastrical administered TiO2 can disturb the trace elements in the brains
of rats and mice [345], and that increased levels of Ti and potential CNS impairment can
be observed after intranasally instilled TiO2 NPs [346]. The potential genotoxicity of
TiO2 nanoparticles is controversial, with some studies showing that it induces a similar
response to asbestos [347], and that P25 can affect gene expression in the heart and lungs
from exposure through drinking water [348], with this effect likely due to OS. Others
however, such as an inhalation study conducted on pregnant mice with commercial NP
UV-Titan [349] or one investigating low oral doses [350] showed no evidence of these
effects.
These in vivo studies have helped to shape our understanding of the potential hazards
in exposure to these nanoparticles and allowed organisations tasks with setting safety and
health guidelines for the population. One example of this would be the substantial evi-
dence for the harmful effects of TiO2 NP through inhalation exposure resulting in recom-
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mendations that these particles not be included in spray sunscreen products [307]. As der-
mal exposure is the main route of concern in the case of topically-applied cosmetics and
sunscreen products, studies covering this will be covered in the following Section 2.2.4.
Figure 2.33: Comparing the cytotoxicity of TiO2 nanoparticles and microparticles on IP15 cells
using WST-1 assay, adapted from Pujalte et al. 2011. [327]
Well known for their bactericidal activity, ZnO nanoparticles have been shown to be
much more cytotoxic on mammalian cells once their mean particle diameter is reduced
to the nanoscale, displaying size-dependent toxicity on immune cells [351, 352], THP1
human monocyte [353] and Caco-2 [354] and HK-2 and IP15 cell lines [327], among
others. The size and shape of these nanoparticles has a significant effect on their cyto-
toxicity [309, 355] (Figure 2.34) with specific surface area being the defining measure
of their cytotoxicity [355]. This cytotoxic effect is well known to be caused by the pro-
duction of ROS by the nanoparticles and induction of ROS in the exposed cells, and has
been displayed for numerous studies featuring different cell lines [107, 121, 356–360].
This ROS generation has been shown to cause a number of negative effects on surround-
ing cellular components such as increased apoptosis [107, 359] and DNA damage [360].
Some studies have claimed that the cytotoxic effect of ZnO nanoparticles is due to their
dissolution and release of [Zn2+] ions into the cytosol, resulting in caspase-dependent
apoptosis on Jurkat cells [361]. Another study observed Fe-doped ZnO exhibiting lower
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cytotoxicity due to lower particle dissolution on BEAS-2B cells [362], which contradicts
other studies on the same cell line [106, 121, 363]. This was also refuted by another study
which showed that the release of these Zn2+ ions were not a major contributor to ROS
and the cytotoxic effect in A549 cells [356]. Zinc oxide nanoparticles have displayed sig-
nificantly high toxicity compared to other metal oxide nanoparticles in the same studies
including TiO2 [364] CdS and Co3O4 [365], SiO2 and carbon black [366]. Unlike TiO2
nanoparticles, it is well known that ZnO nanoparticles can be genotoxic [107, 364, 367]
and the photo-toxicity of ZnO nanoparticles as a result of their photocatalytic activity has
also be reported in numerous studies, with simultaneous and pre-irradiation of UV re-
sulting in concentration-dependant cytotoxicity on human lymphocytes and sperm [334].
A similar exposure study on CHO cells showed that UV irradiation on ZnO treated cells
increases cytotoxicity and chromosomal aberrations, highlighting a clear photo-genotoxic
effect [367]. In vivo studies on ZnO nanoparticles showed some similar effects to TiO2
nanoparticles, such as inflammation and cytotoxicity in the lungs post-inhalation in rats
[368, 369] and have showed their retention and translocation from the lungs [370], as well
as their potential to accumulate in other tissues [371].
Figure 2.34: Effect of ZnO nanomaterials of different aspect ratios on cell viability WIL2-NS




These studies are helpful in understanding how these nanomaterials exhibit a cytotoxic
effect once coming into contact with tissues such as the lungs, or their effects on the
cellular level after being internalised into various types of cells. The relevance of these
studies as a model for assessing the risk of using ZnO and TiO2 nanoparticles in topical
formulations however, is extremely low. The studies which have attempted to address
these shortcomings will be presented in the follow Section 2.2.4.
Dermal Penetration Studies
In order for nanoparticles applied to the skin to result in some adverse health effects, they
must reach viable skin cells in the dermis or epidermis by firstly penetrating through the
layer of dead skin cells in the stratum corneum or the protective barrier in the hair follicle
orifice or sweat gland [109]. The dermal penetration of particles and the adsorption of
chemicals across the skin is formally defined by the Scientific Committee on Consumer
Safety to take place in three steps; penetration, permeation and resorption [372]. Assess-
ing the dermal penetration ability of these nanoparticles is complex, time consuming, and
costly, with many different factors needing to be considered in study design influencing
its validity as a model. These factors include the size and shape of the nanoparticles;
sunscreen composition; site of application; study duration; biological material sampled;
methods for analysing samples; sample size; UV exposure; controls; species studied; and
other factors such as the movement and flexing of the skin at the site. Studies involving
animal skin may also potentially raise some issues, as a comparative study has shown that
the skin of rats and pigs are more susceptible to dermal penetration than humans [373].
There are currently a few different methodologies used in these experiments, including
ex vivo diffusion cell method; and the in vivo skin stripping; skin biopsy; and biological
fluid sampling.
The prevailing evidence suggests that ZnO and TiO2 nanoparticles are not able to pass
through the stratum corneum (SC) to reach viable skin cells after being applied dermally.
The SCCS recently concluding that it is unlikely that TiO2 are unlikely to reach the der-
mis, epidermis or other organs, while ZnO nanoparticles can be considered to not pose
80
CHAPTER 2
Figure 2.35: Schematic of Franz diffusion cell set up [375].
a health risk. There are, however, some ambiguities in these results. The majority of
these studies use the Franz diffusion cell method for measuring skin penetration, whereby
excised human or animal skin in stretched over a membrane with receptor fluid medium
on the other side (Figure 2.35). This medium is at physiological pH and temperature, and
this fluid is sampled intermittently and tested for the presence of Ti or Zn. This method
could potentially underestimate the dermal absorption, given that the skin samples do not
have an intact vasculature, and that nanoparticles must penetrate through the entire skin
sample to reach the receptor fluid for detection. Furthermore, the skin in these studies is
fixed in position, whereas the movement and flexing of skin could aid in the penetration
of the nanoparticles. As such, none of these studies could not detect the presence of TiO2
or ZnO nanoparticles in the receptor fluid [374–378]. One of these studies however, did
detect increased Zn2+ ions in the viable layers of the epidermis [378], indicating that ZnO
could hydrolyse on the skin.
Similarly, the majority of studies using in vivo tape stripping and punch biopsy method-
ologies as a method of assessing dermal penetration showed the presence of these particles
only in the stratum corneum of both human [374, 379–386] and porcine skin [387, 388].
One study by Wu et al. 2009 [389] detected 4 nm TiO2 nanoparticles in the prickle and
basal cell layers but not the dermis after daily application of an emulsion on pig’s ears
for 30 days, with some pathological changes of the epidermis. The same study showed
that after daily application for 60 days on hairless mice, that TiO2 NPs are able to pen-
etrate through the skin and translocate to other organs and induce pathological changes
(Figure 2.37). This study, coupled with the fact that many of these studies reported vari-
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able levels of penetration of these nanoparticles into the SC, the fact that other studies
were conducted over much shorter time periods (45 minutes [379], 2 hours [383]), and
that the preparation of the NP emulsion can affect the penetration [379, 388], indicate
that there are still some influencing factors. Another interesting observation by [388] was
that UV exposure increased the penetration of T-Lite SF TiO2 nanoparticles into the stra-
tum corneum in Weanling white Yorkshire pigs. This study was only conducted over 48
hours, but this may be indicative of influencing factors that is not considered in most of
these in vivo dermal penetration studies. A recent study by Næss et al. 2016 [390] was
able to show the penetration of TiO2 NP through the SC to viable skin cells in two male
human patients in both healthy and UV damaged skin after imaging skin biopsies with
TEM (Figure 2.36). The authors of this study admit that the use of only one commercial
sunscreen and the low number of participants are both shortcomings, and that a larger
scale study is needed.
Figure 2.36: TEM analysis of TiO2 NP located in the human epidermis, after topical application
of commercial sunscreen formulation containing NPs [390].
In two studies by Gulson [391, 392], ZnO nanoparticles enriched with 68Zn were pre-
pared in an emulsion and applied once a day for 5 days. The first of these [391], showed a
small increase in 68Zn in the blood and urine samples but not all of the applied amount was
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Figure 2.37: Pathological changes in organs of hairless mice after dermal exposure to different
TiO2 nanoparticles for 60 days [389].
absorbed, and the second [392] also showed an increase with a maximum being reached
after 9 days. While this is significant, a valid criticism of this study is that because ICP-
MS was used to determine Zn isotope levels, there was no way to distinguish whether the
absorbed zinc was in the form of ions or NPs. Furthermore, the levels of zinc increase
within the urine and blood stream of the participants was negligible compared to the nor-
mal levels of zinc within the body. A subsequent study with hairless mice was also able
to show an increase in 68Zn from enriched NPs applied dermally in a number of different
organs, but was also not able to determine whether these were originating from NP or
free ions. The total increase in zinc within the sample organs was also not significant
[393]. This was reinforced by a long term (36 week) study on hairless mice by the same
group, where TiO2 NP-containing sunscreens were applied coupled with UV exposure.
Along with protecting the mice from UV-induced malignancies, this long-term exposure
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did not cause an increase in the zinc and titanium levels in serum and tissues [394]. A
later study by Homes et al. 2016 [378] that was able to detect increase levels of Zn2+ in
the epidermis using the diffusion cell method, may indicate that the ZnO nanoparticles
were dissolved. Whether the hair follicles could act as a route of penetration is also an
ambiguity within these studies, with some detecting NPs [374, 379, 385] while others
were not able to [382, 387].
As such, there is some ambiguity regarding the ability for TiO2 and ZnO NPs to pene-
trate the SC and reach viable skin cells after being applies topically in a sunscreen formu-
lation. The results appear to be highly protocol dependant, and the validity of particular
techniques, such as the Franz diffusion cell method using excised skin, are highly re-
moved from real world conditions. Other factors, such as the influence of UV irradiation
and composition of the emulsion, have both been shown to influence the ability for the
NPs to penetrate the SC which in some cases have been shown to reach viable skin cells.
Many studies, including the review article by [109], call for the validation and adoption
of a standardised test protocol and give recommendations for the design of an optimised
study. Such a study, while being quite time consuming and costly, would aim to address
multiple ambiguities resulting from previous studies.
Photocatalytically Active TiO2 and ZnO
Both TiO2 and ZnO nanoparticles are well known for their strong photocatalytic activ-
ity, with UV irradiation resulting in promotion of an electron from the valence to the
conduction band and generation of an electron-hole pair. These can then migrate to the
surface of the particle and undergo redox reaction with nearby molecules, including H2O,
to generate free radical species. This is of consequence within the context of their use
within commercial sunscreen formulations, due to the potential that they could interact
with other components within the sunscreen formulation. One such target could be the
organic ultraviolet filters present within the sunscreen which as discussed in Section 2.2.3
that already have issues regarding their photostability. One study calculated the ”relative
toxicity’ of these photocatalytically active TiO2 NP based on the number of active sites
able to generate ROS on anatase particles as a function of particle size [395] (Figure 2.38),
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and compared it to the size dependant UV absorption of the particles, indicating that there
is a trade-off for uncoated TiO2. In order to prevent this activity, there are a number of
commercially available TiO2 and ZnO nanoparticles that are coated with another material
in order to passivate their surface and prevent UV-induced ROS generation. However,
evidence in literature would suggest that some manufacturers either use uncoated TiO2
and ZnO within their sunscreen formulations, or products whose coating is ineffective at
preventing this photocatalytic activity.
Figure 2.38: Relative toxicity of TiO2 nanoparticles based on the calculated number of active
sites for ROS generation, for a particle loading of 50 × 109 NP per unit volume [395].
In a study by Serpone et al. [97] previously covered in Section 2.2.3 showed that the
photostability of organic ultraviolet filters is greatly reduced when found in particular
combinations with others, such as OMC and oxybenzone. They also showed that the
degradation of oxybenzone is even more rapid when in the presence of TiO2 NPs (De-
gussa P25) owing to their free radical generating properties (Figure 2.39). It was con-
firmed that free radical generating TiO2 NPs were present in sunscreens in a study by
[396], which used EPR to show the radical generating properties of a number of commer-
cial sunscreen products under UV irradiation. The presence of similar photocatalytically
active TiO2 nanoparticles was also confirmed in a 2008 study by [102], after the man-
ufacturer of a UV-resistant fluoropolymer-coated steel roofing product designed for the
high UV index exposure in Australia was receiving reports of accelerating weathering of
the coating. A long-term study was undertaken, whereby a small amount of a number of
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commercial sunscreens were coated onto the surface of samples of this coated steel prod-
uct and mounted on an outdoor exposure rack for 6 and 12 weeks. Their results showed
that a number of commercial sunscreen products greatly reduced the retention of gloss on
the steel panels, indicating significant degradation of the coating. They then separated the
inorganic solids from these products and performed XRD analysis to show that the NPs
had very similar spectra to what would be expected for Degussa P25, a mix of the anatase
and rutile phases. By performing ESR spectroscopy, they were also able to show that this
titania sample from one of the sunscreens had similar radical generating ability to Degussa
P25. Similarly, a study by Detoni et al. 2014 [376] found that NanosunT M, a commer-
cially available ZnO NP targeted towards UV filtration applications, had significant UV
photocatalytic activity, marked by the degradation of methylene blue. As such, an update
from the SCCS in 2012 [307] recommended that photocatalytically active nanoparticles
should not be used within commercial sunscreen formulations due to these concerns.
Figure 2.39: Degradation of oxybenzone (5 mg L−1) and Degussa P25 (300 mg L−1) under UV
irradiation (λ ≥ 290 nm) [97].
There are many commercially available TiO2 and ZnO nanoparticles (Table 2.3), some
of which are undoubtedly used in modern formulations. Technical reports on products
from manufacturers, as well as evidence from literature tells us that many of these are
coated with an inert material such as silica, aluminium or dimethicone, that doesn’t im-
pact the UV absorbing properties of the material. As expected however, different surface
coatings have variable effects on the ability to suppress the free radical generation of
these NPs [397]. Organosilane and dimethicone coatings on mixed anatase/rutile TiO2
have shown to not decrease the photocatalytic dye degradation of TiO2 NPs, and caused
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similar apoptosis on the MDCK cell line to uncoated mixed phase TiO2 NPs [105]. Mn
doped or Al2O3 coated rutile TiO2 did have lowered ROS generation and photo-toxicity,
however. Two publications by [398, 399] investigating the effect of these surface coatings
on the ability of TiO2 NPs to peroxidise linoleic acid, an essential fatty acid, under UV
irradiation to form malondialdehyde as a measure of their potential harm. This was done
in the presence of increasing concentrations of different antioxidants as the peroxidation
of the linoleic acid is driven by the UV-generated ROS from the TiO2 NP surface [400].
In both studies, P25 had the highest photo-activity as expected, with PW Covasil S-1, a
TiO2 with the same phase composition but coated with trymethoxycaprylylsilane, show-
ing roughly the same activity. Another 80/20 mixed phase NP coated with SiO2 however,
showed much less photo-activity. This trend was also seen with the rutile NPs covered
in the study, with the presence of SiO2 as a coating agent decreasing the photo-activity
of Maxlight F-TS20 and T-Lite SF-S compared to T-Lite SF, the latter of which only has
Al(OH)3 and Dimethicone (Figure 2.40).
Figure 2.40: Concentration of MDA formed (mmol/mg) from linoleic acid in the presence of
different TiO2 nanoparticles and concentrations of antioxidant phenylalanine Phe. [398]
Another study by [401] which investigated the ROS activity of commercial sunscreens
found that the products they surveyed that contained ZnO NPs generated significant free
radical species as measured by a free radical initiated dye 2’-7’-dichlorofluoroscein (DCFH),
while the TiO2 containing sunscreens did not (Figure 2.41a). The ZnO containing sun-
screens also generated significant ROS when studied with ESR, although this effect was
roughly 3 times lower than that of P25 (Figure 2.41b). Another coating system also ex-
plored in literature is lignin, a naturally occurring polymer that makes up the supportive
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tissues of some plants and algae, has also been shown to reduce the photocatalytic ac-
tivity of rutile and anatase TiO2 NPs, while not impacting the UV filtering properties
[402], making it ideal for cosmetic applications. Despite that a number of commercial
Al2O3 coated TiO2 NPs are available commercially, a study by Jang et al. 2016 [403]
showed that this coating can potentially greatly reduce the photo-toxicity by preventing
ROS generation, while increasing UV absorption of the system. Similarly, novel methods
of coating TiO2 with SiO2 are also still being explored in literature, with a study from
Guo et al. 2017 [404] showing how CVD can be used to prevent UV-generated ROS.
(a) (b)
Figure 2.41: The ability of a number of commercial sunscreen products to generate free radicals
under UV irradiation, as measured by (a) fluorescence of DCFH and (b) concentration of DMPO-
OH adduct generation [401].
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Table 2.3: A list of commercial TiO2 and ZnO nanoparticles [113, 398, 399, 401, 405], the
abbreviations are trymethoxycaprylylsilane (TMCS) and polymethyl methacrylate (PMMA).
Commercial name Composition (%) Crystal Phases (%) SSA Particle size (nm)
(m2 g−1)
Maxlight F-TS20 TiO2 75, SiO2 22 100 rutile 55 100
MT-100Z TiO2 75, Al2O3,
Stearic acid
100 rutile 40-60 15
T-Lite SF TiO22 84, Al(OH)3,
7, Dimethicone 4.5
100 rutile 76 Needle like 30-60 ×
10
T-Lite SF-S TiO2 78, Al(OH)3
3.5, SiO2 7.5, Dime-
thicone 5.5
100 rutile 71 Needle like 30-60 ×
10
Eusolex T-AVO TiO2, SiO2 100 rutile 40-90 Needle < 200
Dupont R-900 TiO2 100 rutile
PW Covasil S TiO2 >90, TMCS
<5, PMMA 5,
80 anatase, 20 rutile 43 28-32
PW Covasil S-1 TiO2 >95, TMCS
<5
80 anatase, 20 rutile 40 28-32
Tego Sun TS plus TiO2 >50, SiO2 10-
25, TMCSa 4.5
80 anatase, 20 rutile 60 -
Aeroxide P 25 TiO2 100 80 anatase, 20 rutile 53 Spherical, 21
Millenium PC 500 TiO2 100 100 anatase 287 5-10
Millenium PC 50 TiO2 100 100 anatase 45
Kerr-McGee TiO2 100 100 anatase 90 20
Hombikat UV 100 100 anatase >250 5
Tranox A-K-1 TiO2 100 anatase 90 20
Zinc oxide NEU-
TRAL
ZnO ≥ 95 30-70 41
TEGO Sun Z500 ZnO > 99.5 10-60
NANOX 200 Zno 99 17 60




Wurtzite 12-24 < 200 nm
Zinc oxide NDM ZnO >90, dime-
thicone
10-70 < 50
Z-Ald ZnO Wurtzite 12.1 42-79
2.2.5 Novel nanomaterials as ultraviolet filters
The shortcomings of ZnO and TiO2 nanoparticles as ultraviolet filters has resulted in a
number of studies exploring other metal oxide nanoparticles as replacements. In order for
these nanoparticles to have efficacy for this application, they must have low toxicity, high,
selective ultraviolet attenuation, and stable within aqueous and non-aqueous phases.
One of the most promising of these materials is cerium dioxide (CeO2), which has a
direct optical band gap of∼3 eV for bulk and extremely high absorption in the ultraviolet
region. While the optical properties of CeO2 films had been long known, the optical and
catalytic properties of CeO2 nanoparticles were first described in literature by Masui et al.
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1997 [406]. Ceria nanoparticles were formed inside polymer thin films using a relaxative
auto-dispersion technique, and were shown to have direct band gaps of 3.42 and 3.37
eV. A subsequent paper from the same group in Japan months later described a method
for preparing ceria nanoparticles with a diameter of 2.6 nm and 4.1 nm using a reverse
micelle method, and they were shown to have Eg’s of 3.44 and 3.38 eV respectively [153].
A subsequent paper in 1999 [407] described the synthesis of 1.5-2 nm CeO2 nanoparticles
through a hydrothermal method, which were completely transparent to visible light and
featured an optical band gap of 3.52 eV. A subsequent paper by Tsunekawa et al. 2000
[408] in 2000 was able to show the quantum size effect within this direct band gap system,
with a reduction in particle size resulting in a larger optical band gap.
The first article to prepare CeO2 nanoparticles for the specific application of ultraviolet
filtration in cosmetics was published by Yabe et al. 2001 [409]. In this paper they doped
CeO2 with a range of different cations with lower valence and larger ionic size in order to
decrease the photocatalytic activity of CeO2. These included Mg2+, Ca2+, Zn2+, Sr2+,
Ba2+ through a soft chemical approach. They reported that both 20 mol% Ca and Zn
doping decreased the photocatalytic activity of ceria nanoparticles while increasing the
visible light transparency. Later they published conference Proceedings from the 23rd
Rare Earth Research Conference UC Davis Campus, July 13-16, 2002 in Journal of Solid
State Chemistry, which on top of these elements also included results from Y3+, La3+,
Nd3+, Sm3+, Eu3+ and Tb3+ doping of CeO2 nanoparticles, none of which performed
better than Zn or Ca [410]. A more in-depth study of the effects of Ca-doping on CeO2
nanoparticles (Figure 2.42) was later performed by Truffault et al. 2010 [112]. This ar-
ticle studied the effect of modifying these particles through Ca-doping, in order to both
increase the ultraviolet absorption and reduce the photocatalytic activity through stabilis-
ing the Ce3+ oxygen deficiencies. A co-precipitation method was used in order to dope
the CeO2 lattice with calcium between 0-50 mol% relative to the cerium content, while
10 mol% doping greatly increased the ultraviolet absorption and absorption edge to 3.51
eV (Figure 2.43 a).
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Figure 2.42: TEM images of (a) pure CeO2 nanoparticles and (b) 50 mol% Ca-doped CeO2
nanoparticles [112].
This same group of authors then compared the effect of different synthesis methods on
the performance of Ca-doped CeO2 nanoparticles, preparing these particles in a sunscreen
emulsion as a replacement for ZnO, and testing the photoprotection efficiency with in
vitro SPF testing [411] (Figure 2.43 b). This article showed that an emulsion prepared
with Ca-doped CeO2 nanoparticles synthesised by co-precipitation had a higher SPF than
commercial ZnO nanoparticles in combination with TiO2.
Figure 2.43: UV-Vis absorption spectra of (a) 20 mol%, (b) 50 mol%, (c) pure CeO2, (d) 30
mol%, (e) 40 mol% and (f) 10 mol% Ca-doped CeO2 nanoparticles prepared by co-precipitation
method (left) [112]. The effect of the synthesis method of photoprotection efficiency of Ca-doped
CeO2 nanoparticles prepared by co-precipitation (CP) and spray pyrolysis (SP) compared to ZnO
nanoparticles [411].
A subsequent paper [161] showed that CeO2 nanoparticles synthesised through a sol-
gel method between 4-6.4 nm diameter had lowered photocatalytic activity compared to
TiO2 and ZnO. Through in vitro tests they also showed that treating L929 mouse fibrob-
last cells with these ceria sols increased cell proliferation if applied either before or after
UV exposure, highlighting the protective effect of CeO2 nanoparticles. The first article
to combine both in vitro SPF and cytotoxicity comparing CeO2 and commercial ZnO
nanoparticles was published by Boutard et al. [113]. The microwave-assisted hydrother-
mal method-prepared CeO2 showed higher SPF compared to ZnO at 3wt% in sunscreen
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emulsions featuring a number of UVA and UVB filters. These CeO2 nanoparticles also
showed no measurable toxicity up to a concentration of 80 µg mL−1 on NCTC2544
keratinocytes up to 72 hours of continuous exposure, while the commercial ZnO nanopar-
ticles showed some marked effect at as little as 20 µg mL−1 (Figure 2.44).
Figure 2.44: Effect of continuous exposure of (a) microwave-assisted hydrothermal method
CeO2 nanoparticles and (b) Zinc oxide NEUTRAL R© on the growth of NCTC2544 keratinocytes
[113].
It is relatively easy to obtain CeO2 nanoparticles commercially now, as there has been
increasing demand for high quality nanoparticles in both research and industry. Being a
rare earth metal however, sources of Ce are quite expensive and the potential for CeO2 to
replace either ZnO or TiO2 in a significant portion of commercial sunscreen products is
extremely low. There is, however, one commercial product that has been specifically made
for UV blocking, AQUA CERIA R© made by GSI EXIM AMERICA, Inc. These cerium
oxide particles are coated with a layer of Pt, which increases the water dispersibility of the
product, according to the manufacturer. The manufacturer also claims a 0% transmission
of photons with λ ≤ 440 nm [412]. Truffault et al. also published an article [209] investi-
gating the effects of Fe-doping of CeO2 nanoparticles between 0-30 mol% as well as the
effects of annealing the co-precipitated precursor in argon and air environments. Similar
to the Ca-doped CeO2, 10 mol% doping caused a blue shift in the absorption spectra, an
effect which was further enhanced by annealing under an argon environment [209]. The
authors propose the use of these particles for pigmented ultraviolet filtration applications
however, as the Fe-doping also caused the usually yellow-white CeO2 nanoparticles to
take on more of a brown colour (Figure 2.45).
Another material investigated by Truffault et al. [413] for pigmented UV filtering in
cosmetics was nanoparticles of hematite (α-Fe2O3) (Figure 2.46). Bulk hematite is an
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Figure 2.45: UV-Vis absorption spectra (left) of pure CeO2 nanoparticles annealed in (a) air and
(b) argon along with 10 mol% Fe-doped CeO2 nanoparticles annealed in (c) air and (d) argon.
The effect of transforming this data into a Tauc plot for band edge determination can also be seen
for each of these samples (right) [209].
n-type semiconductor with an optical band gap of 2.2 eV [414], meaning that it begins to
absorb in the green part of the visible spectrum which it owes to it’s red-brown appear-
ance. While the ultraviolet absorbing properties of α-Fe2O3 had already been described,
this was the first article to investigate the effect of these nanoparticles on the SPF of a sun-
screen emulsion. Through a simple precipitation method, followed by annealing, the band
gap of these particles was increased between 2.94-3.08 eV for the different temperatures.
One of our previous studies also explored the use of Ce-doped Fe2O3 nanoparticles, where
we showed that 10 at% Ce-doping caused a blue-shift in the absorption spectra by increas-
ing the band gap to 2.51 eV, while this also increased the absorption of the nanoparticles
in the UV region [210].
Figure 2.46: UV-Vis absorption spectra (left) of α-Fe2O3 nanoparticles prepared by precipitation
annealed at (a) 300 ◦C, (b) 400 ◦C and (c) 500 ◦C. The effect of transforming this data into a Tauc
plot for band edge determination can also be seen for each of these samples (right) [413].
Another wide band gap semiconductor, SnO2 was investigated by our group in for po-
tential application as a UV filter in cosmetics. Unlike Fe2O3-based systems, SnO2 has a
similar colour to ZnO, TiO2 and CeO2, making it appear as a pale yellow-white powder.
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Doping the SnO2 nanoparticles with Ti increased the band gap from 3.5 eV to 3.73 eV,
and while this did increase the photocatalytic degradation of methylene blue under UV-
irradiation it was found to be significantly less photocatalytically active than commercial
ZnO and TiO2 nanoparticles. Cerium-titanium pyrophosphates Ce1−xTixP2O7 (with x =
0, 0.50, and 1.0) have also been investigated for this application [415]. Other studies have
investigated the use of elemental doping as a method to reduce the ROS generation by
TiO2 and ZnO as a consequence of their UV absorption. Manganese doping has shown
to decrease the photocatalytic activity of both metal oxide NPs [105, 416, 417], an ef-
fect which has been shown superior to SiO2 and Al2O3 coatings. A few studies have
also reported the synthesis of polymer nanomaterials for use in sunscreen products as
ultraviolet filters. Nanoencapsulation of organic ultraviolet filters such as 2-ethylhexyl-p-
methoxycinnamate [418] and OMC [419] by poly(lactic acid) (PLA) have been reported
in the past, and it has been shown to increase their UV stability. The latter of these by
[419] showed that the encapsulation of OMC by PLA significantly reduced its ability to be
absorbed into both the dermis and epidermis of porcine skin over a 3-hour period. Deng
et al. 2015 [420] reported the synthesis of a bioadhesive poly lactic acid-hyper-branched
polyglycerol nanoparticles to encapsulate Padimate-O (Figure 2.47). These nanocompos-
ites remain on the surface of the SC on rats in vivo for extended period, and prevent
photo-induced degradation products and free radicals from the Padimate-O from reach-
ing the skin. While the SPF rating of these particles in a commercial-style emulsion was
not performed, they were able to show that these particles reduced DNA double-stranded





Figure 2.47: (a) Graphic showing the concept of bioadhesive PLA NPs (BNPs) containing UV
filters as an alternative to those currently used in commercial sunscreen products and (c) fluo-
rescence microscopy images showing retention of the BNPs on porcine skin compared to non-




The following chapter firstly outlines the chemical reagents and materials used in this the-
sis work in Section 3.1, followed by experimental details involved in the synthesis of the
various nanoparticles and nanocomposites in Section 3.2. Section 3.3 then outlines the
different characterisation methods used to investigate the various elemental, structural,
morphological, chemical and optical properties of each of these same materials. Each
subsection features a short background on each physical characterisation technique, fol-
lowed by the technical details that were used. Finally, Section 3.4 then highlights the
methods that were used in order to characterise the cell culture experiments used to inves-
tigate the effect of the nanomaterials on biological systems in vitro.
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3.1 Materials and Reagents
Details of the materials and chemicals used throughout this thesis work can be found in
the below table.
Table 3.1: A list of chemicals, materials and reagents used in this work with their purity and
supplier.
Chemical / Material / Reagent Details Supplier
2’-7’-dichlorofluoroscein diacetate




- Invitrogen, Thermo FisherScientific




Chloroform (CHCl3) ≥98 Sigma Aldrich
Crystal violet - Sigma Aldrich
De-Ionised water (H2O) - -
Dimethyl Sulfoxide (DMSO) (CH3)2SO Sigma Aldrich
Dulbecco’s Modified Eagle Media
(DMEM)
High glucose, with









Saline (DPBS + +) with Ca & Mg
Gibco, Thermo Fisher
Scientific
Ethanol (CH3CH2OH) absolute Merck
Foetal Bovine Serum (FBS) - Bovogen
Hydrochloric acid (HCl) 37% Sigma Aldrich
Hydrogen Peroxide (H2O2) 30% Sigma Aldrich
Iron (III) chloride (FeCl3) ≥98% Sigma Aldrich
Iron (III) nitrate nonahydrate
(Fe(NO3)3.9H2O)
≥98% Sigma Aldrich
P-25 (TiO2) ≥99.5% Sigma Aldrich
Penicillin-Streptomycin (PenStrep) 5000 U mL−1
Gibco, Thermo Fisher
Scientific
Poly(lactic acid) (C3H4O2)n Mw ∼ 60,000 Sigma Aldrich
Sodium hydroxide (NaOH) ≥98%, pellets Sigma Aldrich
Trypsin 0.05% Gibco,
-Ethylenediaminetetraacetic acid
(EDTA) with phenol red Thermo Fisher Scientific
Z-Cote HPI (ZnO) BASF




3.2.1 Synthesis of α-Fe2O3 nanoparticles
The synthesis of the α-Fe2O3 nanoparticles featured in Chapter 4 followed very closely
the methods already established in one of the author’s previous works [198] investigating
the differences between precipitation and spray precipitation methods. The reaction, also
described in [209, 210], involves the reaction of iron (III) nitrate (Fe(NO3)3) with a strong
base, in this case sodium hydroxide (NaOH), to form iron oxide or hydroxide products.
These products are then calcinated at a high temperature that results in decomposition fol-
lowed by α-Fe2O3 crystal growth. This firing temperature is chosen specifically to result
in nanoparticles of a particular crystal size.
Iron nitrate nonahydrate powder (Fe(NO3)3.9H2O) and sodium hydroxide pellets (NaOH)
were both dissolved in deionised (DI) water, resulting in 0.15 M Fe(NO3)3 and 1.5 M
NaOH solutions. For the standard precipitation method, the NaOH solution was added
drop-wise to the Fe(NO3)3 solution under magnetic stirring (Figure 3.1), resulting in the
formation of a red-brown precipitate. In the spray precipitation process, the iron nitrate
was delivered via spray nozzle driven by a peristaltic pump (Figure 3.2), also resulting in
a red-brown precipitate. Both solutions were allowed to stand overnight, and the spray









Figure 3.1: Schematic demonstrating the experimental setup for precipitation reaction used to
synthesis α-Fe2O3
text nanomaterials.
Following this, each of the precipitants was separated and washed using a centrifuge
with the same regime in order to remove any impurities and unreacted precursor chemi-
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cals. The reaction mixture was aliquoted into 50 mL centrifuge tubes, weighed to ensure
they were roughly the same weight, placed in a centrifuge, and spun at 11,000 RPM
(16,000 RCF) for 5 minutes. The supernatant was then discarded, and the remaining solid
washed by adding roughly 25 mLs of water, after which the tube was shaken vigorously
in order to re-suspend the solid within the tube. The tube was then filled to the 50 mL
line the centrifuge tube, shaken again, weighed, returned to the centrifuge tube and spun
at 11,000 RPM (16,000 RCF) for 5 minutes. The particles were separated and washed by
re-suspending using this method no less than 4 times per 50 mL tube. The remaining solid
was then placed in an oven (Binder, Tuttlingen, Germany) at 90 ◦C overnight in order to
dry the formed solid. The formed solids were then allowed to cool , and then crushed in a











Figure 3.2: Schematic demonstrating the experimental setup for spray precipitation methods
used to synthesise α-Fe2O3 nanomaterials.
Roughly 1-2 g of this powder was then placed into a ceramic weigh boat and placed
within a horizontal tube furnace . The precipitate formed through standard precipitation
was used to produce two samples annealed at 400 ◦C and 500 ◦C for 4 hours, while the
goethite (α-FeO(OH)) precursor formed through spray precipitation was annealed at 250
◦C for 30 minutes and 500 ◦C for 3 hours. For future ease of communication, each of these
materials will be referred to by a shortened name according to their synthesis method and
annealing temperature which can be seen in Table 3.2.
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Table 3.2: Outline of synthesis parameters for each α-Fe2O3 nanoparticle sample featured in
Chapter 4.
Name Method Annealing Temperature ( ◦C )
CP400 Precipitation 400
CP500 Precipitation 500
SP250 Spray Precipitation 250
SP500 Spray Precipitation 500
These annealing regimes resulted in the formation of reddish-brown powders, typical
for iron oxide powders. Those obtained through the normal precipitation route were much
darker and featured more of a brown tone than the spray precipitation particles, which
where a much brighter red-brown colour and both can be seen in Figure 3.3. Each of the
obtained materials was once again crushed within a mortar and pestle before proceeding
with further experimentation.
(a) (b)
Figure 3.3: Colour of iron oxide powders after annealing at 500 ◦C , formed from (a) standard
precipitation and (b) spray precipitation.
3.2.2 Synthesis of α-Fe2O3/CeO2 nanocomposites
The α-Fe2O3-CeO2 core-shell nanocomposite particles featured in Chapter 5 were pre-
pared through a two-step process, by firstly forming the α-Fe2O3 nanoparticles through
a thermal precipitation, followed by reacting cerium nitrate with a base in the presence
of the particles. The result was a number of nanocomposites materials with large (∼50
nm) hematite cores that were decorated by very small diameter cerium dioxide (CeO2)
nanoparticles. Hydrochloric acid, iron (III) chloride (FeCl3), cerium nitrate hexahydrate
(Ce(NO3)3.6H2O), ammonium hydroxide (NH4OH) and hydrogen peroxide (H2O2) were
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all obtained from Sigma-Aldrich. The core α-Fe2O3 nanoparticles were prepared through
a thermal precipitation method previously reported by Matijević and Scheiner 1978 [421].
A solution of HCl was added to a round bottom flask and partially submerged in a silicon
oil bath which was heated to 100 ◦C while under reflux. Separately a solution of FeCl3 in
DI water was prepared, and once the temperature in the round bottom flask stabilised, this
was added to the solution of HCl. This resulted in a final concentration of 18 mM FeCl3
and 1 mM HCl, resulting in the formation of a dark orange solution. This solution was
then heated at 100 ◦C for 24 hours while under magnetic stirring, during which a red solid
α-Fe2O3 was slowly precipitated. This solid was separated and washed via centrifugation
at 11,000 RPM (16,000 RCF) for 4× 15 minutes and dried in an oven (Binder, Tuttlingen,
Germany) at 100 ◦C overnight, and then transferred to a vacuum oven (ISSCO, Sydney,
Australia) and dried at 120 ◦C for 1 hour under vacuum. The obtained powder Figure 3.4
was then characterised and used in further synthesis in order to prepare the α-Fe2O3-
CeO2 core shell nanocomposite particles.
Figure 3.4: Colour of α-Fe2O3 powder obtained following thermal precipitation.
In the second step of the synthesis (Figure 3.5), 0.2 g of α-Fe2O3 nanoparticles were
resuspended in DI water via sonication for 20 minutes, and a solution of Ce(NO3)3 was
added, for a total of 40 mLs. The amount of Ce(NO3)3 was varied in order to obtain
different stoichiometric Fe/Ce ratios of 2.5, 5 and 10 at%, with the exact quantities used
found in Table 3.3. This suspension of hematite nanoparticles in a solution of Ce(NO3)3
was then heated to 60 ◦C and magnetically stirred for 15 minutes, after which 1 mL of
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concentrated NH4OH was added drop-wise, causing the precipitation of cerium into an
unknown solid. This mixture was then separated and washed via centrifugation, after
which concentrated H2O2 was then added to crystallise the CeO2. This was done in order
to avoid the need for high temperature thermal treatment, which could result undesirable
crystal growth or agglomeration of the core-shell particles. The nanocomposite particles
were then washed and dried through the same method described above for the uncoated
α-Fe2O3 nanoparticles.
Figure 3.5: Schematic representation of the method to synthesise α-Fe2O3 and α-Fe2O3/CeO2
nanoparticles [111].
Table 3.3: Outline of synthesis parameters used to prepare α-Fe2O3-CeO2 core-shell nanocom-
posite particles featured in Chapter 5.
Name Mass α-Fe2O3 Mass Ce/Fe
nanoparticles (g) Ce(NO3)3.6H2O (g) Ratio
α-Fe2O3 0.2 0 0
α-Fe2O3-CeO2 2.5at% 0.2 0.0272 0.025
α-Fe2O3-CeO2 5at% 0.2 0.0544 0.05
α-Fe2O3-CeO2 10at% 0.2 0.1088 0.1
3.2.3 Synthesis of Polymer and Metal Oxide-Polymer Nanocompos-
ite Particles
During this thesis work, two different metal oxide-polymer nanocomposite materials were
prepared for application as ultraviolet filters for cosmetic applications. Both of these
composite materials featured the same concept, that being the encapsulation of iron oxide
nanoparticles within polymer microspheres, in order to have a material which benefits
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from the strong ultraviolet absorption properties of iron oxide nanoparticles and altering
the colour away from red-orange and more towards a natural skin tone.
Synthesis of Poly(Lactic acid)-Iron oxide nanocomposite particles
The PLA-α-Fe2O3 nanocomposite particles were prepared following a similar route de-
scribed by Correia et al. 2016 [422]. Firstly, iron oxide nanoparticles were prepared
through a simple precipitation route as described in Section 3.2.1 and annealed at 400 ◦C for
3 hours. The resulting red-brown powder was then ground very finely in a mortar and pes-
tle. Meanwhile, poly(lactic acid) was dissolved in chloroform (CHCl3) at a concentration
of 3% (w/v), with this solution subsequently added to a solution of 0.5% PVA. This PVA
solution acts like an emulsifying agent aiding in the formation of the particles. This so-
lution was then stirred magnetically overnight at room temperature. During this process
the chloroform was evaporated, resulting in the formation of the polymer microspheres.
The resulting suspension of PLA particles was then centrifuged at increasing speeds be-
tween 1000-4000 RPM (130-2100 RCF) in order to isolate the different size fractions of
the particles. Each of these separations was then centrifuged five times following the first
separation. The solid particles obtained from this separation were then freeze dried for 48
hours. In order to prepare the nanocomposite particles, this same procedure was followed,
with the difference being the suspension of the α-Fe2O3 particles within the PVA solution
to which the chloroform was added. These particles were suspended in this solution firstly
via sonication bath, followed by brief mechanical stirring with a high-speed homogeniser.
Four different samples were prepared by this method, containing weight fractions of 0, 5,
10 and 20% α-Fe2O3. After freeze drying light, fluffy powders were obtained for each of
the samples, with the colour of the PLA particles being white, while those containing the
α-Fe2O3 nanoparticles possessing a pinkish, skin tone colour.
Table 3.4: Outline of α-Fe2O3 content in PLA-Fe2O3 nanocomposite particle synthesis.







3.2.4 Preparing Sunscreen Emulsions
The sunscreen emulsions were prepared at a commercial contract cosmetics manufac-
turer, ABC Texture, located in Dinard, France. As the method and exact ingredients used
to prepare this emulsion are the intellectual property of ABC Texture, they cannot be de-
scribed in their entirety within this work. These emulsions were water-in-oil emulsions,
and were designed in order to determine the performance of the iron oxide-poly(lactic
acid) nanocomposite particles prepared as described in the previous Section 3.2.3. The
water phase was prepared first, with all ingredient added to a large beaker after being
weighed with an analytical balance. This was then heated to 70 ◦C in a microwave to dis-
solve all the ingredients, with the temperature measured via infrared thermometer. This
phase was then homogenised with a mechanical stirrer (Vmi Rayneri, Montaigu, France).
The ultraviolet filters were then added to this phase, resulting in a white solution. The
pH of this solution was then brought back to neutral using diluted NaOH, resulting in the
solution again becoming clear. The oil phase was then prepared by combining all ingre-
dients and heating to 80 ◦C in a microwave, followed by mixing in a L4R homogeniser
(Silverson, Massachusetts, USA). The commercial TiO2 nanoparticles were then added
slowly to the oil phase while under mechanical stirring with this homogeniser, after which
it was again heated to 80 ◦C and homogeniser again for 1-2 minutes. While the oil phase
was being homogenised, the water phase was heated to 70 ◦C and was then slowly added
to the oil phase while under mechanical stirring. The beaker containing the formed emul-
sion was then cooled slowly to 30 ◦C by being submerged in a larger beaker containing
cold water while under slow mechanical stirring. The emulsion was then homogenised
under high speed for 1-2 minutes. The resulting emulsion contained 25 wt.% organic and
5 wt.% inorganic ultraviolet, the latter being in the form of TiO2 nanoparticles. The final
pH of this emulsion was 7.95.
Around 200 g of the sunscreen emulsion was prepared, and in order to add our Fe2O3
and PLA-Fe2O3, a targeted weight of emulsion was weighed into small 50 mL screw
top glass jars. The nanocomposite material to be added to the sunscreen emulsions were
weighed using an analytical balance, and then slowly added to the jar with a spatula, as
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it was intermittently stirred vigorously. Each of these samples, along with some commer-
cially available ZnO nanoparticles (Z-Cote HPI, BASF, Ludwigshafen, Germany), were
added to the sunscreen emulsions for a final concentration of 3 wt.%. The exact quantities
used can be seen in the below Table 3.5.
Table 3.5: Details of the preparation of sunscreen emulsions containing various commercial and
as-synthesised nanomaterials.
Name Weight Emulsion (g) Sample Weight Sample (g) Total Sample (wt.%)
Nude 29.1 DI H2O 0.9 3
ZnO 29.1 Z-Cote HP1 0.9 3
PLA 9.7 PLA microparticles 0.3 3
PLA-5 9.7 PLA-Fe2O3 (5 wt.%) 0.3 3
PLA-10 9.7 PLA-Fe2O3 (10 wt.%) 0.3 3
PLA-20 9.7 PLA-Fe2O3 (20 wt.%) 0.3 3
After ensuring that the emulsions were homogenous, they were then used as described
in the various experiments outlined in Sections 3.3.12 and 3.3.13, with the results and
discussion for this work found in Chapter 6.
3.3 Physical Characterisation
The following section details the various materials characterisation tools used through-
out this body of work to investigate the various structural, morphological and elemental
properties of the prepared nanomaterials.
3.3.1 X-ray Diffraction
In order to characterise the crystalline structure of the nanomaterials synthesised within
this work, X-ray diffraction was used. Typically, a small amount of the powdered sample
to be characterised was added to a mortar and pestle, followed by some small amount
of ethanol. Working with cyclic motion, any large chunks or agglomerates within the
sample were ground down into finer particles until a smooth paste was formed. The
pestle was then used, again in a cyclic motion, to apply an even coating of the sample
onto the quartz glass slide present within the aluminium stage. The ethanol was then
left to evaporate from the sample before proceeding with the analysis. An Enhanced
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Multi-Materials Analyzer (EMMA, GBC Instruments, Braeside, VIC, Australia) was used
to obtained X-ray diffraction spectra of synthesised materials. Powdered samples were
scanned between a 2θ of 10 - 90◦, at a rate of 2◦ min−1 and a step size of 0.02◦. TRACES
software was used to match the reflections of the samples with that of a Powder Diffraction
Card (PDF) in order to identify the phases present. Rietveld refinement was performed
using Material Analysis Using Diffraction (MAUD) software.
3.3.2 Thermogravimetric Analysis
The thermal properties of materials featuring in this work were probed using a DSC-
TGA-1 (Mettler Toledo, Columbus, OH, United States, Figure 3.6). A small amount of
sample, between 5-15 mg, depending on sample volume, was weighed using an analytical
balance in a 600 µL alumina crucible and the weight recorded. This was then placed into
a sample holder within the DSC-TGA 1, to be loaded into the furnace using the robotic
sample arm. Before each analysis was performed on a sample, a ’blank’ sample was first
run on the bare alumina crucibles using the same heating regiment. The change in weight
as a function of temperature for this ’blank’ sample was then subtracted from the mea-
surement containing the sample to be analysed in order to remove the influence of the
alumina crucible on the results (Equation 3.1).
(a) (b)
Figure 3.6: a) The DSC-TGA 1 instrument used for thermal analysis of prepared nanomaterials
and b) the automated sample robot stage with 70 µL alumina crucibles.
Two different heating regiments were used in this work, which were dependent on the
type of sample which was to be analysed. The first was used exclusively on samples purely
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inorganic in nature, such as the metal oxide nanoparticles in this study, or their precursor
material. These samples were heated between 45 - 900 ◦C at a rate of 5 ◦ min−1. Samples
which contained any polymeric component to them were heated between 45 - 600 ◦C at
a rate of 20 ◦C min−1. Before any analysis is performed on the obtained trace, the TGA
curve of alumina crucible under the same experimental conditions must be subtracted in
order to correct for the influence of the crucible. This is performed on each individual
measurement of the sample mass at time t:
mt,net = mt,sample−mt,blank (3.1)
Where mt,blank is the same of the crucible, mt,sample is the mass of the sample, and mt,net
is the corrected weight of the sample. This is because an apparent small change in weight
occurs when the alumina crucible is heating on its own. The important quantities obtained
in this study based off of the TGA curves obtained for the prepared materials include the
residual mass (mr), onset temperature (Tonset) and peak temperature of decomposition
(Tpeak). The residual mass is the mass remaining once all reactions over the given tem-
perature rate have ceased, and can be seen in the TGA curve as a plateau. It is usually
expressed as a percentage, and as such can be found from dividing the final mass m f by





Determination of the onset temperature Tonset can be seen in. This can be achieved by
fitting a straight line to the horizontal linear portion of the TGA curve before any de-
composition or reaction has occurred, and then the linear portion of the decomposition
slope. This results in four parameters, the slope and intercept of the horizontal (ah,bh)
and vertical lines (av,bv) respectively. The onset temperature is located at the tempera-
ture where the both of these intersect, which can be found by solving the two equations
simultaneously for x:
y = ahx+bh (3.3)







Another useful way to present this data is to plot the first derivative of this mass change,
which is referred to as a Differential Thermogravimetric (DTG) curve, which allows for




[423]. The peak temperature of decomposition, or the temperature
at which the rate of decomposition is the highest can be found on the DTA curve at the
temperature which corresponds to a peak (Tpeak) where
dw
dt
= 0. Origin was used in order
to analyse and plot this data.
3.3.3 Electron Microscopy
While many other techniques were employed during this work in order to characterise
the as-prepared nanomaterials, electron microscopy techniques have the unique feature
of allowing us to obtain two dimensional images of these products at the micro- and
nano-scale. This provides invaluable information about the dimensions of the products,
which can greatly determine their properties at this scale, and also the morphology the
present materials and phases. This section focuses on the different electron microscopy
techniques employed in this work, firstly giving a background and application of each
technique, followed by the specific conditions used to image the materials.
Scanning Electron Microscopy
Scanning electron microscopy (SEM) images were obtained using a JSM-7500 FA (JEOL,
Akishima, Tokyo, Japan, Figure 3.7) field emission scanning electron microscope. Gen-
erally, this was a coating of around 14 nm, consisting of gold or platinum. Samples were
generally imaged at 5 kV accelerating voltage, with an emission current of 10 µA and
spot size of 10. Samples were mounted onto a 25 mm alumina stub with conductive
carbon tape. This tape was firstly cut and stuck to the surface of the stub, after which
a small amount of fine powder was then brushed on the surface with a spatula. In the
case that the sample itself was a very poor conductor, which was the case for the vari-
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ous iron oxide-polymer nanocomposites in this study, the sample then had an additional
conductive coating applied to its surface to reduce charging and improve images. This
coating was performed using a Sputter Coater (Dynavac), and the coating thickness was
minimised where possible to prevent the loss of finer features of the particles.
Figure 3.7: JEOL JSM-7500 FA field emission scanning electron microscope [424].
Transmission Electron Microscopy
Transmission electron microscopy was performed on a JEM-2010 (JEOL, Akishima,
Tokyo, Japan), at an accelerating voltage of 200 kV which is fitted with an Orius CCD
camera (Gatan, Pleasanton, CA United States). Images were captured and processed us-
ing Gatan Digital Micrograph software. For sample preparation, ethanol absolute was
added to a small amount of dry powder, which was then sonicated in an ultrasonication
bath (Branson) for up to 2 hours. Following this, one or two drops of the suspension was
dropped onto a lacey carbon-coated 200 mesh copper TEM grid via Pasteur pipette, and
left for the ethanol to evaporate, before being placed in a sample holder for insertion into
the instrument.
Energy-Dispersive X-ray Spectroscopy
In-situ energy-dispersive X-ray spectroscopy was performed during electron microscopy
imaging on a number of different samples in order to determine the presence of spe-
cific elements within synthesised materials, or the ratio between multiple elements. Bulk
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elemental analysis and elemental mapping was performed in the aforementioned JEOL
JSM-7500FA scanning electron microscope, which was outfitted with a X-Flash 4010
10 mm2, 127 eV SDD energy dispersive X-ray detector (Bruker, Billerica, MA, United
States). For this analysis, an accelerating voltage of 15 kV, emission current of 10 µA and
spot size of 15 was used in order to achieve an X-ray signal at sufficient intensity for the
analysis, which was between 2000-3000 counts per second. Bruker QUANTAX software
was used in order to collect and analyse X-ray spectral data between 0-125 eV, or obtain
EDS mapping images. For high-resolution EDS mapping, a more powerful microscope
was needed to characterise some nanomaterials. For this, a JEM-ARM200F (JEOL, Ak-
ishima, Tokyo, Japan, Figure 3.8) transmission electron microscope, fitted with a JEOL
Centurio SDD detector with 100 mm2 detection area was used. NSS 3 X-ray microanal-
ysis software (Thermofischer Scientific) was used to collect, analyse, and prepare high
resolution EDS mapping images.
Figure 3.8: JEOL JEM-ARM200F Cs Corrected S/TEM [425].
3.3.4 X-ray Photoelectron Spectroscopy
X-ray photoelectron spectroscopy (XPS) was conducted using a SPECS PHOIBOS 100
Analyzer, in a high-vacuum chamber of base pressure below 108 mbar. X-ray excitation
was provided by Al Kα radiation with photon energy hν = 1486.6 eV at the high voltage
of 12 kV and power of 120 W. The XPS binding energy spectra were recorded at the pass
energy of 20 eV in the fixed analyser transmission mode. Analysis of the XPS data was
carried out using the commercial CasaXPS 2.3.15 software package.
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3.3.5 Vibrational Spectroscopy Techniques
There are two distinct vibration spectroscopy techniques used within this thesis work,
Fourier Transform Infrared (FTIR) spectroscopy and Raman spectroscopy. The spectra
obtained through these techniques result from the interaction with electromagnetic radia-
tion with the vibrational motions of a material.
Fourier Transform Infrared Spectroscopy
The infrared transmission spectra for each of the synthesised materials were obtained for
dry powdered samples using a Shimadzu AIM8000 FT-IR spectrometer. Samples were
placed underneath and pressed down with a diamond press, and the transmission spectra
was taken between 500-4000 cm−1 and with a resolution of 8 cm−1.
Raman Spectroscopy
Raman spectra were obtained using a H800 spectrophotometer (HORIBA Jobin Yvon)
with a 50x microscope objective and confocal hole size of 1000 µm. A 532.81 nm He-
Ar laser was used to excite Raman scattering between 200-800 cm−1 using a 200 µm
grating. Spectra were collected at a residence-time distribution (RTD) of 20 seconds and
at exposure time of 2 seconds, accumulated from 20 measurements. A small amount of
dry powder was lightly pressed onto the surface of a glass microscope slide, after which
deionised (DI) water was dropped onto the slide to wet the powders.
3.3.6 Ultraviolet-Visible Absorption Spectroscopy
In order to probe the ultraviolet-visible optical absorption properties of the synthesised
nanomaterials, or nanoparticle-dye mixtures resulting from photodegradation experiments
(Section 3.3.10). In a typical experiment, a few mg of nanoparticles were weighed out
using an analytical balance before being added to a small volumetric flask (10 or 25 mLs).
The desired solvent was then added in order to achieve a concentration of 1 mg mL−1,
after which the flask was then placed in a ultrasonication bath (Branson) for 2 hours, in
order to suspend the particles. Once the particles were suspended, the stock solution was
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then diluted to the desired concentration via pipette, before being placed into a quartz
cuvette. The absorption spectra of the sample between 200 - 800 nm was then taken using
a UV1800 spectrophotometer (Shimadzu), with a 0.5 nm step size. At the beginning
of each session, a background spectrum was first taken with the solvent in question in
both the reference cuvette and the sample cuvette, in order remove the absorption of the
cuvettes and solvent from the final spectra. In the context of semiconductors, such as
the metal oxide nanoparticles comprise the majority of this thesis work, the absorption
of incident photons is due to both (1) scattering effects and (2) direct absorption of a
photon of an appropriate energy in the form of an electronic transition. The scattering
effects observed for nanoparticles fall within the range of Rayleigh Scattering which is
an elastic scattering phenomenon and inversely proportional to photon wavelength (λ ),
meaning that shorter wavelengths are scattered more intensely. The size of the band gap
(Eg) that exists within semiconductor materials, as per their definition, is between that of
a conductor and insulator. Semiconductors are able to absorb photons of electromagnetic
radiation of sufficient energy:
E = h̄ω = Eg +Ee,kin +Eh,kin (3.6)
Where Ee,kin and Eh,kin are the kinetic energies of the electron and hole respectively.
This absorption results in generation of an electron-hole pair or a quasi-particle exciton,
as an electron is promoted from the valence band to the conduction band. Due to the
nature of quantum mechanics and the quantisation of energy, a photon may only transfer
the entirety of its energy to the semiconducting material, resulting in the requirement that
the photon energy be greater than or equal to the size of the band gap. As such, within the
context of the ultraviolet-visible spectrum, semiconducting band gaps of energy between
1.7 - 6.2 eV can be observed, due to the relationship between the wavelength of a photon










Where h is Planck’s constant (4.135× 10−15 eV s ) and c is the speed of light in vacuum (3
× 108 m s−1). As such, by suspending semiconducting nanoparticles in the appropriate
solvent, or conducting diffuse reflectance measurements, it’s possible to calculate the
optical band-gap based on their absorption spectra, by constructing a Tauc plot with the





Which yields the attenuation (α) of the sample based on the absorption of the sample, the
density (ρ) and other quantities already defined in this subsection. The Tauc plot is then
constructed by plotting the energy of the incident photons (Eg = hν) in eV, calculated




band gap semiconductors. This results in a plot of the form:
(αhν)n = B(hν +Eg) (3.9)
Where the electronic band gap of the semiconductor in question can be found by ex-
trapolating the linear portion of the curve to the intercept at the x-axis (Figure 3.9).
Figure 3.9: Tauc plot constructed from the UV-vis absorption spectrum of CeO2 nanoparticles




To measure the absorption spectra of dry powders, diffuse reflectance spectroscopy was
employed, using a UV-3600 (Shimadzu) with an integrating sphere attachment (Figure 3.10).
Firstly, a background spectrum was taken between 200 - 800 nm using a completely white
standard barium sulphide (BaS) sample. Following this, the sample holder was filled pow-
der samples and inserted into the instrument. The diffuse reflectance spectra of this sam-
ple was then similarly measured between 200 - 800 nm order to find the 100% reflectance
of the inside of the sphere itself, a standard sample of coated BaSO4 is firstly measured,
after which the sample is measured.[426]
Figure 3.10: Schematic of interior of integrating sphere used in diffuse reflectance spectroscopy
[427]
The intensity of the reflected light as a function of incident wavelength incident light
intensity can then be analysed using the Kubelka-Munk theory of reflectance. This is
because there are two types of reflectance occurring, spectral and diffuse reflectance, the
latter of which is internal reflectance within the sample. Figure 3.11 shows the radiation
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sdx
= aJ− I, and as the reflectance of a sample is the
same as transmittance in the Beer-Lambert equation, which is (intensity out)/(intensity





Following differentiation of this, substitution, and considering that the depth of the sam-








Where R∞ is the
Rsample
Rstandard
[429]. This f (R∞) can then be used in the place of α in
the Tauc equation (Equation 3.9), and [ f (R∞)hν ]2 plotted against hν in order to find the
optical band gap as intercept of the straight line fit to the linear portion of the curve to the
x-axis.
Figure 3.11: The Kubelka-Munk theory of reflectance, where I and J represent the radiation flux
in the upward and downward direction within a sample.
3.3.8 Magnetic Characterisation
Magnetic characterisation of the hematite nanoparticles was performed using a Physical
Properties Measurement System (PPMS, Quantum Design International, San Diego, Cal-
ifornia) in Vibrating Sample Magnetometry (VSM) mode. Magnetic hysteresis curves
were obtained at 4.2 K and 300 K between -5 T and 5 T, and field-cooling curves were
collected at 0.05 T between 4.2 and 300 K.
3.3.9 Dynamic Light Scattering
In order to determine the hydrodynamic diameter of the samples while dispersed in a
solvent, dynamic light scattering was used in order to investigate the particle size distri-
bution of various prepared nanomaterials. In a typical experiment, a few mg of powder
was added to a 15 mL centrifuge tube, followed by a few mLs of DI H2O for a final con-
centration of 1 mg mL−1. This was then placed in an ultrasonication bath (Ultrasonics,
Australia), for 2 hours, after which the stock solution was serially diluted into a flat bottom
96 well-plate (Corning), at concentrations of 0.5, 0.1, 0.05 and 0.01 mg mL−1 in order to
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find the optimal concentration. The distribution of size by intensity was then measured
using a Zetasizer APS (Malvern Instruments). Following 120 seconds of equilibration at
25 ·C, the dynamic light scattering of each well was measured 3 times, with 13 periods of
data acquisition each lasting 10 seconds making up each measurement.
As a consequence of Rayleigh scattering, the hydrodynamic radius (R6H) as determined by
DLS is also weighted by volume squared, or the sixth power of the radius. In DLS mea-
surements the average size is usually reported as the Z-average, which for any arbitrary





Where particles of type i have a hydrodynamic radius of RH,i for ni particles. However,
this is not representative and should not be used in the case that there is a bimodal size
distribution of the particles with obvious size differences. The result is an average that
may not exist within the same, as the bimodal distribution could be due to the agglomer-
ation of two or more single particles such that 2RH,1 = RH,2. Despite this, it is possible to
report the cumulant percentage and average size of each of these curves when describing
bimodally distributed particles. The data was then exported from the Malvern Instruments
software, and plotted and analysed in Origin.
3.3.10 Photocatalytic Measurements
Nanomaterials with high photocatalytic activity are favoured for applications such as
wastewater cleaning, dye-sensitised solar cells and bactericidal surface coatings. As men-
tioned in previous chapters, the absorption of a UV photon results in charge separation
which can then go on to generate free radical species such as OH·. These highly reactive
chemical species can then go on to react with a host of different target molecules. In the
context of free radical scavenging nanoparticles, one particular study demonstrated the
ability of CeO2 nanoparticles to scavenge these OH· radicals through the prevention of
the degradation of crystal violet (CV), after being generated from the decomposition of
H2O2 by Fe2+ ions in solution by Fenton chemistry [81]. Crystal violet is an excellent
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indicator of OH· generation, as these radical species can attack the highly electronegative
middle carbon-carbon double bond (Figure 3.12), yielding a colourless reaction product.
Thus, by slowing or halting the degradation of CV by these OH· radicals we can infer a
free radical scavenging behaviour. In one of the publications resulting from work under-
taken in these doctoral studies, rather than use Fe2+ and H2O2 to generate these radical
species, we conduct the experiment under incident UV light and disperse the CV with
photocatalytically active TiO2 nanoparticles in aqueous solution and show that this de-
crease in degradation is due to free radical scavenging behaviour of our nanocomposite
system [111].
Figure 3.12: Degradation of CV by photo-generated OH· radicals [81].
Methods
A number of dye photodegradation experiments were conducted in order to determine
the ability for the as-prepared nanoparticles to generate free radicals upon exposure to
broad spectrum ultraviolet light. Crystal violet (CV) dye (tris (4-(dimethylamino) phenyl)
methylium chloride) was used to indicate the relative number of free radicals formed
during the experiment, as the generated OH· radicals by metal oxides are able to react
chemically via electrophilic addition with the highly electronegative carbon-carbon dou-
ble bond in its centre. This reaction yields a colourless product, and as such, the decrease
in absorbance ∆A of the CV at its maximum (590 nm) after ultraviolet exposure can be
used to determine the relative number of OH· radicals generated [81]. In order to test the
photoactivity of a particular nanomaterial, a stock of 1 mg mL−1 was firstly prepared,
and dispersed via ultrasonication bath (Branson) for 2 hours. Some amount of this dis-
persion was then added to a 100 mL volumetric flask, along with some stock of CV, and
made up to the mark for the desired concentrations. For the CV, this was 1.2 × 10−5 M,
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which gave an absorption of around 1 a.u., and for the nanomaterial in question, this was
typically 5 mg L−1. This was then added to a fused quartz beaker along with a magnetic
stirring bar, and placed within an RPR-200 photochemical reactor (Rayonet, Branford,
CT, USA) and allowed to stir for 20 minutes in the dark after which, a 10 mL aliquot was
taken via pipette for exposure time t = 0. Following this, the reactor was then switched
on, exposing the solution to a broad UVA-UVB spectrum, due to the 300 and 350 nm
lamps present within the photochemical reactor (Figure 3.13). At 5-minute intervals the
lamps were switched off, and a 10 mL aliquot taken via pipette and this was repeated for a
total experiment time of 30 minutes exposure. The absorbance of these various solutions
was then taken using a UV1800 spectrophotometer (SHIMADZU), as outlined in Section
3.3.6, and was then expressed as relative absorbance = AtA0 . In order to best compare the
relative degradation of the CV by the synthesised materials, the Langmuir-Hinshelwood
[430] model was used in order to determine the linear rate constants k. This linear rate




Where Ct is the concentration at the given time, C0 is the initial concentration and t is the
time in minutes.
λ   300nm  350nm
hv
Figure 3.13: Schematic of photocatalytic dye degradation experiments, where the white spheres
are the TiO2 P25 nanoparticles, and the red spheres are the Fe2O3 nanocomposites being investi-
gated for free radical scavenging properties.
3.3.11 Rheology Measurements
The rheological properties of the sunscreens containing the prepared particles were inves-
tigated and compared to two different sunscreen products available commercially in Aus-
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tralia. One of these commercial products was a more viscous-type, being dispensed from
a tube (OMBRA R©), while the other was less viscous and dispensed through a spray bottle
(Auscreen R©). These experiments were performed in order to show that the spreadability
of the prepared emulsions is comparable to that of a commercially available product. A
Physica MCR 301 (Anton Paar, Graz, Austria) was used to perform these measurements,
in which a small amount of the emulsion was placed on the base plate of the rheometer.
The viscosity of the emulsions was measured with a 0.3 mm test gap over an increasing
rotational shear rate between 0.01-1000 1/s. The viscosity was sampled every 5 seconds,
with a total of 50 measurements points taken.
3.3.12 Outdoor Exposure Tests
In order to further investigate the potential photocatalytic properties of the nanomaterials
designed for use in commercial sunscreens, outdoor exposure tests were used in order
to simulate real-world conditions. These experiments were conducted during summer-
autumn 2017 on the roof of the Sustainable Building Research Center, at University of
Wollongong’s Innovation Campus, Fairy Meadow, New South Wales. A number of 250
mm × 100 mm pre-painted steel panels were obtained from BlueScope Steel (Port Kem-
bla, NSW) were obtained for use as a substrate. Sunscreens were applied to the pre-
painted side of the steel panels by firstly spreading 2-3 g of sunscreen emulsion onto
the test panel, and drawing this down one side using a #10 wire-wound drawdown bar.
This method results in a reproducible 13 µm coating of sunscreen on the painted surface
of the test panel . These panels were then mounted onto a north-facing insulated rack
angled at 45◦ in portrait orientation, with the sunscreen-coated side on the bottom half
(Figure 3.14). These panels were then left for 6 weeks, after which they were removed
from the panel and a 40 mm strip was removed with a hydraulic guillotine. The panels
were then returned to the rack. The removed strips were then gently washed with a paint-
brush and soapy water, with the excess soap removed with a gently running, lukewarm
tap. These strips were then left to dry, and after an additional 6 weeks the panels were
again removed from the testing rack, and another 40 mm strip was removed and cleaned in
119
CHAPTER 3
the same way as previously described. Finally, the 60◦ gloss reading was then measured
using a handheld glossmeter (Byk-Gardner).
(a) (b) (c) (d)
Figure 3.14: (a) Pre-painted steel panel half coated in sunscreen preparation, and (b-d) images
of the steel panels mounted to the outdoor exposure rack.
3.3.13 Sun Protection Factor Determination
There are a number of different methods and standard procedures used internationally
in order to describe the efficacy of sunscreens; and cosmetic products with ultraviolet
blocking properties. The ability for these products to protect consumers from exposure
to terrestrial ultraviolet radiation is defined by their Sun Protection Factor (SPF) rating,
which was first introduced in 1962 by Franz Greiter. It has since become a worldwide
standard for expressing the effectiveness of these products to absorb ultraviolet radiation
at the wavelengths that are firstly able to penetrate through the atmosphere (320 - 400
nm). The SPF rating is defined in relation to the minimum erythema dose (Equation 3.14)
[250].
SPF =
minimum erythema dose on sunscreen-protected skin
minimum erythema dose on non-sunscreen-protected skin
(3.14)
Where the minimum erythema dose (MED) is defined as the minimum amount of ul-
traviolet exposure needed to produce a discernible ’sunburn’, or redness in the colour of a
person’s skin, 24 hours after UV exposure [251]. The ability for ultraviolet light to cause
erythema is wavelength dependant, and this is also considered when calculating the SPF
rating of a sunscreen emulsion. The below Figure 3.15 shows the erythemal effectiveness
spectrum E(λ ); with the spectral irradiance of the ’standard sun’ S(λ ); and the product of
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these, showing the main wavelengths of erythemal action from sun exposure. The product
of these terms is in the equation used for the calculation of the SPF and PF-UVA ratings
of a sunscreen product (Equation 3.15, Equation 3.16) and as such, a greater absorption
of ultraviolet light at in the wavelengths of increased erythemal action results in a higher
SPF rating of the emulsion.
Figure 3.15: (a) Spectral erythemal effectiveness E(λ ) and spectral irradiance of the standard
sun S(λ ) and (b) their product [110].
A standard method known as the COLIPA (The European Cosmetic Toiletry and Per-
fumery Association) method, exists for this type of testing, in which a minimum of 10 test
subjects have 2± 0.04 mg cm−2 of sunscreen product spread onto defined regions on their
back (Figure 3.16), with each region irradiated with a different dose of UV radiation in or-
der to determine the MED [110]. While this method of determining the SPF of sunscreen
products is considered the ’gold standard’, it has many disadvantages including high cost;
ethical issues; long irradiation times and results can vary significantly between testing
laboratories [252]. In order to overcome these disadvantages, there has been significant
research effort to develop and standardise in vitro SPF determination methods whose re-
sults can be correlated with results found through the COLIPA method. This has proven
to be a significant challenge, with significant differences between in vitro and in vivo SPF
values observed for different tests, as well as significant differences between different
laboratories using the same method [431], which can originate from slight differences in
equipment [432] to different users conducting the testing.
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Figure 3.16: Back of a patient with MED test patches, designed to only let a certain UV dose
through, in order to determine their MED for the following COLIPA test featuring sunscreen
products [433].
One of these in vitro SPF test methods is ISO 24443:2012 [434], which uses a very spe-
cific procedure and set of equipment in order to measure the SPF of a sunscreen product.
These strict set of requirements are designed to ensure reproducibility of the results of the
tests between different laboratories. Rather than use the skin of test subject as a detector
of transmitted ultraviolet photons, as in the COLIPA in vivo method, a UV2000S analyser
(Figure 3.17 a,b) is used in order to measure the transmission of a UVA and UVB (290
- 400 nm) light through a substrate coated with the sunscreen product. This device has
an integrating sphere, and as such is able to collect all absorbed and scattered effects as a
result of the sunscreen emulsion after exposure of a broad solar spectrum from a Xe flash
lamp. These substrates are 100 mm x 100 mm poly(methyl methacrylate) plates (Helio-
plates, HelioScreen, Creil, France) which are available in two different types: moulded
and sandblasted, with specific topological features in the form of surface roughness [435].
A weighted amount of sunscreen is pipetted onto the surface of the PMMA plates in at
least 9 droplets (Figure 3.18 a,b), the total weight of which should be equal to 1.2 - 1.3
mg cm−2, depending on the plate type [436], as an increased amount of sunscreen will
result in a higher SPF obtained for the measurements [433]. The sunscreen must then be
spread evenly over the plate, which is generally done by hand, and a source of poor repro-
ducibility as this can vary between different operators significantly [437], and a robotic
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arm with a spreading tool has since been developed by HelioScreen in order to attempt to
improve reproducibility. Specific details of the experimental procedure and used in this
thesis work for this ISO measurement can be found in Section 3.3.13.
A second method was used in order to firstly characterise the SPF of a number of the
as-prepared sunscreen emulsions, and the effect of extended ultraviolet exposure on the
SPF rating. This method also followed ISO 24443:2012, but rather than use a UV2000S
analyser in order to measure the transmission of coated PMMA plates, a UVIKON 922
spectrophotometer (KONTRON instruments) was used. Rather than expose the coated
plate to a broad solar spectrum simultaneously, light from a tungsten halogen and deu-
terium lamps is measured at a specific wavelength which is scanned from the longest to
shortest wavelength in the range using optical filters. The transmitted light is detected
using a photomultiplier tube in order to find a spectrum of absorbance for the sunscreen
emulsion. After finding an initial SPF rating for the as-prepared emulsions, the plates
were then exposed to a solar simulator under parameters also defined in ISO 24443:2012.
The total ultraviolet exposure is generally expressed in terms of minimal erythemal doses
per hour (MEDs h−1), or the effective irradiance in terms of UVA + UVB content, with the
total UV irradiance between 40-200 W m−2 [437]. After this exposure, the SPF is again
measured using the spectrophotometer, and the SPF calculated, in order to highlight any
potential photodegradation of the UV filtering components within the emulsion.
Methods
In vitro Sun Protection Factor (SPF) measurements of the prepared emulsions were ob-
tained using a Labsphere UV2000S in accordance with ISO 24443:2012 at the I. U. T.
Chartres, Site Université d’Orleans in Chartres, France. No more than 30 mg of emul-
sion was transferred onto the surface of the standard poly(methyl methacrylate) (PMMA)
plates via Pasteur pipette in at least nine separate droplets, which was then spread homo-
geneously across its surface with a gloved finger, resulting in a final weight of 15 ± 0.5
mg of emulsion on the plate. The plates were then left to dry under ambient conditions,
after which the transmission between 290 - 400 nm was measured at 6 different locations
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on the PMMA plate.
(a) (b)
Figure 3.17: (a) The Labsphere UV2000S device located at IUT, Chartres, France and (b) the
guide attached to the moving stage, showing the 12 different positions to reproducibly measure
the PMMA plates at multiple locations.
This was repeated for 4 plates, and the final SPF value was calculated from these with
the following equations [113, 411]:
SPF =
∫ 400
290 E(λ )S(λ )dλ∫ 400
290 E(λ )S(λ )T (λ )dλ
(3.15)
Where E is the erythemal spectral effectiveness, S is the solar spectral irradiance and T
is the spectral transmittance of the sample [31] at a particular wavelength. The UVA pro-




290 E(λ )S(λ )dλ∫ 320
290 E(λ )S(λ )T (λ )dλ
(3.16)
Which is a measurement of the ability for the sunscreen emulsion to only absorb the
UVA part of the solar spectrum (290 - 320 nm). The error expressed for these measure-
ments is the 95% confidence interval, and Student’s t-test was performed on each sample
in order to determine any significance. Another important quantity to derive when com-
paring the effectiveness of broad spectrum sunscreen formulations, is the critical wave-
length (λc). The critical wavelength represents the upper limit where 90% of the total area
under the absorption curve of the formulation between 290 and 400 nm falls under [161].
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Figure 3.18: (a) PMMA plate with ∼32.5 mg of emulsion weighed onto the sandblasted surface
and (b) the same plate after allowing for the sunscreen emulsion to dry.
3.3.14 Sun Protection Factor Test Method 2
The stability of the SPF of a number of the emulsions were also tested at Expertise et Con-
seil, an analytic cosmetics laboratory in Marseille, France. These tests were conducted
in order to determine if prolonged ultraviolet exposure resulted in the decomposition of
ultraviolet filters within the product. In these experiments, the above procedure outlined
in Section 3.3.13 was followed in order to coat PMMA plates with a known amount of
sunscreen emulsion. Once dry, the transmission was measured using a UVIKON 922
(KONTRON Instruments) from 800 to 190 nm at a rate of 500 nm min−1. This spectrum
was taken at 6 different locations on the plate by rotating the plate 90 ◦C clockwise af-
ter each measurement for the 2nd-4th measurement, and then 45 ◦C for the 5th and 6th
The SPF rating was then calculated and compared between the different emulsions and





The aforementioned Madin-Darby Canine Kidney cells used throughout this work were
obtained from Sigma-Aldrich (LOT05/L/009). Adherent cell cultures were grown and
maintained in T75 cm2 tissue culture flasks (Falcon Franklin Lakes, New Jersey, USA)
in Dulbecco’s Modified Eagle Medium (DMEM) with L-Glutamine (GIBCO, Life Scien-
tific). Growth media was also supplemented with 10% (v/v) Fetal Bovine Serum (FBS)
(GIBCO, Life Scientific) and 1% (v/v) Penicillin/Streptomycin (GIBCO, Life Scientific).
Cell cultures were incubated at 37 ◦C with 5% CO2 atmosphere. The cells were subcul-
tured every 2-3 days, whereby the old growth media was removed, the cells washed twice
with 5 mLs of Dulbecco’s Phosphate Buffered Saline (DPBS) (GIBCO, Life Scientific)
without calcium or magnesium. After this, 2 mLs of 0.5% Trypsin EDTA (GIBCO, Life
Scientific) was added and the cell culture flask was returned to the incubator for 20 min-
utes. The cells were then resuspended by added 8 mLs of DMEM and mixed thoroughly
through pipetting the volume up and down in the culture flask. A small aliquot of this
suspension was then taken, diluted in Trypan Blue (GIBCO, Life Scientific) and counted






Where C is the concentration of the suspension in cells mL−1, n is the number of cells
counted in the haemocytometer. The equation term s is the number of square areas from
which cells were counted in the haemocytometer, with 10 giving the number of cells per
10 µL. Finally, the term d is the dilution factor and 1× 104 being the conversion factor to
arrive at cells mL−1. The cells were then seeded into a new cell culture flask at a density
of 9 × 10 3 cells cm−2, which for a T75 cm2 flask was roughly 7 × 105. The doubling
time of MDCK was determined to be 24 hours.
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3.4.2 MTT Cell Viability Assay
Currently there are a large number of different biological assays which are able to be used
to measure the number of surviving and/or proliferating cells. First reported by Mosmann
in 1983 [438] in 1983, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
(MTT) assay is quantitative colorimetric assay which is extremely quick, simple, and high
throughput, allowing for the rapid measurement of the impact of a particular treatment on
cell viability. Viable cells growing within a culture medium reduce the yellow MTT tetra-
zole reagent into an insoluble purple formazan product (Figure 3.19), which can then be
subsequently dissolved, and its concentration determined through spectroscopic measure-
ments. While not initially understood, it was later found [439, 440] that the reduction
involved NADH and NADPH dependant enzymes involved in the cell electron transport
chain, resulting from metabolic activity of the mitochondria. As such, the reduction of the
Figure 3.19: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) and it’s re-
duced product, formazan.
MTT to formazan is highly dependent on the D-glucose concentration in the cell culture
medium [441]. The amount of MTT produced increases with the number of viable cells
in a linear relationship to very high cell densities, until the MTT is a limiting reagent.
Methods
In order to determine the effect of various nanomaterials on cells growing in culture,
a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) colorimetric as-
say was used. A protocol provided by the manufacturer was followed [] in order to con-
duct the assay, whereby cells were firstly grown, subcultured and counted according to
Section 3.4.1. They were then seeded onto a 96-well plate (Corning, New York, USA),




Figure 3.20: (a) Linear relationship between the number of EL4.3 cells present per well in a 96-
well plate and the absorbance of the MTT reagent detected between 570 - 630 nm resulting from
absorbance of formazan. This plate was incubated for 2 hours at 37 ◦C with the MTT reagent.
(b) Dependence of MTT absorbance on incubation time at 37 ◦C [438].
curve, with each well containing a maximum of 100 µL volume of liquid in total. For
MDCK, this was between (1.5 - 8) × 103 cells per cm2, or 500 - 2,500 cells per well.
Initial growth curve experiments showed that 1,000 cells per resulted in the optimal ab-
sorbance of 1 a.u. on the spectrophotometer in question, and as such, this density was
used in all of the wells to which a particular treatment would be added. A number of
negative controls were also used, which were wells containing 100 µL of media. After 24
hours, 50 µL of media was removed from each well via pipette, and replaced with pure
DMEM or DMEM containing a nanomaterial treatment and returned to the incubator.
The concentration of the treatment was in the range of 5-50 µg mL−1, and control wells
featuring only the nanoparticles at these particular concentrations, but without any cells,
were also prepared, in order to subtract the contribution of any sedimented nanoparticles
on the absorbance at 540 nm. After another 24 hours the DMEM within in each well was
removed and replaced with media containing 1.2 mM of the MTT (Thermo Fisher Sci-
entific, Waltham, MA USA) reagent. This solution was prepared by dissolving MTT in
Phosphate Buffered Saline (PBS) at a concentration of 5 mg mL−1, and then diluting this
in complete DMEM at a 1:10 ratio. The well plate was then covered in aluminium foil and
returning to the incubator for another 4 hours, after which 85 µL of media was removed
from the wells, leaving ∼15 µL remaining. In order to dissolve the formazan product,
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100 µL of Dimethyl Sulfoxide (DMSO, (CH3)2SO, ≥98%, Sigma-Aldrich) was pipetted
into each well. After 10 minutes, the absorbance in each well was measured at 540 nm
using a plate reader (Spectromax Plus 384, Molecular Devices, Sunnyvale, California,
USA). Before each measurement the plate reader was programmed to shake the 96-well
plate for 30 seconds in order to homogenise the formazan/DMSO solution in each well.
Measurements were repeated on each well plate until the values for absorbance stabilised,
indicating that the solution within the wells was sufficiently mixed.
Both Microsoft Excel and Origin were used in order to analyse the absorption data.
Firstly, the average was taken for the wells with variable seeding numbers, and this was
then plotted against the cell seeding number in order to obtain a linear relationship be-
tween the number of cells seeded and the absorbance at 540 nm. This data was then
subjected to linear regression analysis in order to obtain an equation in the form of a
straight line, y = mx+b. As the term y is the absorbance of the dye and x is the number
of cells seeded, it is this possible to use the slope m and intercept b in order to convert the
absorbance measurements for the other wells into cell number and therefore express this





Where C is the number of cells seeded into the wells, and A is the absorbance at 540
nm (a.u.). Following this, the absorbance of the negative control (nanoparticles no cells;
media only) were subtracted from the absorbance of each of the corresponding wells. The






Where C1 is the cell numbers for a particular treatment, and Cc was the number of cells in
the control (1,000). The average and 95% confidence interval were found from these re-
sults, and then plotted against the concentration of the particular treatment. Each measure-





Clonogenic assay is an in vitro assay for testing the ability for a single cell in suspension
to grown into a colony of at least 50 cells on a petri dish in media, and is typically used in
order to assess cell reproductive death after treating cells with ionising radiation. It was
first reported by Puck and Marcus 1956 [443], which showed the dose-dependent growth
slowing effect of exposing HeLa cells to 240 kVp X-ray irradiation. Initially in these ex-
periments, ”feeder” cells were previously added to the cell culture plate, those being cells
which already had their growth slowed through previous irradiation, in order to condition
the micro environment to allow for a small number of cells to be seeded into the plate
or petri dish. Improvements in cell culture technology over the years has now rendered
these ”feeder cells” mostly obsolete, with modern clonogenic assays following a protocol
to seed cells directly into petri dishes. The clonogenic assay has some flexibility, in that
it is possible to expose cells to the treatment being tested (ionising radiation, chemother-
apeutic drug, nanoparticles) before or after being plated onto petri dishes. In the former,
cells are taken from a stock culture, a known number seeded onto petri dishes, and after
allowing some time to attach (2+ hours) are given the desired treatment. In the latter, cells
are grown in culture to the appropriate density, exposed to the desired treatment, and a
known number seeded onto petri dishes either immediately after or after a pre-determined
delay time. Following the treatment, the dishes are returned to the incubator for a num-
ber of doubling times to allow for the formation of sufficiently large colonies. After this
period of time, the media is removed, and the cells washed with PBS, after which they
are fixed and stained with crystal violet (CV) (Figure 3.21). The number of colonies with
more than 50 cells is then counted for the untreated plates, and this number is used to
find the Plating Efficiency (PE) Equation 3.21, which is the ratio between the number of
colonies formed to the number of cells originally seeded onto the plates, assuming that
each colony was formed from one healthy, viable cell.
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Figure 3.21: Clonogenic assay of SW-1573 lung tumour cells in six-well plates, showing the
influence of seeding number on the ability to count the number of formed colonies. The first two
control plates (top-left, top-middle) were seeded with 100 and 200 cells each, and as such the
colonies are well separated and easy to count. The control well (top-right) was seeded with 400
cells, and features too many overlapping colonies, which is not reliable for counting. The bottom
row shows the number of colonies formed following 4 Gy radiation exposure, after seeding 400,
800 and 1,600 cells respectively. Again, the last plate (bottom-right) has too many overlapping





The effect of the treatment on the ability of the cells to form colonies is then determined






Between 20,000-50,000 cells were firstly seeded into T12.5 cm2 tissue culture flasks, and
incubated for 3-4 days before conducting the assay. The nanomaterials being tested on
the cell cultures were prepared by firstly autoclaving the powders for sterility, followed
by the addition of sterile calcium and magnesium free Dulbecco’s Phosphate Buffered
Saline (DPBS) (GIBCO, Life Scientific,) and sonication in an ultrasonic bath for 2 hours.
These suspensions were then added to the cell culture flasks under sterile conditions for
the desired concentration (50-100 µg mL−1). After a further 24 hours of incubation
with the nanoparticles, the adhered cells were washed twice with DPBS (no calcium, no
magnesium) and detached with 0.05% Trypsin-ethylenediaminetetraacetic acid (EDTA)
solution. The number of cells was then determined using a haemocytometer, and the cells
were then seeded at low density into 10 mm cell culture plates (BD Falcon). After 15
doubling times, the dishes were then washed with DPBS, followed by fixing and stain-
ing with 25% (v/v) crystal violet stain (Sigma-Aldrich) and 75% ethanol. The plating
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Flow cytometry is a powerful biological characterisation tool used to analyse multiple
characteristics of a cell within a heterogenous population. The basic principles of this
technique involve passing a suspension of cells through a beam of light, and the interaction
of this light with the passing cells forming the basis of the characterisation. This can relate
information on the size (forward scattered light) and granularity of the cell (side-scattered
light), allowing for the identification of different populations within the suspension [445].
The optical system within a flow cytometer is comprised of optics for excitation and
subsequent detection, with often a number of sources of different wavelengths, as well
as filter and detector combinations to allow for the use of a wide variety of different cell
labels and dyes. Cells in suspension are firstly draw into a stream surrounded by isotonic
fluid, moved through laminar flow, which brings the individual cells into the path of the
incident laser beam. This beam is monochromatic, and at this point interacts with the
cells, scattering in all directions (Figure 3.22a), which is subsequently collected by the
complex optical system that comprises the detection system of the flow cytometer. In this
system, a series of filters isolate particular wavelength bands Figure 3.24b.
Nanoparticle Internalisation Studies
There are an enormous number of properties of cells that can be probed using flow cy-
tometry and in this thesis work flow cytometry was used in order to determine the degree
of internalisation of nanomaterials within the cultured mammalian cells. It has been pre-





Figure 3.22: (a) Illustration showing the interaction of incident light beam with single cell in
suspension in flow cytometry and (b) schematic showing the layout of components within a flow
cytometer [446].
side-scattered light (SS) and decrease in forward-scattered light (FS) in a dose-dependent
manner Figure 3.24a. The below Figure 3.23A from Suzuki et al. 2007 [447] shows a
number of forward-scatter (FS) side-scattered (SS) graphs showing the increase in aver-
age side-scattered light of CHO-K1 cells with increasing concentration of TiO2 nanopar-
ticles. This can be seen more clearly in Figure 3.23b (right), where SS is plotted against
number of counts, where the peak of each of these curves can be seen to shift to higher
SS with increasing nanoparticle concentration.
Figure 3.23: (A) Forward-scattered light against side-scattered light graphs along with (B)
forward-scatter (left) and side-scatter (right) against number graphs, from flow cytometry mea-
surements of CHO-K1 cells exposed to increasing concentrations of TiO2 nanoparticles for 3
hours [447].
This is dependant, however, on a number of different properties of the internalised
particles, such as their size, refractive index and the wavelength of excitation, which have
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been shown experimentally with a number of different nanoparticles in both mammalian
cells [448–450] and bacteria [451]. This is because the increase in side scatter is due
to the light scattering off the internalised particles, and it can be seen in Figure 3.24b
how increasing the particle size also increases SSC relative to the same concentration of
smaller Ag nanoparticles.
(a) (b)
Figure 3.24: (a) Side-scattered light of ARPE-19 cells exposed to 0-20 µg ml−1 of 75 nm PVP-
coated Ag nanoparticles for 24 hours and (b) size-dependence on SSC signal for these same
PVP-coated Ag nanoparticles with ARPE-19 cells [449].
DCFH-DA Assay
The complex optical system within most modern flow cytometer equipment also allows
for the excitation and subsequent detection of fluorescence molecular probes. These
probes give additional information about the cells being characterised, and in this work,
we used a 2’-7’-dichlorofluoroscein diacetate (DCFH-DA) assay in order to probe the
cellular ROS levels of our cultured cells after exposure to the synthesised nanomaterials.
While DCFH-DA itself is a non-fluorescent molecule, it has its acetate groups cleaved
by intracellular esterases upon crossing the cell membrane, resulting in DCFH [452].
This molecule is also non-fluorescent, but can then be reduced to the fluorescent 2’-7’-
Dichlorofluorescein (DCF) by a number of different radical species. While it was initially
thought to be a specific indicator for H2O2 [453], it was later shown to be oxidised by
a number of different ROS and RNS species including H2O2, OH., ROO., NO. ONOO−
[454, 455]. The resulting DCF molecule has an excitation wavelength of 498 nm and
emission wavelength of 522 nm. However, many substances have been known to inter-
fere with the formation of DCF from DCFH-DA and as such, is more suited for a marker
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of oxidative stress and not one of ROS or RNS exclusively [456].
Figure 3.25: Reaction scheme highlighting the mechanism of de-esterification of DCFH-DA to
DCF, and further oxidation to the fluorescent DCF [456].
This assay has been used in a large number of previous studies, in order to investi-
gate the effect of nanoparticles on cultured mammalian cells for toxicological purposes.
These include nanoparticles of Ag , silica, and a variety of metal and oxide nanoparticles
[120, 457–459] on a number of different cell lines. Along with flow cytometry, it is also
possible to use DCFH-DA in fluorescent microscopy, with Figure 3.26a showing the in-
crease in fluorescence resulting from exposing BRL 3A rat liver cells with an increasing
concentration of Ag nanoparticles. This graph was constructed from the fluorescent mi-
croscopy images seen in Figure 3.26b where the green fluorescence of the DCF molecule
can be fully visualised. It can be seen that the fluorescence is localised nearly entirely
within the cell membranes, due to the action from intracellular esterases being required
to cleave the diacetate group from DCFH-DA before it can react with ROS.
(a)
(b)
Figure 3.26: (a) Fluorescence intensity of DCF following exposure of BRL 3A rat liver cells to
two different size of Ag nanoparticles for 3 hours. (b) Fluorescent microscopy images showing
DCF fluorescence in the same BRL 3A cells, showing the control (left), 25 µg mL−1 of 15 nm




An LSR FORTESSA X20 (BD, Franklin Lakes, NJ, USA) Flow Cytometer was used in
order to determine the internalisation of the iron oxide nanomaterials into the cultured
MDCK cells, and their influence on the levels of internal cellular reactive oxygen species
(ROS) was quantified using 2’-7’-dichloro fluorescein diacetate (DCFH-DA). T12.5 cm2
cell culture flasks were seeded with 30,000-50,000 cells, and after 2 days of incubation a
suspension of nanorods in DPBS (calcium free, magnesium free), for a total concentration
of 50 µg mL−1. After a further 24 hours of incubation, the cells were removed from the
cell culture flask with a portion of 5% Trypsin- EDTA solution, after which the suspension
was diluted with DMEM and the cell concentration determined with a haemocytometer.
Around 150,000 cells were then seeded into 5mL polystyrene flow and analysed with a




and Morphology of Hematite
Nanoparticles and Their Effect on
Cytotoxicity in vitro
The following chapter highlights the research reported in a publication in ACS Applied
Materials and Interfaces in 2016, [111], sharing its title with this chapter. As such, sec-
tions of this chapter may be taken from this publication verbatim. This chapter also makes
use of a number of abbreviations in order to describe the samples featured herein, so as to
more easily refer to their synthesis parameters. These parameters and their abbreviations
have been described in Section 3.2.1.
4.1 Introduction
The unique properties of nanostructured materials have led to increasing interest and ap-
plication in industry, medicine and consumer products. Metal oxide nanoparticles have
been investigated for use in a range of different fields, including catalysis [207, 208],
energy storage [460–462], gas sensing [463, 464], biomedical [6, 83, 87, 170, 219, 465–
467] and cosmetic [113, 210] applications. The same nanosized features which give these
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particles their unique properties can also affect their biological activity. The small size
of such particles means that they are able to more easily evade the immune system of the
body, and to penetrate cellular membranes to come into close proximity of sensitive bio-
logical components [468, 469]. Generally, these cytotoxic effects are the result of metal
cations on the surface of the oxide particles which catalytically generate harmful free
radical species within the cytoplasm [470, 471], and are then able to chemically attack
sensitive cellular components. Such an increase in free radical concentrations can lead to
apoptosis [107, 122], or can play a role in potential carcinogenesis [472, 473]. In many
cases, this problem is overcome by shielding or binding the highly reactive surface of
these particles with some organic ligand or polymer molecules [474, 475].
It has also been shown, however, that some metal oxide nanoparticles can be engi-
neered to decrease their toxicity, or even provide some protective effects [6, 80, 83, 87,
89, 114, 115, 174, 178]. The most investigated of these metal oxides is ceria (CeO2−x)
which has been shown to be able to selectively scavenge free radical species as a result
of a slightly oxygen-deficient surface, resulting in the presence of Ce3+ states [6]. This
activity has been proved in photometric studies [81], in vitro [82, 87, 114, 169] and in
vivo [89] studies, even being shown to scavenge reactive oxygen species (ROS) generated
from ionizing radiation [88–90, 114]. It has also been shown that magnetic iron oxide
nanoparticles, specifically maghemite (γ-Fe2O3) have similar selective free radical scav-
enging behaviour to CeO2−x nanoparticles, decomposing H2O2 to harmful radical species
at acidic pH (4.8), but breaking down the same species to H2O and O2 under neutral con-
ditions [83] in vitro. Such nanoparticles have great potential applications in the treatment
of oxidative stress, cancer radiotherapy, and radiation protection.
In this study we report the high biocompatibility, and potential free radical scaveng-
ing behaviour of hematite (α-Fe2O3) nanoparticles, which is attributed to spinel defects
of tetrahedrally-coordinated Fe sites (T-defects) on their surface [220]. The nature of
these defects are comparable to the coordination of Fe atoms present in maghemite (γ-
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Fe2O3) and can be seen as small regions of this phase resulting from a size-induced struc-
tural transformation, dependent on the type of synthesis method used in their fabrication.
They are shown to be present in these samples through X-ray Photoelectron Spectroscopy
(XPS) and Raman characterization. In the present study, after controlled annealing of
hematite precursors formed through a standard precipitation and spray precipitation tech-
nique, the hematite particles were then subjected to in depth materials characterisation,
followed by biological characterisation in order to show the in vitro effects of altering the
synthesis parameters of these particles.
4.2 Results and Discussion
4.2.1 Materials Characterisation
Analysis of the X-ray diffraction patterns (Figure 4.1) obtained for the precipitation sam-
ples P400 and P500 show a small decrease in FWHM (full-width half-maximum) when
the annealing temperature is increased from 400 ◦C to 500 ◦C (Figure 4.1 c,d). This high-
lights an increase in particle size due to additional thermal energy during annealing. The
patterns obtained for the spray precipitation sample annealed at 500 ◦C (S500) (Figure 4.1
b) show small differences from the precipitation samples, with a slightly higher intensity
of the (1 0 4) and (1 1 0) peaks relative to less intense peaks in the pattern. The diffrac-
tion pattern obtained for the porous nanorods formed at 250 ◦C (S250) (Figure 4.1 a)
reveals characteristic hematite peaks with much lower intensity and larger full width half
maximum (FWHM) than those obtained for the precipitation samples.
The (1 0 4) peak in this S250 sample also shows much lower relative intensity compared
to the (1 1 0) peak than any of the other samples (Table C.1). The other samples show an
I(104)/I110 ratio > 1, with P400 being 1.07, P500 yielding 1.10 and S500 showing 1.05,
while this value is 0.49 for the P250 sample. This difference in relative peak intensity
between these two peaks would indicate some preferred orientation of the growth of the
particles in this plane, indicative of the rod-like morphology of the particles. Calculation
of the mean crystallite size of these particles based on the Scherrer equation using the
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Figure 4.1: X-ray Diffraction patterns of hematite nanomaterial (a) S250, (b) S500, (c) P400 and
(d) P500 samples.
most intense (1 0 4) peak yields 29 nm (400 ◦C) and 38 nm (500 ◦C) for the precipitation
samples (Table 4.1). The S250 sample yields a very small crystallite size of 7 nm due to
the broad nature of this peak, and gives 30 nm for the S500 sample.
These differences in both morphology and size can be seen in the SEM and TEM im-
ages of the nanoparticles (Figures 4.2). Transmission electron microscopy images of the
P400 and P500 oxides formed through precipitation (Figure 4.2 c,d & g,h ) confirm the
presence of spherical nanoparticles with a diameter of 26 ± 7 nm and 40 ± 10 respec-
tively, which agrees with the values for mean crystallite size as determined by XRD. The
rod-like morphology is also confirmed by TEM for the spray precipitation samples, with
rods 19 ± 4 nm in width and length of 220 ± 40 nm seen for S250 (Figure 4.2 a, Ta-
ble 4.2). The TEM images of the S500 sample reveal a width of 50 ± 30 and length
of 200 ± 60 nm, which is substantially larger than the Scherrer mean crystalline size as
calculated from the (1 0 4) peak in the X-ray diffraction patterns. This could indicate that
both particles P250 and P500 as seen in TEM images are actually comprised of 2-3 crys-
Table 4.1: Selected data on hematite nanomaterials covered in this study
Annealing Scherrer Mean BET Specific
Sample Temperature Crystallite Surface
Name Preparation (◦C) Size (nm) Area (m2.g−1)
S250 Spray Precipitation 250 7 100 ± 10
S500 500 30 17 ± 2
P400 Precipitation 400 29 33 ± 3
P500 500 38 18 ± 2
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talline regions. As these nanorods were formed upon the decomposition of the goethite
(α-FeO(OH)) precursor nanoparticles, it is possible that the spindle shape of these parti-
cles could be the result of the aggregation of a number of smaller goethite crystals. The
larger size distribution both the S500 and P500 samples comes from the effects of the
higher annealing temperature and movement of grain boundaries. Images of this material
also show evidence of significant porosity in the low temperature nanorod sample. This
is confirmed through Brunauer-Emme-Teller (BET) surface area measurements, indicat-
ing that each particle seen in the TEM images might be agglomerated from a number of
highly porous rods as smooth particles of this diameter should not show such high values
of surface area. BET surface area measurements for each of the as-prepared nanostruc-
tured hematite particles reveal a very high surface area indicative of nanoporosity for the
S250 sample. The surface area of the S500 sample is close to that of the precipitation
samples, indicating that much of this porosity is lost during high temperature annealing.
This probably resulted from the loss of the pores through particle aggregation and growth.
The surface area of the spherical particles formed through precipitation decreases with in-
creasing annealing temperature, which is expected as the size of the particles increases.
e) f)
g) h)
Figure 4.2: SEM images obtained for the hematite nanomaterials a) S250, b) S500, c) P400 and
d) P500 and TEM images obtained for e) S250, f) S500, g) P400 and h) P500.
The field cooling curves (Figure 4.3) for both precipitation samples reveal some signif-
icant information regarding the magnetic properties of the synthesised hematite nanopar-
ticles. The curves showing the magnetisation upon cooling of the particles (Figure 4.3(i))
from 300 to 4.2 K with a 0.05 T field show a peak occurring at 227 K for P400 and 240
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Table 4.2: Mean particle size of hematite nanomaterials obtained from TEM images, error values
quoted are standard deviation of the mean
Sample Diameter/Width (nm) Length (nm)
S250 19 ± 4 220 ± 40
S500 50 ± 30 200 ± 60
P400 26 ± 7 -
P500 40 ± 10 -
K for the P500 sample, which represents the Morin transition temperature (TM) of the
hematite particles. Below this temperature, the hematite behaves as a uniaxial antifer-
romagnetic, while above TM has weak ferromagnetic properties. This is due to that the
Morin transition is a spin-flop transition, below which, the spins are directed along with
[111] axis. Above the Morin temperature, the spins are directed perpendicular to this axis
with a very small degree of spin canting [476], which results in the weak net ferromag-
netic moment. The temperature of TM upon cooling has been shown to decrease with
decreasing particle size [477], but has also been showed be lowered due to be lowered by
the structure of the surface, stoichiometry and crystallinity [478]. As the P400 particles
were formed under a lower temperature, and as such should feature a more disordered sur-
face structure than P500, and given that the formed of this has a larger surface-to-volume
ratio due to smaller particle size, would mean that the effects of any surface anisotropy
are more pronounced. Upon heating (Figure 4.3 (ii)) the observed TM is close to that ob-
served for bulk hematite (∼ 260 K), which can be observed at 251 K (P400) and 256 K
(P500) for the two samples. It is this transition that can be used to explain the magnetic
hysteresis curves for both precipitation samples (Figure 4.4).
Curves obtained above TM (300 K) show both materials displaying a weak ferromag-
netic moment, with a spontaneous magnetisation of σs of 0.146± 0.003 emu g−1 for P400
and 0.077± 0.001 emu g−1 for P500. This is in agreement with the field cooling and heat-
ing curves (Figure 4.3), which show a higher magnetic response for the P400 sample at
P500 sample above the Morin temperature. In the case of hematite nanoparticles, the
trend is typically to see an increase in spontaneous magnetisation with increasing particle
size, which is not the case here. This indicates that there is some other factor influenc-
ing the magnetic properties of these nanoparticles, with one possible explanation being
the presence of other surface phenomenon, contributing some uncompensated spins. The
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Figure 4.3: Field cooling curves for hematite nanoparticles P400 and P500, featuring the initial
cooling (i) and subsequent heating (ii) of the samples from 300 K to 4.2 K under 0.05 T field.
presence of such a surface defect impurity phase is shown to be present in the follow-
ing XPS and Raman analysis sections. Both samples formed through spray precipitation
show the lack of any ferromagnetic or antiferromagnetic states, with both materials dis-
playing paramagnetism (Figure C.1). This is likely due to the competition between the
shape anisotropy energy and the magneto-crystalline energy, which are comparable for
nanorods. Due to the preferential growth along the c-axis, shown through the analysis
of the X-ray diffraction patterns of the S250 and S500 nanorod samples (Figure 4.1), the
spin alignment is along this axis in order to minimise the shape anisotropy energy [479].
This coupled with the highly porous and defective nature of the surface of the particles,
results in their paramagnetic behaviour.
Figure 4.4: Magnetic hysteresis curves for P400 (a) and P500 (b) hematite nanoparticle samples.
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Analysis of the XPS data obtained for each of the characterised nanostructured hematites
(Figure 4.5) may give some insight into the properties of the samples. The presence of
Fe(III) 2p1/2 and Fe(III) 2p3/2 peaks were observed in the sample, along with their ex-
pected satellites (Figure 4.5). However, it can be seen that the shape of the Fe(III) 2p3/2
peak, that the samples formed through precipitation appeared at lower binding energies.
Analysis of the multiplet splitting within this peak (Figure 4.6) revealed some interesting
results. The 4 multiplet peaks, excluding the Surface and Pre-Peak appeared at lower
binding energies compared with literature values. The splitting indicates that some of
the Fe3+ cations within the hematite sample are tetrahedrally coordinated, when all of
the cations in this phase should be octahedrally coordinated [480]. This can be seen in
the different area ratios between Peak 1 and Peak 2 in the different samples, with a Peak
1/Peak 2 ratio close to 1 indicating that some of the Fe3+ cations in the material are tetra-
hedrally coordinated, similar to the spinel γ-Fe2O3 iron oxide phase, in which one quarter
of the Fe3+ cation are tetrahedrally coordinated. It has been described that as hematite
nanoparticles become smaller, a size-dependant structural transformation can occur, re-
sulting defects of maghemite on the surface [220]. The frequency of these defect states
increase with decreasing particle size. It was shown that particles which were grown by
annealing smaller particles of iron oxide precursors however, such as the precipitation
samples (P400 & P500) covered in this study, featured more defects at a particle size of
around 30 nm compared to the same particles of a smaller or larger diameter. This would
explain why there is an increase in the difference in the two peak areas of the Peak 1 & 2
multiplets, away from parity, as the annealing temperature of the precipitation samples is
increased from 400 ◦C to 500◦C, as these states begin to disappear as additional particle
growth occur. This is also reflected in the ratios between the first and second peaks in the
Fe(III) 2p3/2 spectra (Table 4.3) of the nanoparticles formed through precipitation (Fig-
ures 4.6 c,d). The particle size of the P400 sample is the closest (29 nm) to the maximum
defect frequency diameter (30 nm) as shown in the previous study [220] . Multiplet peaks
1 and 2 almost feature a peak area which is very close to being equal (29.7 & 29.3%).
This is markedly different to the ratio for the spray dried materials, where peak 1 is the
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Figure 4.5: Analysis of the Fe 2p3/2 and O 1s X-ray photoelectron spectra of a) S250, b) S500,
c) P400 and d) P500.
more intense (Figures 4.6a,b), and has a much larger peak area than the second multiplet
peak. The greater intensity and integrated peak area for the first multiplet (Peak 1) is
to be expected for hematite particles. This difference in multiplet splitting could be the
result of very small amounts of maghemite on the surface of the hematite particles, which
could also be a contributor to the weak ferromagnetism present within the two materials
prepared by this method. As no discernible peaks from the maghemite phase are present
with the diffraction pattern of this material, this large difference in the Peak 1 and Peak 2
ratios within the precipitation samples is likely to exist due to the presence of the phase
as a defective surface state. While the mean crystallite size from XRD is similar, and
in one case, smaller in the spray precipitation sample, the difference could be the result
of these materials being formed from the decomposition of goethite, and not due to the
annealing of an amorphous precursor. The broadness of the O1s peak (Figure 4.5b) at
higher binding energies in both of the spray precipitation samples, is most likely due to the
presence of some residual hydroxyl groups still bonded to the surface, as a consequence
of the material undergoing decomposition from the goethite (α-FeO(OH)). The observed
shift toward lower binding energies for both P400 and P500 samples is likely due to a
lower concentration of such hydrated or ’defective’ oxygen sites on the surface of these
nanoparticles resulting from the creation of pores during the evaporation of water from
the goethite structure. The presence of the aforementioned spinel defects upon the surface
of the particles would have little effect on the binding energy of the oxygen peak, as the
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Figure 4.6: Analysis of the multiplet splitting of the Fe 2p3/2 peak of each hematite nanomaterial
obtained through X-ray photoelectron spectroscopy, a) S250, b) S500, c) P400, P500.
difference in binding energy between these two phases is minimal [481].
The Raman spectra obtained for each of the hematite nanomaterials (Figure 4.7 (left))
exhibit the characteristic peaks for crystalline α-Fe2O3 [209], appearing at slightly lower
frequency than reported in literature. These peaks exist at around 224 (A1g), 244 (Eg),
293 (Eg), 298 (Eg), 410 (Eg), 494 (A1g) and 612 (Eg) cm−1 [220]. There are a num-
ber of features in the Raman spectra which differentiate the spray precipitation samples
from those formed through normal precipitation, with the S250 sample featuring much
broader, less intense peaks, which can most obviously be seen in the 224, 244, 293 cm−2
bands. This broadening is to such a degree that evidence of the 293, 298 cm−1 doublet
is not fully resolved in this spectrum as it is in the spectrum of all the other samples, and
this is accompanied by the shifting of many of the peaks for this sample shifted to lower
wavenumbers than in the spectra of the other hematite samples. This peak broadening
is expected for hematite nanoparticles with smaller crystalline size, which is the case for
these highly porous nanorods. Another feature differentiating this sample from the other
hematite nanomaterials covered in this study, is a greater peak intensity of the 410 cm−1
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Table 4.3: Ratio of peak position, areas and relative position in multiplet splitting of Fe 2p3/2
























S250 709.12 35.5 710.20 27.67 1.06 711.24 22.66 1.041 712.41 14.17 1.17
S500 709.60 35.74 710.61 26.48 1.02 711.57 25.59 0.96 712.65 12.18 1.08
P400 708.90 29.71 710.00 29.29 1.1 711.18 17.59 1.183 712.27 7.63 1.09
P500 708.79 33.03 709.85 31.45 1.06 710.84 20.06 1.00 711.82 15.46 0.97
line, relative to the 293 cm−1 line, which is not present in any of the other samples. This
could be the consequence of the highly disordered, porous nature of these nanorods. An-
other feature which differentiates the Raman spectra of the spray precipitation nanorods
is the very low intensity of the 612 cm−1 Eg peak. This is much more prevalent in the pre-
cipitation samples. The Raman spectra of the two samples formed through precipitation
show very little difference between them, with slight peak broadening seen in the P400
sample compared to P500, which can be expected due to the smaller crystalline size of
the former. The region between 525-800 cm−1, shown in Figure 4.7 (right) contains three
peaks at 612 (Eg), 660 (LO) and 690 (T) cm−1, and was subjected to further analysis and
deconvolution. This was performed as the intensities of the LO and T peaks (Table 4.4)
have been interpreted as related to the degree of disorder in the hematite lattice, and the
presence of tetrahedrally coordinated FeO4 spinel defects on the surface of nanoparticles,
respectively.
Regardless of the synthesis method used, material subjected to higher annealing tem-
peratures show a decrease in intensity of the LO band, as the disorder in the hematite
lattice is minimised. The most intense LO band can be seen in the highly porous S250
sample (0.1), followed by P400 (0.098), P500 (0.09) and finally S500 (0.056). As ex-
pected, the intensity of the T band decreases with the intensity of the LO band, with the
most intense being seen in S250 (0.036), followed P400 (0.023), P500 (0.02) and S500
(0.012). The appearance of this T band is expected in both of the precipitation samples
due to the evidence of these defects being present in the XPS data obtained from these
samples. Surprisingly, the S250 nanorods shows the largest T band among all the samples,
which could either be over-expressed as a result the large intensity of the LO band due to
the highly disorder nature of its porous structure, or this same porous structure affecting
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Figure 4.7: Full Raman spectra of all hematite nanomaterials (left) and corresponding peak
deconvolution of the Eg, LO and T bands (right) of the (a,e) S250, (b,f) S500, (c,g) P400 and
(d,h) P500 samples.
the Fe 2p3/2 peak in such a way as to mask this effect. The S500 has the T band peak with
the lowest intensity, indicating that this material has the smallest number of such defects
at their interface among all the samples. Full peak assignment for each sample can be
seen in Appendix C.2.
Table 4.4: Intensity of the fitted Eg, LO and T bands present in the Raman spectra (Figure 4.7)
of the hematite nanomaterials present at 612, 660 and 690 cm−1
Sample IEg ILO IT
S250 0.13 0.1 0.036
S500 0.096 0.056 0.012
P400 0.344 0.098 0.023
P500 0.34 0.09 0.02
4.2.2 Biological Characterisation
Flow cytometric analysis (Figure 4.8, left) of the effect of the hematite nanomaterials on
the MDCK cell line, reveal some interesting differences between the particles. Firstly,
the S250 highly porous rodlike particles were internalised to the greatest degree than any
of the other particles (234 ± 9%), followed by the S500 (195 ± 14%) and P400 (173
± 4%) particles, with the P500 particles being internalised the least (121 ± 4%). This
trend is not inversely proportional to the size of the particles, and interestingly the rod-
like particles are more favoured to be taken up by the cells despite their length being in
excess of 200 nm (Table 4.2). This is much larger than the mean diameter of both of the
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precipitation nanoparticles P400 and P500, and it is possible that the weak room temper-
ature ferromagnetism exhibited in these samples could be influencing their ability persist
in suspension and be effectively internalised into the MDCK cells. However, the much
more likely explanation for this phenomenon is the difference in morphology between
the nanoparticles synthesised through the two different methods. Numerous studies have
investigated the effects of nanoparticle aspect ratio and size on their internalisation, with
some finding that discs were more favoured than rods for hydrogel [482] nanoparticles,
while a higher aspect ratio is more favourable for silica nanoparticles [483, 484]. It has
also been shown that spherical nanoparticles with a diameter of 50 nm have the highest
internalisation for gold nanoparticles [485–487]. Comparing materials of the same syn-
thesis method (S250 & S500, P400 & P500) it can be seen an increase in temperature of
annealing and hence particle size, results in a decrease in the internalisation of the nano-
materials into the MDCK cells. As such, future investigations of such nanoparticles for
biomedical applications where a high degree of internalisation is desired, could consider
the design of their system to include rod-shaped nanostructured materials.
The concentration of reactive oxygen species following their incubation with each of
the different hematite nanomaterials was quantified using the relative mean fluorescence
of the DCFH-DA dye (Figure 4.8, right). This analysis (Figure 4.8, right) revealed that
the S500 nanorod sample generated significant concentrations of ROS in the MDCK cells,
similar to the amount generated by the positive control (commercial ZnO nanoparticles).
Despite this, none of the other hematite nanomaterials were shown to generate significant
free radical species, displaying average ROS levels lower than the control. Each of the
nanomaterials that did not display an increase in the fluorescence in DCFH-DA (S250,
P400 & P500) showed much larger intensity of the T-band and hence, frequency of T-
defects, than the S500 sample which was shown to generate ROS. As these tetrahedral
defects appear at the surface of hematite nanomaterials, at the interface between the par-
ticle and the cellular environment, it is possible that these features are responsible for the
lack of ROS generation, or could be exerting a potential scavenging effect, similar to that
displayed by maghemite (γ-Fe2O3) [83] or cerium dioxide (CeO2) [82, 87, 89, 114, 169]
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nanoparticles. It can be seen that between each synthesis method, that increasing the tem-
perature of annealing and hence the crystallinity of the nanoparticles also resulted in an
increase in the levels of ROS following 2 hours of incubation. The increase in annealing
temperature can also be seen to negatively affect the frequency of T-defects in each of the
samples.
Figure 4.8: Flow cytometry results for the nanoparticle internalisation in MDCK cells (left)
following incubation for 24 hours at a concentration of 50 µg mL−1 and mean ROS levels of
MDCK cells (right) following 2 hours of internalisation with samples at 50 µg mL−1. Samples
are (a) S250, (b) S500, (c) P400, d) P500 and e) commercial ZnO nanoparticles.
Each hematite nanomaterial investigated in this study exhibited slightly variable cyto-
toxic effects on the MDCK cell line (Figure 4.9), which can be directly related to the vari-
able internalisation and ROS activity of each of the samples and as such, their materials
properties. Both nanorod materials exhibited typical concentration dependant cytotoxic-
ity, with S250 showing no significance from the control at a concentration of 25 µmL−1
(1.08 ± 0.05) and S500 appearing to be cytotoxic at all concentrations. The higher tox-
icity of the S500 nanorods is likely a direct result of the increase in ROS in the MDCK
cell line associated with incubation with this sample, as compared to the S250 sample.
The nanoparticles synthesised through normal precipitation displayed much higher bio-
compatibility overall, with the P400 nanoparticles exhibited cytotoxic effects only at 100
µg mL−1 (0.70± 0.06). The larger spherical nanoparticles P500 however, only displayed
a small decrease in survival fraction at 25 µg mL−1 while showing no difference from
the control at higher concentrations. The CTC50 values for the S250, S500 and P400
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nanomaterials were calculated to be 358, 240 and 401 µg mL−1 respectively. This value
was unable to be determined for the P500 nanoparticles, due to the high levels of bio-
compatibility at higher nanoparticle concentrations. The higher cytotoxicity of the P400
nanoparticles at the highest concentration is likely due to the higher internalisation of this
sample relative to the P500 sample. The lowered cytotoxicity of the P400 & P500 nano-
materials as compared to S250 & S500 is likely due to the differences in internalisation
resulting from the morphological differences between the two synthesis methods. The
significant decrease in the CTC50 for the S500 nanorods from the S250 sample displays
the how the ROS activity of the nanoparticles can significantly impact the cytotoxicity
of nanoparticles. These results are in agreement with a previous study into the effects
of morphology on the cytotoxicity of hematite nanoparticles on RAW 264.7 cells, which
found that rod shaped particles cause significant membrane damage, which they claim is
a result of their higher surface area [488]. The dependence of internalisation on particle
morphology could also help to explain the reason that the S250 sample showed similar
toxicity to the S500 sample, despite any evidence of free radical generation. This study
reinforces the findings of previous studies, in both the formation of T-defects for hematite
nanoparticles of particular size, as well as an explanation for the increase in biocompati-
bility of such nanoparticles of a size around 50 nm [215].
4.3 Conclusion
In this study, a number of different hematite nanoparticles were synthesised through pre-
cipitation and spray precipitation and their fine structure probed using a number of ma-
terials characterization techniques. It was shown that the morphology and particle size
of these particles can be tailored through altering the synthesis parameters and annealing
temperatures, and both spherical and rod-like nanostructured materials were obtained. In
agreement with previous studies, it was shown that the differences in size and morphol-
ogy between the hematite nanoparticles effected their degree of internalisation into the
MDCK cells, with rod-shaped nanoparticles favoured. Through XPS and Raman char-
acterization, it was shown that the formation of tetrahedral or T-defects [220], were able
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Figure 4.9: Cytotoxicity of hematite nanomaterials on the MDCK cell line after 24 hours of
incubation at concentrations 25, 50 & 100 µg mL−1, a) S250, b) S500, c) P400 and d) P500.
Error bars indicate standard error.
to be induced or destroyed through annealing of the iron oxide or iron oxide-hydroxide
precursors, in agreement with previous studies. These defects, which are present at the in-
terface between the particle and the surrounding cellular environment, significantly affect
the overall cytotoxicity displayed by the iron oxide nanoparticles. This impurity phase
could be responsible for the lack of any ROS generation or potential scavenging effects, as
previous studies have shown that small maghemite nanoparticles have pH-dependant ROS
activity in vitro. While this property has already been previously reported for maghemite
nanoparticles, the ability to form such defects in hematite nanoparticles could open up
new ways to control the free radical behaviour of such nanoparticles. This, coupled with
the shape-dependant uptake of the iron oxide nanomaterials, governed their overall tox-
icity on the MDCK cell line. This study highlights the importance of in-depth materials
characterization when assessing the cytotoxicity of nanostructured ceramic compounds,
as well as how a number of different materials properties can impact the potential appli-




Nanocomposites for Free Radical
Scavenging Ultraviolet Protection
The following chapter highlights the research reported in a publication in RSC Advances
in 2016 [111], sharing its title with this chapter. As such, sections of this chapter may be
taken from this publication verbatim. The Fe2O3-CeO2 nanocomposite particles featured
in this chapter are referred to by the cerium content of the solution in at% during the
stage of synthesis in which the CeO2 is precipitated onto the surface of the hematite
particles. I would also like to acknowledge the contributions of Martin Weiss to this
chapter, who assisted with the optimisation of the thermal precipitation synthesis of the
Fe2O3 nanoparticles.
5.1 Introduction
Since they were first introduced into cosmetic products, there has been concerns regarding
the use of inorganic nanoparticles as ultraviolet (UV) blockers in sunscreen formulations.
The possibility of negative health effects resulting from the use of cosmetic products con-
taining such particles is a topic of debate in the scientific community, with more research
needed [489]. Many sunscreen formulations contain a combination of organic or inor-
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ganic UV blocking agents, with the latter usually in the form of zinc oxide (ZnO) or
titanium dioxide (TiO2) [17]. These inorganic nanoparticles are used due to their im-
proved optical properties compared to their micro-sized counterparts, such as enhanced
UV absorption and greater transparency in the visible spectrum [381]. The use of such
nanoparticles in cosmetic products also raises general safety concerns, as they have been
shown to have different biological effects compared to their micro-sized counterparts, be-
ing able to more effectively penetrate into cells and come into close contact with sensitive
biological targets. Nanoparticles of ZnO are well-known free radical generators and have
shown to be highly cytotoxic [107] and genotoxic [211] to human cells. Similar concerns
have also been raised for TiO2 nanoparticles, as while they do not significantly effect cell
death or cell cycle [490], they have a substantial effect on the mitochondrial activity of
human keratinocytes [491]. Titanium dioxide nanoparticles also can exhibit very strong
photocatalytic activity under UV irradiation, producing highly reactive hydroxyl (OH•)
radicals [101]. Despite that the photocatalytic properties of TiO2 are well known, there is
evidence to show that some companies use highly photoactive particles in their commer-
cial cosmetic products [102]. Direct interaction between these nanoparticles and human
cells aside, there is also some concern with how these free radical generating particles
interact with other organic compounds inside the sunscreen formulations, including other
UV blocking agents. Despite many claims, organic UV filters are not very photostable,
and their degredation is futher enhanced when they are combined with other active organic
or inorganic compounds, including TiO2 [97], more quickly reducing the sun protection
factor (SPF) of the protective formulation after being applied on the skin. One reported
example of this interaction is the photocatalytic transformation of 4-methylbenzylidene
camphor (4-MBC) into unknown, more toxic intermediates when irradiated under UV
light in the presence of TiO2 [492]. Such degradation products have unknown health ef-
fects, and as such, the free radical generating properties of these photocatalytically active
nanoparticles are not ideal for use in cosmetic products.
A solution to this would be a nanoparticle system with similar UV blocking proper-
ties to TiO2 and ZnO, which does not feature significant free radical generation or a free
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radical scavenging agent to act as an antioxidant to prevent accelerated decomposition of
the organic components of the formulations. There has been a number of studies inves-
tigating other metal oxide nanoparticles for use in such products, including pure CeO2
[113, 161], rare earth- [410], alkali earth- [112, 410] and transition metal [413] doped
CeO2, α-Fe2O3 [209], Ce-doped Fe2O3 [210] and most recently, Ti-doped SnO2 [493].
Ceria (CeO2) nanoparticles and compounds encorporating cerium are of particular inter-
est for such application, as it features a optical bandgap close to that of TiO2 (3.2 eV)
[494], showing strong selective absorbance in the UV region, as well as the ability to
scavenge radical species through the Ce3+ states that exist on their surface. These states
are size-dependent property of CeO2 nanoparticles, formed as a consequence of the oxy-
gen deficiencies on their surface, and they are able to act as a catalyst and scavenge excess
free radicals by moving between thesh!e two oxidation states [6, 174]. In addition to this
scavenging ability being highlighted through a number of in vitro [6, 87, 161] and in vivo
[89] studies, they have been also shown to increase cell viability if applied before or after
UV light exposure [161]. This would indicate that when exposed to UV light they do not
form significant radicals in vitro, as well as that they are able to repair some of the damage
to the cells upon ultraviolet light exposure by scavenging excess free radicals, acting as
an antioxidant. One of the the most effective UV-blockers of all the ceria-based nanopar-
ticles has been shown to be Ca-doped CeO2, shown to produce a higher SPF rating than
ZnO when combined with TiO2 [411]. This doping however, decreases the concentration
of Ce4+ states [112], which would in turn likely decrease any potential radical scavenging
activity [174], as well as increases the band-gap of the nanoparticles, decreasing it’s ab-
sorbance in the UVA (320-400 nm) There is at least one commerically available cosmetic
product already containing ceria nanoparticles [495], this material however, features a
platinum coating thus potentially removing the positive free radical scavenging properties
of the core particles. Furthermore, CeO2 and Pt core-shell nanoparticles are well-known
catalysts [496] and thus could have an unknown effect on both the other components of
the sunscreen, and potentially the user.
A big drawback of cerium-based materials however, is their relatively high cost, es-
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pecially when compared to the more abundant TiO2 and ZnO. As such, in this study,
we synthesised a nanocomposite system which encorporates hematite (α-Fe2O3) a low-
cost inorganic compound broad band UV blocking properties, with nanoparticles of ceria
(CeO2) precipitated on the surface. Such nanocomposites have previously been studied
as CO/CO2 oxidation/reduction catalysis applications [497, 498], and more recently as
a visible light photocatalyst and supercapacitor electrodes [499]. The visible light pho-
tocatalytic properties was reported for a nanocomposite system which featured a higher
amount of ceria relative to hematite and large particle size of the ceria phase. In this study
we show that combining these two phases in the form nanocomposite particles, that there
is a synergistic effect between the two materials. The final composite particles featuring
greater UV absorption and free radical scavenging properties than the bare α-Fe2O3 or
CeO2 nanoparticles at particular ceria coating concentrations. In order to show these free
radical scavenging properties, the synthesised nanoparticles were suspended in a solution
of crystal violet (CV) and photocatalytically active commerical TiO2 nanoparticles (P-25)
before being exposed to broad spectrum ultraviolet light. The presence of the ceria parti-
cles as part of the nanocomposite system greatly reduces the degradation of the CV dye.
We propose that the reason for this is the due to the scavenging or neutralization of the
photogenerated OH· generated by the TiO2 by the surface CeO2 phase of the nanocompos-
ite particles. These nanocomposite particles also showed improved UV absorbance and
scavenging properties as compared to pure CeO2 and α-Fe2O3 nanoparticles. We pro-
pose the use of such multifunctional nanocomposite particles as alternative UV filtering
components in cosmetic sunscreen formulations, or to be used as an antioxidant stabilizer
of these products by scavenging the photogenerated free radicals and thus preventing the
accelerated decomposition of the organic filter components.
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5.2 Results and Discussion
5.2.1 Materials Characterisation
The crystalline state of each of the synthesised nanomaterials was investigated using X-
ray diffraction, and the diffraction patterns obtained for all synthesised nanoparticles (Fig-
ure 5.1) exhibited sharp peaks corresponding to the hematite (α-Fe2O3) phase of iron
oxide (PDF Card 96-9000140). While the 2.5 at% nancomposite particles showed no
reflections from the CeO2 phase (PDF Card 96-900-9009), one broad peak was present
in the samples with higher Ce content. This peak, located at ∼28◦ corresponds to the
(111) CeO2 reflection, and can be seen to increase in intensity as the amount of Ce was
increased from 5 to 10 at%. This indicates that there is likely a higher amount of CeO2
resulting from an increased Ce(NO3)3 concentration during synthesis. The low intensity
and large FWHM for this ceria reflection indicates that the crystalline size of this cerium
dioxide phase is quite small relative to the iron oxide phase and an increase in intensity
between the 5 and 10 at% samples could be indicative of some crystalline growth of the
surface phase as the concentration of cerium is increased.
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Figure 5.1: X-ray diffraction patters for α-Fe2O3 and α-Fe2O3/CeO2 composite nanoparticles
with 2.5, 5, and 10 at% Ce, with PDF lines for matching CeO2 and α-Fe2O3.
High-resolution TEM images (Figure 5.2) show hematite particles roughly spherical
in shape and feature cracks or dislocations running from the center of the particle out
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to the surface. The size of individual particles were measured from TEM images, and
the average size of the hematite nanoparticles was calculated to be 50 ± 10 nm. Images
of the particles following the precipitation of ceria (Figure 5.2 C, D & E) shows the
presence of much smaller particles to the surface of the hematite. These particles are
comprised of ceria, and appear to have a much darker contrast than the previous formed
hematite (Figure 5.2 C & D), which can be attributed to the significant difference in atomic
number between iron (ZFe = 26) and cerium (ZCe = 58). This was also confirmed by
measuring the d-spacings of these nanoparticles (Figure 5.2 E), which was found to be
3.17 Å, corresponding to the (111) plane of CeO2.
Figure 5.2: Bright field TEM images of (A, B) α-Fe2O3, (C, E) 5 at%, and (D) 10 at% Ce
composite nanoparticles.
The size of these particles was also measured from the images, and it was found that
the size of these particles were 2.5 ± 0.1, 3.5 ± 0.4, and 4.7 ± 0.4 nm, for the 2.5, 5
and 10 at% samples respectively, which shows the effect of the concentration of cerium
nitrate upon precipitation of the ceria particles. Comparing the images of the 5 and 10 at%
composite particles (Figure 5.2 C, D), it can be seen that increasing the cerium content
did not result in a more evenly distributed surface covering of CeO2 particles. The 10 at%
composite certainly features a higher frequency of ceria particles on the surface of the
hematite core, but they appear to be more aggregated with other ceria particles. It is likely
that the observed defects in the hematite nanoparticles act as a precipitation center for the
CeO2 phase, and as the concentration is further increased, additional particles precipitate
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or aggregate on the surface of the other ceria particles, as opposed to the bare, smooth
surface of the hematite core particles.
High resolution EDS mapping images were also obtained (Figure 5.3), using a JEM-
ARM200F atomic resolution microscope fitted with a Centrino SDD 100 mm2 detector
(JEOL, Akishima, Tokyo, Japan) in order to further verify that the were CeO2. The below
EDS mapping images show a dark field image, followed by the iron highlighted in green
and cerium in red. The pure hematite particles feature no cerium at all, while a significant
contribution of cerium can be seen about the surface of the particles for the composite par-
ticles. These images confirms the presence of the secondary ceria phase that can be seen
in the TEM images of the composite particles on the surface of the hematite particles.
The iron/cerium ratio of each of these composites was calculated from EDS measure-
ments, and it was found that the actual ratio was slightly lower than the target ratio for the
2.5 and 5 at% nanocomposites, which was 0.9 ± 0.9 and 4.5 ± 0.5 % respectively. The
actual ratio for the 10 at% sample was much closer to the target ratio, which was 10.1 ±
0.1 %.
Figure 5.3: High resolution EDS mapping of α-Fe2O3 (top) and α-Fe2O3/CeO2 (5 at% Ce)
nanoparticles. The images depict greyscale (A), iron (green) content (B), ceria (red) content (C)
and an overlay of the two.
Thermogravimetric analysis (Figure 5.4) was performed between 50-900 ◦C on both
the hematite nanoparticles synthesised through thermal precipitation and the 10 at% Ce
nanocomposite particles (Figure Figure 5.4). As the hematite nanoparticles were dried
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at low temperature (100 ◦C) and feature a number of large cracks and dislocations on
their surface, the slow weight loss curve is likely the loss of some surface hydration and
reaches 2.1% at 900 ◦C. The 10 at% nanocomposite material shows a larger total drop in
mass, which is equal to 6.1 % at 900◦C and also features a sharp loss between 370-450
◦C which could be due to the presence of some unreacted Ce(NO3)3 within the sample.
FTIR analysis was also performed on the powdered samples (Figure 5.5), with each of the
samples featuring a strong peak at ∼570 cm−1 corresponding to the A2u + Eu vibrational
mode of hematite [500], as well as the large shoulder centered around 600 cm−1. Three
very weak, broad peaks corresponding to the CeO2 phase can also be seen at 1200, 1400
and 1600 cm−1. These are most visible in the pure CeO2 and can be seen in the 5, 10 and
20 at% Ce composites [501].
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Figure 5.4: Thermogravimetric weight loss curves for α-Fe2O3 nanoparticles and 10 at%
Fe2O3/CeO2 nanocomposite particles.
The ultraviolet-visible absorption spectra (Figure 5.6) of the synthesised hematite and
composite nanoparticles was measured using a UV-1800 spectrophotometer (Shimadzu,
Kyoto, Japan), in order to determine the effects of the ceria precipitates on the optical
band-gap and ultraviolet filtering properties of all the particles. Also measured was a
commercial TiO2 nanoparticle (Aeroxide R© P 25, Sigma-Aldrich) as a comparison of
relative ultraviolet filtering compatibility, as TiO2 is a common additive to commercial
sunscreen formulations as an inorganic UVA filter. Conducting all experiments at the
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same concentration (25 µg mL−1), it can be seen that P-25 had a higher and more selective
absorbance within the ultraviolet region compared to the as prepared nanoparticles. The
uncoated hematite nanoparticles showed significant absorption over the entire ultraviolet
range, and the addition of the ceria phase to he surface of these particles further enhanced
this. It can also be seen that the absorption of these composite particles had more selective
absorbance in the ultraviolet region as compared to the uncoated hematite particles. This
is most accurately reflected in the increase of the optical band-gap of composite particles
compared to the hematite particles which was calculated to be 2.48 ± 0.03 eV from the
construction of a Tauc plot (Figure D.1 (a)), which is slightly larger than that for bulk
hematite (2.1 eV) due to the effects of quantum confinement.
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Figure 5.5: FTIR spectra obtained for (a) α-Fe2O3, (b) CeO2, (c) α-Fe2O3/CeO2 2.5 at% Ce,
(d) α-Fe2O3/CeO2 5 at% Ce, (e) α-Fe2O3/CeO2 10 at% Ce nanomaterials.
The presence of the CeO2 in the composite particles was shown to increase the optical
band gap of the system, which was maximized at 5 at%. Optical band gaps of 2.74 ±
0.02 eV, 2.82 ± 0.03 eV and 2.77 ± 0.04 eV were calculated for the 2.5, 5 and 10 at%
composite particles (Figure D.1 (b-d)). The calculation of the band gap was performed
by creating a Tauc plot using the ultraviolet-visible absorption spectra [502], and details
can be found in the supporting information. As ceria has a higher band gap relative to
hematite, the additional of ceria content on to the surface of the core particles resulted in
an increase in band gap for the nanocomposite particles. The significant aggregation and
slight crystal growth of the surface ceria particles in the 10 at% nanocomposite is likely
the reason that no further increase in optical band gap is seen relative to the 5 at% sample,
despite the increase in ceria content. The UV blocking properties of these composites
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Figure 5.6: Ultraviolet-visible absorption spectra of commercial TiO2 (P25), hematite and com-
posite nanoparticles at 25 µg mL−1 in DI water
was also compared to pure ceria nanoparticles, synthesised using spray pyrolysis [411].
A band gap of 3.30 ± 0.02 eV was calculated for these pure CeO2 nanoparticles from
ultraviolet-visible absorption spectra. These particles featured a much lower absorbance
than the other nanoparticles in this study, highlighting the synergistic effect of the hematite
core on the UV absorbance of the nanocomposite particles.
5.2.2 Photocatalytic Characterisation
Each of these materials were then tested for their photocatalytic activity under a broad
UVA-UVB ultraviolet spectrum, using a RPR-200 photochemical reactor (Rayonet, Bran-
ford, CT, USA) fitted with 3000 and 3500 Å lamps. In this experiment, crystal violet
(Tris(4-(dimethylamino)phenyl)methylium chloride) (99% anhydrous, Sigma-Aldrich) was
used as a indicator of the amount of generated hydroxyl radicals, as the P-25 generates
OH• radicals upon exposure to ultraviolet light, which subsequently react with the central
double bond of crystal violet, rendering it colourless [81]. Exposing the solution of crystal
violet and P-25, a well known and highly active photocatalyst, to the ultraviolet light of the
photochemical reaction caused the dye to be almost completely degraded over a 30 minute
period (Figure 5.7). The addition of 5 mg L−1 of any of the as-synthesised nanoparticles
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resulted in a decrease in this degradation of the crystal violet dye (Figure 5.7), and the
relative absorbance at 590 nm after different exposure times, for each material, can be
seen in Figure 5.7. The linear rate constants k for the effect of each of the materials on the
degradation of crystal violet was also calculated using the Langmuir-Hinshelwood model
[430] (Table 5.1) and the plots used to find this constant can be seen in Figure 5.10.
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Figure 5.7: Relative decrease in absorbance of crystal violet solutions containing P25 and
nanocomposite particles both at 5 mg L−1 concentration under ultraviolet light exposure.
The addition of the uncoated hematite particles caused a slight decrease in the degra-
dation and rate constant ((6.3 ± 0.3) × 10−2 min−1) as compared to the control ((8.65
± 0.06) × 10−2 min−1). This is likely due to the effects of absorption and scattering by
the additional particles. While this decrease in degradation was more pronounced when
the 2.5 at% composite particles were added ((5.5 ± 0.2 ) × 10−2 min−1) , a very large
decrease in the dye degradation was seen upon the addition of the 5 at% nanocompos-
ite ((3.1 ± 0.1) × 10−2 min−1) and 10 at% nanoparticles ((3.3 ± 0.5) × 10−2 min−1)).
While this effect could be attributed to the increased absorption in the ultraviolet region
compared to the uncoated α-Fe2O3 nanoparticles, further experiments conducted at in-
creased concentrations (10 and 25 mg L−1) of hematite nanoparticles only show that even
at a substantially higher concentration of particles, the uncoated hematite particles and
did not have as significant effect on the dye degradation. This can be seen in only a slight
decrease in linear degradation rate constant to (4.8 ± 0.3) × 10−2 min−1 at the highest
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concentration of hematite particles (25 mg L−1).
Thus, this substantial decrease in the degradation of the crystal violet upon addition
of the 5 at% coated hematite nanoparticles can be attributed to the scavenging of OH•
generated from the photocatalytic activity of the P-25 by this nanocomposite. This is a
well-known property of ceria nanoparticles, and the very small diameter of the ceria par-
ticles in our nanocomposite system maximises this effect. The lack of any increase in this
scavenging effect after increasing the cerium content to 10 at% is likely due to the sig-
nificant aggregation of the ceria particles at this concentration. This aggregation reduces
the available surface area of the ceria content to engage in the OH· radical scavenging
reactions, compared to if the particles were evenly distributed about the surface of the
hematite particles.
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Figure 5.8: Decrease in relative absorption of CV solutions containing 5 mg L−1 of P25
and hematite nanoparticles at increasing concentration, and degradation curves for CV and α-
Fe2O3/CeO2 both in the absence of P25.
The pure ceria particles only slightly decreased the dye degradation rate when added
to the P-25 and dye mixture ((7.2 ± 0.1) × 10−2 min−1), which could be attributed to
a very weak scavenging or absorbance effect. The small size of the ceria particles in
the nanocomposite material resulting in a large concentration of Ce3+ surface states, is
the likely the reason for their substantial free radical scavenging properties as it has been
shown in other studies that ceria nanomaterials [503], and nanocomposites containing
ceria can be photocatalytically active [499, 504]. Furthermore, when added to the reaction
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Table 5.1: Experimental parameters from photocatalytic dye degradation experiments probing
the free radical scavenging ability of Fe2O3/CeO2 nanocomposite particles, including the con-
centration of the sample (Creagent), concentration of the photocatalytic TiO2 NPs (CP25) and the
resulting linear degradation rate constant k and it’s correlation coefficient (R2).
Reagent Creagent (mg L−1) CP25 (mg L−1) k (x 10−2 min−1) R2
CV only - - -0.07 ± 0.04 0.31
P-25 only - 5 8.65 ± 0.06 0.99
α-Fe2O3 5 5 6.3 ± 0.3 0.99
α-Fe2O3 10 5 5.9 ± 0.2 0.99
α-Fe2O3 25 5 4.8 ± 0.6 0.97
α-Fe2O3/CeO2 2.5 at% 5 5 5.5 ± 0.2 0.99
α-Fe2O3/CeO2 5 at% 5 5 3.1 ± 0.1 0.99
α-Fe2O3/CeO2 10 at% 5 5 3.3 ± 0.5 0.99
α-Fe2O3/CeO2 2.5 at% 25 0 -0.05 ± 0.03 0.24
CeO2 5 5 7.2 ± 0.1 0.99
mixture in the absence of P-25, the 5 at% composite did not degrade the dye over the
30 minute exposure period, meaning that these nanocomposite particles do not generate
OH• radicals upon exposure to UV light. The linear fitting used to determine the kinetic
dye degradation coefficient k all returned correlation coefficients (R2) of 0.99 except for
the 25 mg L−1 hematite particles reacted along with P25, as well as the crystal violet
alone, and the 5 at% composite nanoparticles with crystal violet and without P25. The
R2 value obtained for 25 mg L−1 α-Fe2O3 particles was 0.97, and was likely lowered
due to the high concentration of particles resulting in some small amounts of aggregation
and enhanced inter-particle scattering of incident ultraviolet light. Both experiments with
crystal violet only, and 25 mg L−1 of the 5 at% nanocomposite sample showed a negligible
overall degradation to the crystal violet, and as such did not return good R2 values or
meaningful values for the linear rate constant k.
5.3 Conclusion
The free radical generating properties of ZnO and TiO2 nanoparticles currently used in
some commercial sunscreen products could have the potential to cause adverse health ef-
fects, either through the direct interaction of these radicals with human tissue, or through
causing the accelerated decomposition of other organic compounds within the formula-
tion. These reactions not only have the potential to decrease the SPF of the formulation
more rapidly, but also yield photoproducts of unknown structure and toxicity. In this
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Figure 5.9: Linear rate constant curves for ultraviolet dye degradation of crystal violet shown in
Figure 5.7.
chapter we highlighted the work surrounding combination of α-Fe2O3 and CeO2 in the
form of nanocomposite particles. This combination results in a material with greater,
more selective absorbance in the UV range, and greater free radical scavenging properties
than either pure ceria or hematite nanoparticles. This effect was maximised at 5 at% load-
ing of Ce, as a further increase in ceria content did not increase the distribution of ceria
particles about the surface of the hematite particles, instead resulting in larger regions of
aggregated ceria nanoparticles. Nanoparticles such as these could provide a novel and
cost-effective approach to both improve the UV blocking properties of commercial sun-
screen formulations, as well as act as an antioxidant stabiliser for the organic components
of the product, reducing potential harm of these products on the health of the consumer.
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Nanoparticle Composites for Sun
Protection Factor in Cosmetic Products
6.1 Introduction
It is well established that significant exposure to the ultraviolet component of sunlight
can result in the development of skin cancer [505]. The high ultraviolet index of cer-
tain countries and regions [127], such as Australia and New Zealand, results in a higher
than average incidence of these types of cancer. In both these countries, melanoma has
the third highest incident among all cancers for both men and women. It is also more
prevalent in developed regions, being the eighth highest among men and seventh highest
incidence rate of all cancers [506].
Affording protection from the harmful effects of exposure to the ultraviolet component
of sunlight, modern sunscreens and cosmetic products typically contain a mixture of dif-
ferent ultraviolet filters, both organic and inorganic in nature [97, 254]. These filters aim
to minimize the UVA (320-400 nm) and UVB (290-320 nm) exposure on the skin in order
to reduce the risk of developing skin cancer [131, 507], UV induced cutaneous photoag-
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ing and immunosuppression [508, 509]. Of these, the two most prevalent inorganic filters
are titanium dioxide (TiO2) and zinc oxide (ZnO).
In terms of commercial sunscreens and cosmetic products, nanoparticles of TiO2 and
ZnO have gained favor due to their higher, selective attenuation of ultraviolet radiation as
well as improving the texture and pigment of the resulting formulations, compared to their
micro-sized counterparts [381]. Moreover, when optimally dispersed, these properties al-
low the nanoparticle formulations to be invisible on the skin, rather than the traditional
white appearance of larger sized particles. Due to the effects of Rayleigh Scattering,
smaller nanoparticles significantly scatter shorter wavelength light [97], such as that in
the ultraviolet range (200-400 nm). The band gap of both of these materials also falls
within the photon energies of the ultraviolet region, which results in the selective absorp-
tion of incident photons with equal to or higher energy. Concerns over the application
of nanotechnology into new fields such as cosmetics, from members of both the General
Public and the scientific community [510], have prompted investigations into the poten-
tial cytotoxicity of these metal oxide nanoparticles. A number of in vitro studies have
shown significant cytotoxicity in ZnO nanoparticles, owing to their generation of free
radicals and contribution to oxidative stress [106–108]. While TiO2 has not shown to
exhibit significant cytotoxicity in the absence of light, they have been reported to effect
and mitochondrial activity of human cells following 24 hours of exposure [491]. For a
sunscreen to have cytotoxic effects however, the nanoparticles would firstly need to in-
teract with viable skin cells in the dermis or epidermis, after penetration of the stratum
corneum, which would most likely occur via a sweat gland or hair follicle orifice where
the stratum corneum is thinner. Previous studies have shown that the majority of applied
nanoparticles remain on the surface of the skin, although varying levels of penetration of
TiO2 or ZnO nanoparticles has been reported [387, 388, 511, 512]. However, there are a
number of ambiguities in comparing these results, due to the number of variables present
in conducting such assays [109]. These include species tested on, size, shape and coat-
ing of nanoparticles, application site, frequency of application, length of study, analysis
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methods, sample size and influence of exposure to UV light. The previous studies do not
standardize the type of TiO2 employed and seldom conduct toxicological assays under the
influence of UV radiation, Irrespective of these previous results, TiO2 nanoparticles can
have strong photocatalytic behaviour under UV-light exposure [513], and this fundamen-
tal property is used beneficially in a number of applications including as dye-sensitized
solar cells [292], water-splitting [293], and wastewater clean-up [514]. A previous study
from Barker and Branch [102] isolated TiO2 nanoparticles of different morphology from a
number of commercially available sunscreen products. Those containing the highly pho-
toactive, mixed phase (anatase-rutile) TiO2, were found to be responsible for the damage
caused to pre-painted steel products employed in roofing and walling. A number of stud-
ies have also raised concerns as to what effect this photoactivity could have upon other
components within formulations. Thus, studies have shown that the stability of a number
of organic ultraviolet filters is reduced when they are combined together under UV expo-
sure [515, 516]. This decomposition is further enhanced when in the presence of TiO2,
with the potential for modified decomposition products, due to the strong free radical gen-
eration of these nanoparticles [97]. This activity undoubtedly decreases the effective Sun
Protection Factor (SPF) of the formulation at an enhanced rate, which in turn would de-
crease the time needed between applications needed by the consumer in order to prevent
hazardous levels of UV exposure.
There is no doubt that the culpable component of thee Barker and Branch study does
destroy viable cells when testing is performed in the presence of UV light [102]. Thus
Rampaul et al showed [105], by apoptosis assay of cultured epithelial cells (3 cell lines
: HaCaT (human skin epithelium), MDCK-1 (dog kidney epithelium) and PtK2 (potoroo
kidney epithelium) that cell death in the presence of TiO2 isolated from commercial sun-
screen formulations was dependent upon the crystal phase. Most damaging were grades
similar in crystal structure to the IUPAC standard photocatalyst, Evonik Aeroxide P25
TiO2 which typically killed 90% of cells post-UVA irradiation. On the other hand, UV
light alone killed up to 30% of the viable cell population, while other types of coated
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particle with different crystal type were protective, having little or no effect on viable
cell count. Similarly, in a subsequent study upon commercial TiO2 concentrates avail-
able to sunscreen formulators by Damiani [517], performed a wide range of in-vitro tests
for ROS generation, including human skin fibroblasts and found that that just one type
of TiO2 concentrate in particular, that with the mixed anatase/rutile phase typical of the
commercial P25 product, was responsible for cellular destruction, a result in accordance
with the Rampaul paper.
In light of the findings above, the current recommendation by the Scientific Com-
munity for Consumer Safety (SCCS) [104], is to avoid the use of photocatalytically
active TiO2 within cosmetic products. As such, there has been some effort in order
to explore possibilities for alternative inorganic nanomaterials for use in such formula-
tions. The current aims in such studies are to find inorganic nanoparticles which fea-
ture high, selective ultraviolet attenuation, with negligible photocatalytic activity. The
materials investigated to date include metal oxide-based systems featuring ceria (CeO2)
[112, 113, 161, 410, 411, 413, 518], iron oxide (Fe2O3) [209, 210], tin oxide (SnO2)
[493], while Fe2O3 nanoparticles can be now found in commercially available cosmetic
and sunscreen products. In on of our recent studies [111], these two materials were com-
bined, utilizing a ceria (CeO2) shell which, in a nanocomposite system with an iron oxide
(Fe2O3) core, showed a synergistic effect and an increased attenuation of ultraviolet light.
Ceria nanoparticles are a promising material for this application, as they possess similar
optical properties to TiO2. This material however, is a rare earth element, and as such,
much more expensive compared to the current standard materials. In contrast to this, iron
oxide nanoparticles have great potential for further commercialization in this field due to
their abundance and low cost. It does, however, have a major drawback due to its non-
selective absorption of ultraviolet light. The band gap of bulk hematite is 2.1 eV, and in
previous studies, we have shown that through specific materials synthesis parameters this
can be increased to 2.5 eV [198]. However, significant absorption within the short wave-
length region of the visible spectrum results in powders with a characteristic brown or red
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color and this restricts the use of such particles to pigmented sunscreen and other cosmetic
products. The synthesis method used in the current study to prepare the Fe2O3 nanopar-
ticles is identical to that used previously where it was shown that that these nanoparticles
exhibited very low cytotoxicity and did not increase oxidative stress in MDCK cells over
24 hours. In this study, we improve the efficacy of using such Fe2O3 nanoparticles in
cosmetic products, through incorporating them into a nanocomposite system with poly
(lactic acid).
Poly (lactic acid) (PLA) is a aliphatic polyester, which has garnered a large amount of
research interest, due to its biodegradable and biocompatible nature [519, 520]. These
properties, along with the relative low cost and ease of processing has seen it targeted
towards applications in food packaging and biomedical applications [521]. Moreover,
PLA is bio-derived, and the monomer, lactic acid (2-hydroxy propionic acid), may be
produced by renewable processes, such as the fermentation of corn starch . The use of
petrochemical-derived polymer microspheres in beauty and skincare products [522], and
their release into the environment has come under close scrutiny recently and thus the
eco-friendly properties of lactic acid based materials are highly prospective for commer-
cial development [523]. PLA does not have significant ultraviolet absorption and has
been used as a nanoencapsulation system to stabilise octylmethoxy cinnamate [419], an
organic ultraviolet filter widely used in cosmetics and sunscreen. This study was able to
show a decrease in the degree of photo-isomerization of OMC to the cis-form, which has
lower ultraviolet attenuation in the UVB range. Poly(lactic acid) films and particles de-
compose under ultraviolet light very slowly [524], and the proposed mechanism for this is
β -scission, the mostly likely of which results in the formation of anhydride groups [525].
In this study, we seek to improve the efficacy of using Fe2O3 nanoparticles in cosmetic
products, through incorporating them into a nanocomposite system with poly (lactic acid)
(Figure 6.1). Once incorporated, agglomeration of Fe2O3 nanoparticles would be min-
imized and UV attenuation maximized, leading to a stable, enhanced SPF. We describe
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that the resulting material features micro-sized poly (lactic acid) particles featuring em-
bedded iron oxide nanoparticles resulting in an increase in ultraviolet attenuation, while
the polymer content the red color of the iron oxide is offset, resulting in a pleasant, pink-
ish skin-tone colored powder. Characterization of the materials is described, followed by
preparation into emulsions similar to those used in modern cosmetic products, and their
measured effects on Sun Protection Factor (SPF).
Table 6.1: Summary of sample compositions.
Sample Name Composition
ZnO Z Cote HPI
PLA Poly(lactic acid) microspheres
PLA-5 Poly(lactic acid)-Fe2O3 nanocomposite (5 wt% Fe2O3:PLA, 3 wt% in emulsion)
PLA-10 Poly(lactic acid)-Fe2O3 nanocomposite (10 wt% Fe2O3:PLA, 3 wt% in emulsion)
PLA-20 Poly(lactic acid)-Fe2O3 nanocomposite (5 wt% Fe2O3:PLA, 3 wt% in emulsion)
6.2 Results and Discussion
6.2.1 Materials Characterisation
In order to probe the thermal properties of the PLA-nanocomposites (Figure 1) and con-
firm the final wt% of Fe2O3 nanoparticles within the nanocomposites, the samples were
analysed using TGA (Figure 6.1a). The pure PLA nanoparticles showed a typical decom-
position curve for this material, with 2% of the initial weight remaining at 600 ◦C. The
onset temperature (Tonset) for the pure PLA nanocomposites was 306 ◦C, which is typical
for poly (lactic acid) [526]. The addition of the Fe2O3 nanoparticles resulted in a decrease
in the onset temperature in the TGA curves of the nanocomposite particles (Table 6.2).
The Tonset for these are ◦C, 280 ◦C and 295 ◦C for PLA-5, -10 and -20 respectively.
These were calculated by fitting a straight line to the horizontal and vertical segments
of the weight loss curve, and can be seen in Figure B.4. The pure PLA microparticles
showed a residual mass of 2% at the final temperature in the TGA curve, while each of
the nanocomposite materials showed a residual mass which was close to that of the tar-
geted percentage of encapsulated Fe2O3 nanoparticles. These were 6% for PLA-5, 11%
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Figure 6.1: (a) TGA and (b) first derivative of weight lost per unit temperature (δm/δT) curves
and for the as-prepared PLA-Fe2O3 nanocomposites and Fe2O3 nanoparticles
for PLA-10 and 19% for PLA-20. When taking into account the residual mass of the
pure PLA particles, as well as the 1% decrease in mass of the Fe2O3 particles, this lowers
these to 5%, 10% and 18% respectively. This could indicate a decreasing efficiency of in-
corporation at higher weight percentages, likely through increased particle agglomeration
and settling during the microemulsion synthesis route. The first derivative of the TGA
curve for each material was also plotted as a function of temperature in order to deter-
mine the temperature at which the decomposition of the PLA was greatest (Tpeak). While
the pure PLA particles had a Tpeak of 332 ◦C this was lowered in the nanocomposites to
300 ◦C, 295 ◦C and 309 ◦C for the PLA-5, -10 and -20 samples respectively (Figure 6.1b).
Table 6.2: Values calculated for the onset temperature (Tonset, temperature of highest thermal
degradation rate (Tpeak), and the residual mass at 600 ◦C, for each of the prepared samples.
Sample Tonset (◦C) Tpeak (◦C) mresidual (%)
PLA 306 322 2
PLA-5 287 300 6
PLA-10 280 295 11
PLA-20 295 309 19
Fe2O3 - - 99
Electron microscopy images obtained of both the PLA particles and the PLA nanocom-
posite particles reveal a number of properties inherent in understanding of their perfor-
mance within the sunscreen emulsions. Secondary electron images (Figure 6.2, top) re-
veal roughly spherical particles with a broad size distribution, with particles of diameters
between 0.1-3 µm present within the various samples. Particle size distribution analysis
was performed on these images, and the resulting size distribution histograms can be seen
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in Figure 6.2 and summarised in Table 6.3. As the Fe2O3 mass percentage is increased the
size distribution of the particles becomes less broad, which can be seen clearly in the sig-
nificant decrease in d50 and d90 values from 5 to 10 wt% iron oxide. This is also marked
by a decrease in the d10, d50 and d90 values as the iron oxide content in the particles is in-
creased, which are roughly the same for the PLA-10 and PLA-20 samples. Backscattered
electron images (Figure 6.2) show the presence of hematite nanoparticles encapsulated
within the PLA microspheres. These particles are present within the PLA microspheres in
varying degrees of agglomeration, likely resulting from particle-particle attractive forces
during the chloroform evaporation step of the microemulsion method used to fabricate
the nanocomposite particles. However, it is also true that the size of these agglomerates
may be over-estimated through backscattered electron imaging, which has a lower spatial
resolution than secondary scanning electron microscopy, which could be causing a region
of high particle density to appear as a significant aggregate. Transmission electron mi-
croscopy images and scanning electron microscopy images of the hematite nanoparticles
themselves can be found in Chapter 4 Figure 4.2, as the same ’P400’ nanoparticles were
used in this study. Analysis of these particles using ImageJ showed that these particles
have a mean particle size of 26 ± 7 nm.
Figure 6.2: Scanning electron microscopy images of PLA-20 at high magnification (right) and
(top, left to right) PLA, PLA-5, PLA-10, PLA 20 and backscattered electron images (bottom,
left to right). Inset scale bar is equal to 1 µm.
Energy dispersive X-ray mapping images of each of the different PLA nanocomposites
shows the presence of the Fe2O3 particles encapsulated by PLA (Figure 6.4). While map-









































































































Figure 6.3: Particle size distribution with cumulant frequency distributions of PLA nanocom-
posites particles as measured from SEM images. An average of 500 particles were surveyed in
order to obtain the size distribution for each sample. Scale bar indicates 1 µm.
signal can be seen to become more widespread and intense within regions of the PLA-10
sample. The Fe contribution can then be seen to be throughout the entirety of the PLA-20
sample, highlighting the widespread presence of the iron oxide nanoparticles within. An-
other indicator of the presence of the Fe2O3 nanoparticles is the strong oxygen signal from
these same regions, due to the iron oxide being much denser than the PLA. Due to the
measurements being conducted on carbon tape, a strong contribution of this element can
be seen throughout the entirety of each of the mapping images. Obtaining EDS images of
this material proved to be a difficult task, due to the low temperature of crystallisation of
PLA and the higher accelerating voltage (15 kV) required for the technique. The image
taken as characteristic X-rays were being surveyed is of diminished quality compared to
those SE- and BE-images taken at a lower accelerating voltage, and the interaction of the
beam with the oxide particles within further enhance this crystallisation of the PLA.
Table 6.3: Table with d10, d50, and d90 values from cumulant frequency distribution of PLA
nanocomposites as measured from SEM images.
Sample d10 (µm) d50 (µm) d90 (µm)
PLA 0.476 0.955 1.852
PLA-5 0.240 0.565 1.104
PLA-10 0.170 0.349 0.673
PLA-20 0.174 0.356 0.696
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Figure 6.4: Energy dispersive X-ray spectroscopy mapping images of PLA-5 (top), PLA-10
(middle) and PLA-20 (bottom) showing the (left to right) combined map image, followed by the
C, O and Fe content separately.
Particle size distribution measurements (Figure 6.5) for the PLA and PLA-Fe2O3 parti-
cles reveal some significant information about these particles, especially when compared
to the results obtained through measuring the diameter of individual particles from SEM
micrographs. The pure PLA microsphere feature a bimodal distribution, with two peaks
centered around 0.399 µm and 1.81 µm respectively, while all of the composite particles
have a single peak, whose maxima decrease with increasing oxide content. All of the
samples apart from the PLA showed a larger d10 and d50 values from DLS compared to
those found from measuring the diameters of particles from SEM images initially. This
could indicate that while the inclusion of the hematite into the PLA-Fe2O3 samples results
in smaller sizes with increasing oxide content, these particles may more readily aggregate
while in suspension compared to the pure PLA micospheres. The d90 values for all sam-
ples were very similar between the two techniques, indicating that the sonication regime
used for preparing the suspensions can adequately disperse the larger particles observed
within the SEM images. After allowing the suspensions to stand for 24 hours and mea-
suring them without sonication, a shift of the maxima to lower diameters. The second
peak present within the PLA distribution with a larger maxima also disappears from the
distribution after this period. This is accompanied by a drop in the d10, d50 and d90 values
for all samples compared to the initial measurements. The most significant of these is d90
values, with the largest decrease for the pure PLA particles (1.83 µm to 0.477 µm), and
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the magnitude of this drop decreases with increasing Fe2O3 content. This effect is the
result of the larger particles within samples undergoing sedimentation and falling out of
suspension, resulting in the overall statistics shifting to smaller values for particle diame-
ter. All of these values are detailed in Table 6.4. This highlights that the smaller particle
present in each sample is able to persist in a neutral pH without sedimentation. This could
increase the efficacy of using PLA to encapsulate other inorganic UV-filtering nanopar-
ticles for application in cosmetic and sunscreen products, as a way to hinder significant
agglomeration over time.
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Figure 6.5: Particle size distribution of synthesised PLA-Fe2O3 nanocomposites from DLS mea-
surements at 0 hours and 24 hours at 100 µg mL−1.
Diffuse reflectance spectroscopy was used in order to show the difference between the
relative absorption of the solid materials in order over the ultraviolet-visible spectrum.
These results (Figure 6.6) show a very sharp absorption edge for the Z-Cote nanoparti-
cles. The onset of this is around 400 nm, right at the beginning of the visible spectrum and
shows very high reflectance in the visible range. This highly selective absorbance in the
ultraviolet range is the reason that this commercially available ZnO is used by manufactur-
ers is commercial cosmetic and sunscreen products and optical band gap of this material
was found to be 3.3 ± 0.3 eV. The reflectance curve for the hematite nanoparticles is
typical for this material, and strongly resembles the ultraviolet-visible absorption spec-




Table 6.4: Data obtained from particle size distribution for each of the PLA nanocomposites in
PBS, at a concentration of 0.1 mg mL−1.
Diameter at 0 hours (µm) Diameter after 24 hours (µm)
Sample Peak (µm) d10 d50 d90 Peak (µm) d10 d50 d90
PLA 0.399, 1.81 0.333 0.443 1.83 0.327 0.248 0.338 0.477
PLA-5 0.665 0.496 0.641 0.836 0.359 0.276 0.349 0.442
PLA-10 0.479 0.360 0.464 0.598 0.367 0.305 0.371 0.459
PLA-20 0.463 0.369 0.470 0.607 0.394 0.322 0.385 0.466
The absorption profile of the hematite nanoparticles increases sharply to 500 nm with
significant absorption in the visible range, which limits its application in commercial cos-
metic and sunscreen products and corresponds to a optical band edge of 2.10 ± 0.01 eV.
The PLA microparticles display high reflectance in the visible region, slowly increasing
in absorbance until a sharp absorption band beginning aroudn 250 nm. The bandgap of
this material was found to be 5.2 ± 0.2 eV, which shows that this material should not
absorb significant proportions of the UVA or UVB portion of the ultraviolet spectrum.
The incorporation of the hematite into the PLA nanocomposite particles results in the ap-
pearance of absorption bands around 500 and 400 nm, due to the presence of the Fe2O3
nanoparticles, matching the positions for those seen in the pure Fe2O3 sample. They all
show the same absorption feature of the pure PLA microparticles which appears at 250
nm. The PLA-10 and PLA-20 samples show very similar overall reflectance, compared to
the PLA-5 samples, indicating that there may be some wt% threshold beyond which the
Fe2O3 nanoparticles are incorporated into the nanocomposite most effectively for the ab-
sorption of light. This could be a larger portion of nanoparticles present on the surface of
the PLA microsphere, as opposed to embedded inside them, or increased agglomeration
of the Fe2O3 nanoparticles at increasing concentrations. The band gaps of each of these
materials were found to be 2.4± 0.1 eV, 2.3± 0.2 eV and 2.23± 0.02 eV for the PLA-5,
PLA-10 and PLA-20 samples, which could also be indicative of increasing agglomeration




6.2.2 Photocatalytic Dye Degradation
The relative photoactivity of the PLA-Fe2O3 with the highest hematite loading (20 wt%)
was compared to two different commercially available nanoparticles used in suncreen
formulation, Z-Cote HP1 and P-25 (6.7). The commercial TiO2 nanoparticles, P-25, are
an efficient photocatalyst and as such degraded the majority of the crystal violet ( 89%)
present in the sample after only 30 minutes of exposure. This is due to optical band gap of
TiO2 being ideal for the selective absorption of ultraviolet photons, with the resulting ex-
cited eletrons migrating to the surface of the nanoparticles and producing hydroxyl (OH.)
radicals by interacting with neighbouring water molecules. The Z-Cote HP1 nanoparticles
showed a similar response to the P-25 nanoparticles, but had a much less marked effect
on the dye, with roughly 53% of the crystal violet remaining after 30 minutes of exposure.
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Figure 6.6: Ultraviolet visible diffuse-reflectance spectroscopy displaying the relative transmit-
tance of the light through the solid nanomaterials between 200-800 nm.
As expected, the PLA-Fe2O3 nanocomposite particles had no effect and did not degrade
the crystal violet dye, producing a reponse identical to the blank sample. This would
indicate a lack of any hydroxyl radical generation from these particles as compared to the
P-25 and Z-Cote HP1 samples. These results are reflected in the linear rate constants k for
each of these samples, with P-25 having the highest (0.0315 ± 0.0003), followed by Z-





The effect of each of the nanomaterials on the cell viability of MDCK cells as determined
via MTT assay can be seen in Figure 6.8. There was no significant difference between the
control (100 ± 10 %) wells and those treated with PLA, PLA-5, PLA-10, PLA-20 MP, or
Fe2O3 NP, up to a concentration of 50 µg mL−1. This is the expected result, as it has been
well established in previous studies that PLA microparticles are extremely biocompatible,
one of the influencing factors for its use within this study. Similar can be said for Fe2O3
NP, with many previous studies highlighting its relatively low toxicity in comparison to
other metal oxide nanoparticles.
Figure 6.7: Relative absorbance at 590 nm of aliquots containing crystal violet and the indicated
nanomaterial, taken after ultraviolet exposure (left) and the linear rate constant curves for these
degredation curves (right).
These nanoparticles were synthesised through the same method as our previous work
[111], in which these particles displayed relatively low toxicity up to 100 µg mL−1
through use of a clonogenic (colony-forming) assay. As such, it’s logical that upon com-
bining these into a composite material that there is no significant decrease in the cell
viability up to similar maximum concentrations. Treating the MDCK cells with the com-
mercial ZnO however, results in a significant decrease in cell viability at 25 and 50 µg
mL−1 concentrations to 15 ± 13 % and 10 ± 3 % respectively. This is also an expected
result, given that ZnO nanoparticles are well known to be cytotoxic to cell culture due to
the generation of free radical species. As such, in the extremely likely event that these
UV filter components where able to come into contact with viable cells, our synthesised




In order to further provide the efficacy of applying these materials in commercial sun-
screen formulations, the rheological properties of the prepared emulsions were investi-
gated and compared to two sunscreen products available in Australia (Figure 6.9). These
two commercial products were packaged in a squeeze tube-type bottle (1) and a spray
bottle (2). It can be seen that the latter of these was much less viscous over the measured
shear rates, no doubt intentionally, in order to be most effectively dispensed from the spray
bottle. Both of these commercial available products feature only organic active ingredi-
ents, and as such have a very smooth, linear relationship over the tested shear rate range.
All of the sunscreens prepared for this study all fell in between these two commercially
available products, signifying that the addition of 3 wt% of the ZnO or PLA nanocompos-
ites did not have a marked effect on the rheological properties of the emulsion. Having all
been prepared from the same base emulsion, there was very little difference seen between
these.
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Figure 6.8: Effect of different nanomaterials on the cell viability of MDCK cell line at increasing
concentration following 24 hours of incubation.
It can be seen however, that at shear rates above 300/s that the emulsions featuring
the PLA particles start to become less linear, with some peaks present within the curve.
These abnormalities also become more pronounced as the wt% of the Fe2O3 becomes
higher within the nanocomposite particles, with a number of larger peaks seen in the
PLA-20 sample. A similar effect is also seen in the ZnO emulsion, with the viscosity
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steadily increasing again above these shear rates. There is a high chance that these dif-
ferences in the curves of our prepared materials to that of the commercial products is due
to the presence of the inorganic particles within them, with these particles undergoing
agglomeration at significantly high shear rates. Regardless, all of the prepared emulsions
have a viscosity that fall within the range outlined by two different commercial sunscreen
products, indicating their desirable rheological properties.
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Figure 6.9: Gloss readings from pre-painted steel panels coated with a particular sunscreen
emulsion after the specified exposure period.
Gloss readings were taken on the pre-painted steel panels after being coated with a par-
ticular sunscreen emulsion and placed on the outdoor exposure rack for 6 and 12 weeks
(Figure 6.10 & Table 6.5). There was no difference seen in the control sample (no emul-
sion) after 6 and 12 weeks, while the panels coated with the emulsions containing PLA
nanocomposite particles and ZnO nanoparticles had on average, a higher gloss value than
the control after 6 and 12 weeks. The PLA-5 sample was the only emulsion to show less
than the control after 12 weeks exposure. Both of the commercial sunscreen products
showed some decrease in gloss retention after the experimental period, with Commercial
4 product showing an enormous loss of gloss after both 6 and 12 weeks (4.4, 2.5 respec-
tively). This loss of gloss on this panel is undoubtedly through photocatalytic degradation
of the protective topcoat on the surface of the steel panels, resulting from anatase-rutile
TiO2 nanoparticles present within the commercial product. This significant result mir-
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rors that found in a previous study, which used this same outdoor exposure method, and
isolated these inorganic particles from the emulsion to show they had a similar crystal
structure to that of the commercial available TiO2 nanoparticle product P-25. The other
commercial product also showed some degradation to the surface coating, likely due to
the TiO2 particles also present within this product. A third commercial product was also
tested as a negative control, as it does not contain any inorganic filters whatsoever, and it
can be seen that this emulsion did not cause any effect on the gloss retention of the steel
panels. As all of the other emulsions tests contain some form of TiO2 nanoparticles as an
inorganic UV filter, these results confirm that the type of TiO2 used in sunscreen emulsion
can effect the photocatalytic activity of the emulsion.
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Figure 6.10: Gloss readings from pre-painted steel panels coated with a particular sunscreen
emulsion after the specified exposure period.
The results of the ultraviolet-visible transmission measurements were used to calcu-
late the SPF and PF-UVA for each prepared emulsion, and those results are displayed in
Figure 6. The emulsion containing Z Cote HPI nanoparticles had an SPF of 39 ± 1, the
lowest of all the measured emulsions. The emulsions containing the PLA nanocomposites
returned SPF values of 47 ± 4, 45 ± 3, 48 ± 4, and 45 ± 1 for PLA, PLA-5, PLA-10
and PLA-20 respectively. After performing Student’s t-test on each of these samples, and
using α =0.05 as a limit of significant, it was found that while there was no significance
between the ZnO and PLA samples, that there was indeed significant between the ZnO
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Table 6.5: Glossmeter readings taken of pre-painted steel panels following coating a sunscreen
emulsion and periods of outdoor exposure.







Commercial Sunscreen 4 4.4 2.5
Commercial Sunscreen 5 21 19
Commercial Sunscreen 6 21 25
and the PLA-5, PLA-10 and PLA-20 emulsions. There was also no significant difference
between the obtained PF-UVA values of any of the samples.
These results would suggest that these PLA-Fe2O3 nanocomposites display higher per-
formance than the commercially available ZnO nanoparticles. However, the lack of differ-
ence between the level of hematite nanoparticles would suggest that the PLA component
of the composites are the dominating factor in their performance, with the PLA emulsion
showing the same SPF rating as the PLA-5, PLA-10 and PLA-20 emulsions. There was
also no significant between the PF-UVA of each of the tested emulsions, indicating that
the nanocomposite particles can work in a similar way to the ZnO as a broadband ultravi-
olet absorber. Each of the emulsions also displayed a critical wavelength (λc) greater than
370 nm, reinforcing that the nanocomposites can allow the sunscreen emulsions to act as
broadband UV filters. There was also no significant difference between the PF-UVA of
each of the prepared emulsions, with each sample showing a value between 15-15.8 for
this metric. The ZnO sample also featured the highest UVA/UVB ratio of all of the sam-
ples (0.560± 0.002) which is due to its lower SPF value relative to the PLA nanocompos-
ite particles. The UVA/UVB ratio of the PLA nanocomposites were significantly lower
than this, showing between 0.517-0.530. These values, along with the critical wavelength
(λc), which was 373 nm for ZnO and 371 nm for the other samples (Table 6.6).
The SPF values calculated using the ultraviolet spectrophotometer method (Figure
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Figure 6.11: Sun Protection Factor and PF-UVA results for each tested emulsion.
These results show that the SPF rating of the PLA-10 (39 ± 3) and PLA-20 (39 ± 3)
emulsions were significantly higher than the PLA-5 emulsion (32 ± 2) to 99% confi-
dence, as was the ZnO (37 ± 3) with 95% confidence. The SPF rating for the PLA-10
and PLA-20 was also significantly higher than the PLA emulsion (34± 2), none of which
were significantly different from the ZnO emulsion. There was no significant difference
in the SPF ratings obtained for any of the emulsions after the ultraviolet exposure, other
than PLA-20 (28 ± 2) being significantly lower than that of PLA (34 ± 2), PLA-5 (32
± 2) and ZnO (35 ± 2) emulsions. There was no significant difference in the PF-UVA
values obtained for the each of the sunscreen emulsions, which was also the case for the
previous method. By this method, the critical wavelengths observed for each sample were
all above 370 nm. The combination of these two factors can be reflected in the UVA/UVB
ratios for each sample, with the 10 and 20 wt% nanocomposite materials showing a lower
ratio compared to other samples due to having a lower PF-UVA values than the ZnO (14.0
± 0.4 & 14 ± 1 compared to 14.8 ± 0.7) but slightly higher SPF values than the other
composites.
This testing, compared to the first SPF method, shows that there is some advantage in
the inclusion of these nanoparticles within the PLA, as the SPF rating as found through
this method increases upon increasing the loading of Fe2O3 nanoparticles to 10 wt%. The
discrepancies between the SPF ratings obtained for each of these emulsions results from
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Table 6.6: Sun Protection Factor, Protection Factor-Ultraviolet A, Ultraviolet A/Ultraviolet B
ratio and critical wavelengths (λc) for each sunscreen emulsions as tested by ISO 24443:2012.
Sample SPF PF-UVA UVA/UVB λc (nm)
ZnO 39 ± 1 15.0 ± 0.4 0.560 ± 0.002 373
PLA 47 ± 4 15.6 ± 0.9 0.530 ± 0.008 371
PLA-5 45 ± 3 15.0 ± 0.7 0.539 ± 0.004 371
PLA-10 48 ± 4 15.7 ± 0.7 0.517 ± 0.005 371
PLA-20 45 ± 1 15.8 ± 0.8 0.525 ± 0.008 371
the fact that there is some significant difference between the two techniques used to arrive
at these values. While the SPF values found for the ZnO sunscreen emulsion was the
same between the two methodologies (39 ± 1, 37 ± 3), there was a decrease between 9-
13 for each of the PLA nancomposite materials (Table 6.7). Previous studies comparing
the differences between the SPF rating found experimentally by spectroscopic methods;
using sunscreen testers; and that declared by the sunscreen manufacturer, have shown it
is possible to arrive at widely varied results for individual ultraviolet filter components of
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Figure 6.12: SPF and PF-UVA ratings for the prepared emulsions as obtained from the second
SPF method utilizing the spectrophotometer.
Despite both methods making using of sandblasted PMMA plates as a testing sub-
strate, the SPF determination using the UV2000S and Uvikon spectrophotometer show
contradictory results. Comparing these results to those obtained for the absorbance of
the material alone using diffuse reflectance spectroscopy would suggest that the second
method using the spectrophotometer is closer to the actual SPF rating of each of the
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creams. Both results show a greater UV attenuation with higher hematite mass load-
ing in the PLA particles, which is still slightly lower than that of the ZnO. This is due
to the high ultraviolet and visible attenuation of the hematite nanoparticles prepared by
this method, which should be the dominating contributor of the optical properties in this
PLA-Fe2O3 system. As these nanomaterials are one of the many ultraviolet filters present
within the emulsions, this difference is does not translate to a significant difference in
SPF rating as found with the spectrophotometer method. Further testing of these PLA-
Fe2O3 nanocomposites through other in vivo SPF methods such as the COLIPA (The
European Cosmetic Toiletry and Perfumery Association) method or ISO 24444:2010 and
AS/NZS 2604:2012 currently used to regulate products in Australia, could be used to fur-
ther explore the efficacy of PLA-metal oxide nanocomposite particles for application in
sunscreens and cosmetic products as an ultraviolet filter.
Table 6.7: SPF values obtained for the synthesized emulsions using method 2.
Sample SPF pre-exposure PF-UVA UVA/UVC λc (nm)
PLA 34 ± 2 14.4 ± 0.9 0.59 ± 0.02 371.5 ± 0.6
PLA-5 32 ± 2 13.9 ± 0.6 0.594 ± 0.006 371.5 ± 0.6
PLA-10 39 ± 3 14.0 ± 0.4 0.56 ± 0.01 372.0 ± 0.5
PLA-20 39 ± 3 14 ± 1 0.534 ± 0.009 371 ± 1
ZnO 37 ± 3 14.8 ± 0.7 0.584 ± 0.007 371.8 ± 0.5
6.3 Conclusion
In this study, we highlighted the potential application of PLA encapsulated Fe2O3 nanopar-
ticles synthesized via microemulsion for application in sunscreen and cosmetic products
as an ultraviolet filter. Emulsions containing PLA with 10-20% Fe2O3 displayed a high
SPF rating, in some cases comparable to commercially used ZnO nanoparticles. These
nanocomposites also showed significant stability after being suspending in a neutral aque-
ous environment and displayed lowered cytotoxicity and photocatalytic activity compared
to commercially available ZnO nanoparticles. Subsequent testing of the UV filtering ca-
pabilities of this composite system in sunscreen emulsions using different methodologies
is needed in order to determine its feasibility in commercial products. Encapsulating
metal oxide nanoparticles such as Fe2O3 with biocompatible polymers could provide an
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additional route to improving the SPF rating of modern commercial sunscreen formula-
tions through preventing interaction between the surface of these oxides with surrounding
organic components of the emulsion as well as increasing their dispersion properties.
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Conclusion and Future Work
In this thesis work we explored the application of iron oxide-based nanocomposites for
two distinct, but connected applications in the fields of healthcare and medicine. Expo-
sure to ultraviolet light is a known carcinogen, and regular application of sunscreens and
cosmetic products containing ultraviolet filters are an important component of harm min-
imisation strategies to lower these risks to health. Continuing to develop and improve
on the nanomaterials and ultraviolet filtering agents in these products is of commercial
interest to the cosmetics industry and in the interest of the general public, especially in
countries with higher than average yearly UV-index including Australia. Free radical
scavenging nanoparticles both have potential application in this field, as well as have a
possible future as the basis of a targeted antioxidant therapy for the treatment of oxidative
stress. Given the overarching role that free radicals and oxidative stress play in a num-
ber of diseases and injuries, antioxidant nanoparticles could provide the means for novel
forms of treatment for such conditions.
The potential free radical scavenging properties of hematite nanoparticles synthesised
precipitation and spray precipitation were also investigated as a part of this thesis work.
Given that the free radical scavenging properties of ceria nanoparticles are dependent on
certain materials properties, we tailored our hematite nanoparticles through employing
different synthesis techniques and processing variables. Through this, both spherical and
rod-like nanomaterials were obtained with varying surface characteristics, as well as op-
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tical and magnetic properties. The presence of tetrahedral-, or T-defects, surface impurity
states of maghemite were confirmed to be dependent on these synthesis parameters, as
determined by XPS and Raman characterisation. In vitro experiments conducted utilis-
ing flow cytometry highlighted the favourable uptake of the rod-shaped nanoparticles by
MDCK cells, compared to the spherical particles. The T-defects present on these spher-
ical particles influence the cytotoxicity of these nanomaterials on the MDCK cells, as
they are present at the interface between the particle and the surrounding cellular envi-
ronment. This impurity phase could be responsible for the lack of any ROS generation
or potential scavenging effects, as previous studies have shown that small maghemite
nanoparticles have pH-dependant ROS activity in vitro. While this property has already
been previously reported for maghemite nanoparticles, the ability to form such defects in
hematite nanoparticles could open up new ways to control the free radical behaviour of
such nanoparticles. This work highlighted the importance of in-depth materials charac-
terisation when assessing the cytotoxicity of nanostructured ceramic compounds, as well
as how a number of different materials properties can impact the potential application of
these new materials in biomedical applications. It also shows that free radical scavenging,
or antioxidant properties could be also tailored in other metal oxide nanoparticles. Fur-
thermore, given the role that redox reactions play within a range of chemical processes,
the influence of these maghemite defects on the surface of hematite nanoparticles could
have an influence on their catalytic properties in a range of applications including Li-ion
batteries, supercapacitors, fuel cells and dye-sensitised solar cells.
In the next chapter of this thesis work, Fe2O3/CeO2 for 2.5, 5 and 10at% Ce, core-shell
nanocomposites were synthesised for application as free radical scavenging nanocompos-
ite particles for ultraviolet filtration applications. While CeO2 is an ideal candidate for ap-
plication in sunscreens and cosmetic products, its scarcity means its high price reduces its
efficacy for widespread use. Thermally precipitated Fe2O3 nanoparticles were decorated
with ultra-small CeO2 nanoparticles, increasing their ultraviolet attenuation and optical
band gap compared to the core particles alone. Increasing the ceria content of these par-
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ticles resulted in a decrease in the mean crystalline size of the CeO2 phase, and resulted
in larger, discreet aggregates of this phase, as opposed to a more even distribution of this
phase on the surface. This was hypothesised to be due to the initial precipitation of the
ceria on the surface of the hematite particles nucleating at cracks or dislocations visible
on the surface of the Fe2O3 particles, observed from TEM images. The presence of these
particles also imparted free radical scavenging properties to the nanocomposite particles,
which was observed through photocatalytic measurements. These nanocomposites were
able to quench the OH· generated by photocatalytic TiO2 nanoparticles (P25) upon UV
exposure to prevent the degradation of crystal violet. This system creates a synergistic ef-
fect between the two properties of these distinct phases, and could provide the basis for a
novel free radical scavenging ultraviolet filter, with the aim to increase the stability of the
organic filters present within the sunscreen or cosmetic product in a cost-effective way.
Ongoing experimentation on this system is needed in order to firstly optimise the particle
size of the thermally precipitated Fe2O3 nanoparticles for the most selective absorption
in the ultraviolet. This should then be followed by further characterising the nature of
the relationship between Ce content in precipitation and rate of free radical scavenging
to establish the minimum Ce content for the desired level of enhancement. Once these
parameters within the system are fully optimised, a full assessment of the cytotoxicity of
these nanoparticles on human skin and lung cells should be performed in order to assess
any potential exposure risks. In addition, both in vivo and ex vivo skin penetration stud-
ies should also be undertaken, given the highly stable and extremely small nature of the
composite system and the surface CeO2 phase. If the particles are shown to have a negli-
gible impact on human health, then they should be prepared within sunscreen emulsions
and tested for their SPF rating to establish their efficacy for application in a tinted sun-
screen product, alongside TiO2. This technique to grow ultra-small CeO2 nanoparticles
on the surface of Fe2O3 nanoparticles as a type of heterogeneous catalyst, could provide
a method to support CeO2 for a range of applications within photocatalysis, fuel cells,
water-splitting organic reaction catalysts.
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The development of iron oxide-base nanocomposites with high ultraviolet attenuation
that are compatible with the sunscreen emulsion, such that an SPF value could be success-
fully obtained, was the first aim of this thesis work. By using a microemulsion synthesis
procedure, α-Fe2O3 nanoparticles were encapsulated by poly(lactic acid) at a concen-
tration of 5, 10 and 20 wt.% and the materials and optical properties of these particles
were investigated using a number of techniques including thermogravimetric analysis,
electron microscopy, energy dispersive X-ray spectroscopy and ultraviolet-visible diffuse
reflectance spectroscopy. The cytotoxicity in vitro of these nanocomposites on the Madin-
Darby Canine Kidney cell line, showing lowered cytotoxicity compared to commercial
ZnO nanoparticles. They also showed lower photocatalytic activity as compared to com-
mercial ZnO and TiO2 nanoparticles, which was shown through ultraviolet dye degrada-
tion studies. These nanocomposites were then incorporated into a sunscreen emulsion
containing other ultraviolet absorbers and tested for their SPF and rheological properties.
Two techniques were used in order to determine the SPF and PF-UVA of these emulsions,
and as a result there are some discrepancies on the subject of how these perform relative to
each other and the commercial ZnO nanoparticles. Furthermore, in the second SPF char-
acterization technique, the 10 and 20 wt.% nanocomposites displayed a similar SPF rating
to the emulsion containing the commercial ZnO nanoparticles. The rheological properties
of these emulsions were very favourable however, and the ability to obtain reproducible
SPF measurements from novel nanomaterials such as the PLA-Fe2O3 nanocomposites
hints to the possibility that PLA may indeed be an ideal encapsulating agent to be utilised
in increasing the efficacy of other metal oxide nanoparticles to be applied as ultraviolet
filters in sunscreen and cosmetic products. However, given the small size of the Fe2O3
nanoparticles encapsulated within the PLA microspheres, experimentation needs to be
conducted regarding their stability under extended ultraviolet exposure and elevated tem-
peratures to ensure that they are not released. Both in vivo and ex vivo skin penetration
studies should also be undertaken as mentioned for the core-shell nanocomposite particles
created in previous chapters.
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Overall, this thesis work aimed to highlight the versatility and potentially undiscovered
properties of iron-oxide nanoparticles and nanocomposite systems, specifically in relation
to their application in biomedical and cosmetic applications. Free radical species play
a role within a plethora of chemical reactions, including integral biological processes.
As such, the surface properties of any ceramic materials proposed for use within any
applications related to human health must be characterised within the context of their
interaction with these free radical species.
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A.1 Sunscreen filters
Table A.1: A list of active ingredients currently approved by the TGA for use in therapeutic
sunscreens in Australia [249].
Australian Approved Name Chemical Name Maximum Concentration
(w/w) allowed by TGA
Bemotrizinol Bis-ethylhexyloxyphenol methoxyphenol triazine, Be-













methyl sulfate, Meroxyl SO
5%




hexyl ester, Uvinul A Plus
10%









phenol, Silatrizole, Mexoryl XL
15%
Ecamsule Terephthalylidene dicamphor sulfonic acid, Mexoryl SX 10%
Homosalate Homomenthyl salicylate, 3,3,5-Trimethylcyclohexyl 2-
hydroxybenzoate
15%











Bisotrizole, Tinosorb M 10%
Octocrylene Octocrilene, 2-cyano-3,3-diphenyl acrylic acid, 2-ethyl
hexyl ester, 2-Ethylhexyl-2-cyano-3,3 diphenylacrylate,
Uvinul N
10%
Octyl methoxy-cinnamate Ethylhexyl methoxycinnamate, Octinoxate, Uvinul MC 10%
Octyl salicylate Ethylhexyl salicylate, 2-Ethylhexyl salicylate, Octisalate 5%
Octyl triazone Ethylhexyl triazone, 2,4,6-Trianalino-(p-Carbo-2’-
ethylhexyl-1’oxy)-1,3,5-triazine, Uvinul T
5%
Oxybenzone (BP-3) Benzophenone-3, 2-Benzoyl-5-methoxyphenol, Uvinul M 10%
Padimate O Ethylhexyl dimethyl PABA, 2-Ethylhexyl 4-
dimethylaminobenzoate, Octyl dimethyl PABA
8%








Polysilicone-15 Dimethicodiethylbenzalmalonate, Parsol SLX 10%
Sulisobenzone Benzophenone 4, 5-Benzoyl-4-hydroxy-2-methoxybenzene
sulphonic acid, Uvinul MS
10%
Sulisobenzone sodium Benzophenone 5, 5-Benzoyl-4-hydroxy-2-methoxybenzene
sulphonic acid, sodium salt
10%
Titanium dioxide E171 25%
Triethanolamine salicylate TEA-salicylate, Trolamine salicylate 12%
Tris-biphenyl triazine 1,3,5-Triazine, 2,4,6-tris([1,1’-biphenyl]-4-yl), Tinosorb
A2B
10%
Zinc Oxide Pigment white 4 No limit
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B.1 Thermogravimetric Analysis
The plots below show the method used to find the Tonset for the degradation of the PLA
in each of the PLA-Fe2O3 nanocomposites. A straight line was fit to the horizontal and
weight loss portions of the curve in the form of y = mx+ b. The x value of where these
lines intersected was then found using simultaneous equations, and this is the temperature
onset of the degradation curve.
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Figure B.1: TGA curves for (a) PLA and (b) PLA-5 PLA-20 nanocomposite particles, showing
the straight lines used to find the onset temperature, which is listed on the graph for each material.
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Figure B.2: TGA curves for (a) PLA-10 and (b) PLA-20 nanocomposite particles, showing the
straight lines used to find the onset temperature, which is listed on the graph for each material.
B.2 Additional Electron Microscopy Images
Transmission electron microscopy images were obtained of the commercial Z-Cote ZnO
nanoparticles using a JEOL JEM-2010. These images, shown below, display the broad
particle distribution and morphology of the ZnO particles.
Figure B.3: TEM image of commercial ZnO nanoparticles Z-Cote.
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B.3 Diffuse Reflectance Band Gap Calculation
The raw reflectance data for each sample was firstly converted into a Kebulka-munk plots,
after which F(r∞) was then used in the Tauc equation, in order to arrive at the below
plots. Extrapolating from the linear portion of each of these curves to the x-axis was then
performed in order to determine the optical band gap (Eg).
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Figure B.4: Plots used to determine that optical band gap Eg for (a) PLA microparticles and (b)
PLA-5 nanocomposite particles.
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Figure B.6: Plots used to determine that optical band gap Eg for for (e) Z Cote commercial ZnO
nanoparticles and (f) synthesized Fe2O3 nanoparticles.
B.4 Additional SPF-Derived Quantities
Table B.1: UVA/UVB and λc values for the prepared sunscreen emulsions, both before and after
exposure to 4MED.
Sample UVA/UVB λc (nm)
PLA 0.59 ± 0.02 371.5 ± 0.6
PLA-5 0.594 ± 0.006 371.5 ± 0.6
PLA-10 0.56 ± 0.01 372.0 ± 0.5
PLA-20 0.534 ± 0.009 371 ± 1
ZnO 0.584 ± 0.007 371.8 ± 0.5
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C.1 X-ray Diffraction Peak Intensity Comparison
Table C.1: Comparison of the intensities of the (104) and (110) peaks from the X-ray diffraction
pattern for the synthesised hematite nanomaterials.
Sample I(104) I(110) I(104)/I(110) Ratio
P400 592 554 1.069
P500 743 674 1.102
S250 194 393 0.494
S500 704 666 1.057
C.2 Full Raman Assignment of Hematite Nanomaterials
Figure C.1: Room temperature magnetic hysteresis curves for spray precipitation hematite
nanorods annealed at (a) 250 ◦C and (b) 500 ◦C.
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Table C.2: Assignment, position and FWHM of peaks in Raman spectra of hematite nanomate-
rials featured in Chapter 5.
Spray Precipitation 250 ◦C Spray Precipitation 250 ◦C
Assignment Position (cm−1) FWHM (cm−1) Position (cm−1) FWHM (cm−1)
A1g 224 11 225 6
Eg 243 14 244 7
Eg 294 18 291 9
Eg - - 298 9
Eg 408 14 410 11
A1g 490 16 493 18
Eg 609 27 612 16
LO 659 30 660 25
T 687 42 680 40
Precipitation 400 ◦C Precipitation 500 ◦C
Assignment Position (cm−1) FWHM (cm−1) Position (cm−1) FWHM (cm−1)
A1g 225 6 225 5
Eg 244 6 245 6
Eg 291 7 292 7
Eg 298 8 298 8
Eg 410 10 410 10
A1g 494 20 495 20
Eg 611 15 611 15
LO 659 27 660 33
T 681 39 687 32
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D.1 Tauc Plots
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Figure D.1: Tauc plots of the different nanomaterials featured in this study, highlighting how
the optical band edge (Eg) was calculated for (a) α-Fe2O3, (b) α-Fe2O3/CeO2 2.5 at%, (c) α-
Fe2O3/CeO2 5 at%, (d) α-Fe2O3/CeO2 10 at% and (e) CeO2 nanoparticles.
D.2 P25 Transmission Electron Microscopy Images
Images of the commercially available TiO2 nanoparticles, Degussa P25 were obtained
using a JEOL-JEM 2010 transmission electron microscope.
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Figure D.2: Transmission electron microscope images of Degussa P25 commercial TiO2
nanoparticles.
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